A tablet is a solid unit dosage form of medication, typically prepared by compressing a mixture of active pharmaceutical ingredients (APIs) and specialized inactive substances called excipients.
As of 2026, tablets remain the most widely manufactured and consumed dosage form globally due to their precise dosing, chemical stability, and cost-effectiveness.
1. Types of Tablets
Tablets are classified based on their design and how they release medication into the body:
| Type | Function/Characteristics | Examples |
| Film-Coated | A thin polymer layer protects the drug from light and masks bitter tastes. | Ibuprofen, Multivitamins |
| Enteric-Coated | Designed to resist stomach acid and dissolve only in the small intestine. | Aspirin (protects the stomach) |
| Effervescent | Dissolves in water with a fizzing effect for rapid absorption. | Vitamin C, Antacids |
| Modified-Release | Releases medication slowly over 12–24 hours (Sustained or Extended Release). | Metformin ER, Pain relievers |
| Dispersible | Disintegrates in a small amount of water to form a uniform suspension. | Pediatric Antibiotics |
| Sublingual/Buccal | Placed under the tongue or in the cheek for direct bloodstream absorption. | Nitroglycerin |
2. How Tablets are Manufactured
The manufacturing of tablets in 2026 is a high-tech, automated process involving several critical stages:
Sifting & Milling: Raw materials are screened to ensure uniform particle size.
Granulation: The most common step where powders are turned into granules to improve “flow” and prevent the mix from separating.
Wet Granulation: Uses a liquid binder (preferred for moisture-stable drugs).
Dry Granulation: Uses high pressure (slugging) for moisture-sensitive drugs.
Blending: Granules are mixed with lubricants (like magnesium stearate) so they don’t stick to the machinery.
Compression: A high-speed Rotary Tablet Press uses punches and dies to compress the powder into the final shape.
Coating: Tablets are placed in a rotating drum where a fine mist of coating material is applied.
3. Significance of Tablet Manufacturing in India
India is the global leader in oral solid dosage (OSD) production. In 2026, the significance of sourcing from India is rooted in:
Revised Schedule M Compliance: Indian facilities now adhere to harmonized global standards, ensuring quality equal to US and EU markets.
Massive Scale: Indian plants can produce billions of tablets annually, providing the “economies of scale” that keep global healthcare affordable.
Complex Generics: India has moved beyond simple pills into complex Triple-Layer and Targeted Release tablets.
4. Why Healthy Inc. is Your Strategic Sourcing Partner
As a Strategic Sourcing Hub, Healthy Inc. acts as your technical bridge to India’s most advanced tablet manufacturing lines.
Associated Multi-Factory Network: We are not limited to one production line. We match your specific product—whether it’s a moisture-sensitive effervescent or a complex sustained-release tablet—to the facility with the exact technical setup required.
Pharmacist-Led Technical Vetting: We evaluate the Hardness, Friability, and Dissolution profiles of every batch. We provide “straight answers” to ensure your tablets won’t crumble during shipping and will dissolve correctly in the patient’s body.
Regulatory Mastery: We provide the full suite of WHO-GMP certifications and CTD/ACTD dossiers required for you to register and sell these products in your home market.
Customization: Through our network, we offer flexible private labeling, including custom shapes (caplets, rounds, ovals) and branding.
Showing 1–500 of 652 results
Abacavir & Lamivudine Tablets.
FreeProduct Composition & Strength
We supply this product in the globally standardized “600/300” ratio, optimized for maximum efficacy with a convenient once-daily dosing schedule.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP 600 mg The Guanosine Analogue: Stops viral DNA synthesis by mimicking the guanosine building block. Lamivudine USP/BP 300 mg The Cytidine Analogue: A highly potent NRTI that works synergistically to block the reverse transcriptase enzyme. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to ensure consistent absorption and protect the APIs from environmental degradation. Abacavir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to allow for both adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP/Ph.Eur. 300 mg The Standard Dose: Usually taken twice daily as part of a multi-drug regimen. Abacavir (as Sulfate) USP/BP/Ph.Eur. 600 mg The Once-Daily Anchor: Optimized for patient compliance in simplified treatment schedules. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and protect the API from environmental degradation. Abiraterone acetate Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths designed for high-dose oncology regimens.
Active Ingredient Strength Primary Clinical Function Abiraterone Acetate USP/Ph.Eur. 250 mg The Standard Unit: Used in a 4-tablet daily regimen to reach the 1000 mg therapeutic dose. Abiraterone Acetate USP/Ph.Eur. 500 mg The High-Compliance Unit: Reduces “pill burden” for elderly patients (2 tablets daily). Excipients Micronized Matrix Enhanced Bioavailability: Engineered to ensure consistent absorption of this lipophilic (fat-soluble) molecule. Acarbose Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets. The dosing is highly dependent on patient tolerance to GI side effects.
Active Ingredient Strength (Standard) Role Acarbose USP/BP 25 mg Initiation Dose (To minimize gas) Acarbose USP/BP 50 mg Standard Maintenance Dose Acarbose USP/BP 100 mg High Carbohydrate Load Dose Excipients Q.S. Microcrystalline Cellulose / Magnesium Stearate Acebrophylline (SR) Montelukast & Fexofenadine Tablets
FreeProduct Composition & Strength
We supply this product as a Sustained-Release, Film-Coated Tablet, engineered to provide a steady-state therapeutic concentration over a full 24-hour cycle.
Active Ingredient Strength Primary Clinical Function Acebrophylline (SR) USP/BP 200 mg The Broncho-Mucolytic: Relaxes airways and thins mucus for 24-hour breathing comfort. Montelukast (as Sodium) USP/BP 10 mg The LTRA: Prevents chronic inflammation and asthma triggers in the lungs. Fexofenadine HCl USP/BP 120 mg The Antihistamine: Provides non-sedating relief from upper respiratory allergic symptoms. Acebrophylline & Montelukast Tablets
FreeProduct Composition & Strength
We supply this product as a Sustained-Release, Film-Coated Tablet, engineered to provide synchronized therapeutic levels with convenient once-daily dosing.
Active Ingredient Strength Primary Clinical Function Acebrophylline (SR) USP/BP 200 mg The Airway Opener: Provides 24-hour bronchodilation and thins thick mucus. Montelukast (as Sodium) USP/BP 10 mg The Inflammation Blocker: Prevents asthma triggers and reduces lung swelling. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide a smooth plasma curve, minimizing heart palpitations. Acebrophylline Tablets
FreeProduct Composition & Strength
We supply this product as both an Immediate-Release Tablet for acute management and a Sustained-Release (SR) Tablet for 24-hour protection.
Active Ingredient Strength Primary Clinical Function Acebrophylline USP/BP 100 mg The Standard Relief Unit: Taken twice daily to manage active symptoms of bronchitis and asthma. Acebrophylline USP/BP 200 mg SR The 24-Hour Anchor: A sustained-release format that provides consistent airway stability with once-daily dosing. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide a smooth plasma concentration curve, minimizing the risk of “Theophylline-like” side effects. Aceclofenac ,Paracetamol & Trypsin-Chymotrypsin 150000AU Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated, Enteric-Shielded Tablet to ensure the enzymes are protected from stomach acid and absorbed in the intestine.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint pain and physical swelling of the tissues. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Trypsin-Chymotrypsin 150,000 AU The Enzyme Payload: Resolves inflammation and clears edema to accelerate tissue repair. Aceclofenac , Paracetamol and Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated, Enteric-Shielded Tablet to ensure the enzyme remains active through the stomach acid.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Serratiopeptidase 15 mg The Enzyme Payload: Resolves inflammation and clears edema to accelerate tissue repair. Aceclofenac , Paracetamol and Tizanidine Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for synchronized absorption to ensure the muscle relaxant and pain reliever reach therapeutic levels at the same time.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Tizanidine (as HCl) USP/BP 2 mg The Muscle Relaxant: Relieves painful muscle spasms and improves physical mobility. Aceclofenac & Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for rapid disintegration and synchronized absorption.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Targets tissue inflammation and reduces joint stiffness. Paracetamol USP/BP 325 mg / 500 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure both APIs reach therapeutic levels within 30–60 minutes. Aceclofenac & Thiocolchicoside Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the semi-synthetic Thiocolchicoside component.
Active Ingredient Strength Primary Clinical Use Aceclofenac BP/Ph.Eur.
Thiocolchicoside INN/Ph.Eur.100 mg
4 mgStandard Orthopedic Dose: Twice-daily therapy for moderate-to-severe acute back pain and torticollis. Aceclofenac BP/Ph.Eur.
Thiocolchicoside INN/Ph.Eur.100 mg
8 mgSevere Trauma Dose: Maximum therapy for severe, immobilizing orthopedic spasms (strictly twice daily). Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for immediate gastric dissolution and rapid onset of relief) Aceclofenac Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Standard) or Sustained Release (SR) Tablets.
Active Ingredient Strength Release Type Role Aceclofenac IP/BP/USP 100 mg Immediate Release Standard Adult Dose Aceclofenac IP/BP/USP 200 mg Sustained Release (SR) Once Daily Dosing Excipients Q.S. — Disintegrant / Binder Aceclofenac, Paracetamol & Chlorzoxazone Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for synchronized absorption to ensure the muscle relaxant and pain reliever reach therapeutic levels at the same time.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Chlorzoxazone USP/BP 250 mg / 500 mg The Muscle Relaxant: Relieves painful muscle spasms and improves physical mobility. Acenocoumarol Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for the precise, micro-gram level titration required for safe anticoagulation.
Active Ingredient Strength Primary Clinical Function Acenocoumarol USP/BP/Ph.Eur. 1 mg / 2 mg The Titration Unit: Used for fine-tuning the maintenance dose to keep the INR within the target range (usually 2.0–3.0). Acenocoumarol USP/BP/Ph.Eur. 3 mg / 4 mg The Loading/Anchor Dose: Used for initial therapy or for patients requiring higher systemic anticoagulation. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and predictable pharmacokinetics. Acetaminophen & Tramadol Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized “325/37.5” ratio, optimized for maximum efficacy with minimal opioid-related side effects.
Active Ingredient Strength Primary Clinical Function Acetaminophen (Paracetamol) USP/BP 325 mg The Rapid Starter: Provides quick onset of analgesia and antipyretic (fever-reducing) effects. Tramadol Hydrochloride USP/BP 37.5 mg The Sustained Blocker: Provides moderate-to-severe pain relief via opioid and neurotransmitter pathways. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure both APIs reach therapeutic plasma levels simultaneously for a synergistic effect. Acetazolamide Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White, round). The 250 mg strength is the universal standard.
Active Ingredient Strength (Standard) Primary Role Acetazolamide USP/BP/IP 250 mg Glaucoma / Altitude Sickness / Edema Excipients Q.S. Starch / Povidone / Sodium Starch Glycolate Acetyl Salicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product in two distinct clinical ranges: the “Cardio-Shield” range and the “Analgesic-Power” range.
Active Ingredient Strength Primary Clinical Function Acetylsalicylic Acid USP/BP 75 mg / 100 mg The Cardio-Shield: Once-daily “Baby Aspirin” for long-term prevention of heart attack and stroke. Acetylsalicylic Acid USP/BP 300 mg The Emergency Loading Dose: Used immediately during a suspected heart attack to break up clots. Acetylsalicylic Acid USP/BP 500 mg The Analgesic Anchor: For the relief of headache, toothache, and musculoskeletal pain. Aciclovir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to cover everything from simple cold sores to severe shingles cases.
Active Ingredient Strength Primary Clinical Function Aciclovir USP/BP/Ph.Eur. 200 mg The Herpes Unit: Standard dose for the treatment and suppression of Herpes Simplex (HSV-1 and HSV-2). Aciclovir USP/BP/Ph.Eur. 400 mg The Prophylactic Anchor: Used for long-term suppression in immunocompromised patients. Aciclovir USP/BP/Ph.Eur. 800 mg The Zoster Payload: High-potency dose required to treat Shingles (Herpes Zoster) and Chickenpox. Acitretin Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to allow for precise clinical titration, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Acitretin USP/Ph.Eur. 10 mg The Titration Unit: Used to start therapy or for maintenance in patients sensitive to retinoids. Acitretin USP/Ph.Eur. 25 mg The Therapeutic Anchor: The standard dose for achieving rapid clearance of severe skin lesions. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption (approx. 60% bioavailability when taken with food). Activated Charcoal Tablets
FreeProduct Composition & Strength
We supply this product as a High-Density, Compressible Tablet, engineered to disintegrate rapidly in the stomach for maximum surface area exposure.
Active Ingredient Strength Primary Clinical Function Activated Charcoal USP/BP/Ph.Eur. 250 mg The GI Relief Unit: Used primarily for over-the-counter (OTC) management of gas and bloating. Activated Charcoal USP/BP/Ph.Eur. 500 mg The Emergency Payload: High-potency format for clinical detoxification and poisoning management. Excipients Binder/Disintegrant Rapid-Discharge Matrix: Engineered to ensure the charcoal particles disperse immediately upon contact with gastric fluid. Acyclovir Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated, Dispersible Tablets (often flavored/sweetened for palatability), packed in moisture-resistant blister strips.
Active Ingredient Strength Primary Clinical Use Acyclovir USP/BP/Ph.Eur. 200 mg HSV-1 & HSV-2 (Genital/Labial Herpes) Treatment Acyclovir USP/BP/Ph.Eur. 400 mg Recurrent HSV Suppression / Chronic Prophylaxis Acyclovir USP/BP/Ph.Eur. 800 mg Varicella (Chickenpox) & Herpes Zoster (Shingles) Excipients Crospovidone / Aspartame / Flavoring Agents Superdisintegrant / Sweetener / Taste-Masking Acyclovir Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets or Dispersible Tablets (DT). The dosage varies significantly based on the viral strain being treated.
Active Ingredient Strength (Standard) Primary Indication Acyclovir USP/BP/IP 200 mg Herpes Simplex (Genital/Labial) Acyclovir USP/BP/IP 400 mg Suppression / Prophylaxis Acyclovir USP/BP/IP 800 mg Shingles (Herpes Zoster) / Chickenpox Excipients Q.S. Disintegrant / Binder Adefovir Dipivoxil Tablets
FreeProduct Composition & Strengths
We supply this therapeutic in the globally accepted standard therapeutic strength optimized for adult daily maintenance therapy.
Active Ingredient Standard Strength Primary Clinical Target Adefovir Dipivoxil IP / BP / USP 10 mg The Polymerase Blocker: Daily oral dose to suppress chronic Hepatitis B viral loads. Excipients Pharma Grade The Matrix: High-stability lactose/microcrystalline cellulose binders. Adrenochrome Monosemicarbazone Tablet
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (often Orange/Red) to protect the drug from oxidation and light.
Active Ingredient Strength (Standard) Formulation Type Primary Role Adrenochrome Monosemicarbazone 10 mg Sugar Coated Tablet Minor Bleeding / Maintenance Adrenochrome Monosemicarbazone 25 mg / 30 mg Sugar Coated Tablet Surgical Prophylaxis Excipients Q.S. Titanium Dioxide / Sucrose Light Protection Coating Afatinib Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for precise dose titration based on patient tolerability.
Active Ingredient Strength Primary Clinical Function Afatinib (as Dimaleate) USP/Ph.Eur. 20 mg / 30 mg The Dose-Adjustment Unit: Used for patients requiring a lower dose due to gastrointestinal or skin toxicity. Afatinib (as Dimaleate) USP/Ph.Eur. 40 mg The Standard Therapeutic Anchor: The globally validated starting dose for first-line treatment of EGFR+ NSCLC. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive dimaleate salt and ensure consistent systemic absorption. Agomelatine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the API.
Active Ingredient Strength Primary Clinical Function Agomelatine USP/Ph.Eur. 25 mg The Therapeutic Anchor: The globally validated dose for restoring circadian rhythm and treating major depression. Excipients Proprietary Matrix Bio-Synchronized Release: Engineered to ensure a rapid $T_{max}$ (approx. 1-2 hours) to align with the body’s natural melatonin surge. Albendazole Tablet
Freeduct Composition & Strength
We supply this product as Chewable Tablets (Fruit Flavored) or Standard Film Coated Tablets. The chewable format is critical for Mass Drug Administration (MDA) in children.
Active Ingredient Strength (Standard) Formulation Type Role Albendazole USP/BP 200 mg Chewable / Film Coated Pediatric (1-2 Years) Albendazole USP/BP 400 mg Chewable (Uncoated) Standard Adult / MDA Dose Albendazole USP/BP 400 mg Film Coated Systemic Therapy Excipients Q.S. Mannitol / Orange Flavor Palatability Alendronate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White/Oval). The 70 mg strength is the international standard for weekly administration.
Active Ingredient Strength (Standard) Dosing Frequency Role Alendronate Sodium USP/BP 10 mg Once Daily Maintenance / Male Osteoporosis Alendronate Sodium USP/BP 70 mg Once Weekly Postmenopausal Osteoporosis Excipients Q.S. — Disintegrant / Filler Alfuzosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer or Capsule-in-Tablet format, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Dutasteride.
Active Ingredient Strength Primary Clinical Function Alfuzosin HCl (Extended-Release) USP/BP 10 mg The Rapid Reliever: Provides immediate improvement in urine flow by relaxing prostate muscles. Dutasteride USP/BP 0.5 mg The Long-Term Shaper: Reduces the physical size of the prostate to prevent the need for surgery. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide synchronized 24-hour therapeutic coverage with once-daily dosing. Alfuzosin Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release (ER) Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Alfuzosin Hydrochloride USP/BP 10 mg The Standard Therapeutic Anchor: The globally validated once-daily dose for moderate-to-severe BPH symptoms. Excipients Extended-Release Matrix Controlled-Delivery System: Engineered to provide synchronized 24-hour therapeutic coverage, eliminating the need for multiple daily doses. Allopurinol Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration).
Active Ingredient Strength (Standard) Role Allopurinol IP/BP/USP 100 mg Initial Dose / Renal Adjustment Allopurinol IP/BP/USP 300 mg Standard Maintenance Dose Excipients Q.S. Binder / Disintegrant Allylestrenol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bio-Stable Tablet, packed in high-barrier Alu-Alu blister strips to ensure hormonal stability.
Active Ingredient Strength Primary Clinical Function Allylestrenol USP/BP/Ph.Eur. 5 mg The Standard OB-GYN Anchor: The globally validated dose for maintaining the corpus luteum and supporting the early placenta. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure rapid oral absorption and high plasma concentration to provide immediate uterine stability. Alpelisib Tablets
FreeProduct Composition & Strength
We supply this product in standardized daily dose packs, designed to achieve the 300 mg daily therapeutic target.
Active Ingredient Strength Primary Clinical Function Alpelisib USP/Ph.Eur. 50 mg / 150 mg The Combination Unit: Used together (150mg x 2) to reach the standard 300mg daily dose. Alpelisib USP/Ph.Eur. 200 mg The Dose-Reduction Unit: Used for patients requiring a lower dose due to side effects (Hyperglycemia/Rash). Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive API and ensure consistent systemic absorption. Alpha Ketoanalogue Tablets
FreeProduct Composition & Strength
We supply this product as a Multi-Mineral, Amino Acid Complex, carefully balanced to meet the Nutritional Requirements of Uremic Patients.
Component (Active) Amount per Tablet Clinical Function Alpha-Keto-Isoleucine / Leucine / Valine / Phenylalanine Calcium Salts The Protein Builders: Converted into essential amino acids using waste nitrogen. Alpha-Hydroxy-Methionine Calcium Salt The Sulfur Source: Provides the essential hydroxy-analog of methionine. L-Lysine / L-Threonine / L-Tryptophan Acetate/Pure Form Essential Amino Acids: Direct supplementation of AA that the body cannot synthesize. L-Histidine / L-Tyrosine Pure Form Conditional Amino Acids: Critical for maintaining nitrogen balance in renal failure. Calcium Content ~50 mg (approx) Phosphate Binder Support: Provides calcium which helps in managing hyperphosphatemia. Alprazolam & Sertraline Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Sertraline (as HCl) USP/BP 25 mg / 50 mg The Antidepressant Anchor: Provides long-term correction of serotonin levels to treat depression and OCD. Alprazolam USP/BP 0.25 mg / 0.5 mg The Anxiolytic Bridge: Provides rapid relief from acute anxiety and prevents panic spikes. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid release of Alprazolam for immediate relief while Sertraline maintains steady-state plasma levels. Alprostadil Tablets
FreeProduct Composition & Strength
We supply this product in high-purity oral and specialized dispersible formats, primarily for hospital and specialist use.
Active Ingredient Strength Primary Clinical Function Alprostadil USP/BP/Ph.Eur. 0.5 mg The Neonatal Unit: Used in controlled hospital settings for maintaining ductal patency in infants with congenital heart defects. Alprostadil USP/BP/Ph.Eur. 1 mg The Vascular/Urology Anchor: Used for severe peripheral vascular disease or refractory erectile dysfunction. Excipients Proprietary Matrix Bio-Stable System: Engineered to prevent the rapid degradation of the sensitive prostaglandin molecule during transit. Aluminium hydroxide Magnesium Trisilicate Tablet
FreeProduct Composition & Strength
We supply this product as Chewable Tablets (Mint/Orange Flavor). The chewable format is essential to increase the surface area for rapid reaction.
Active Ingredient Strength (Standard) Role Dried Aluminium Hydroxide Gel USP/BP 250 mg Acid Neutralizer / Astringent Magnesium Trisilicate USP/BP 500 mg Acid Neutralizer / Adsorbent Excipients Q.S. Mannitol / Menthol (Flavor) Amantadine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed in moisture-resistant Alu-Alu or Alu-PVC blister strips.
Active Ingredient Strength Primary Clinical Function Amantadine Hydrochloride USP/BP 100 mg The Standard Therapeutic Anchor: The globally validated dose for both Parkinsonian motor control and antiviral prophylaxis. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 to 4 hours for reliable daily protection. Ambrisentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Ambrisentan USP/Ph.Eur. 5 mg The Initiation Unit: The standard starting dose for adults to establish tolerance and initial pulmonary dilation. Ambrisentan USP/Ph.Eur. 10 mg The Maximum Maintenance Payload: For patients requiring additional symptomatic improvement after the 5 mg dose. Excipients Proprietary Matrix Bio-Optimized System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 hours for reliable daily protection. Amiloride & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized strength ratio, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amiloride (as HCl) USP/BP 5 mg The Potassium Guard: Prevents the loss of potassium, protecting against heart arrhythmias and muscle weakness. Hydrochlorothiazide USP/BP 50 mg The Volume Reducer: Excretes excess sodium and water to reduce the load on the heart and vessels. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure a consistent diuretic effect over a full 24-hour cycle. Aminosalicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Delayed-Release (DR) Tablet, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function 4-Aminosalicylic Acid USP/BP 500 mg The Standard Titration Unit: Allows for gradual dose escalation to manage gastrointestinal side effects. 4-Aminosalicylic Acid USP/BP 1000 mg The Maintenance Payload: High-dose format for adult MDR-TB regimens requiring up to 8–12g daily. Excipients Acid-Resistant Polymer Enteric Shield System: Engineered to bypass the stomach and release the API in the upper intestine for maximum absorption. Amiodarone Tablet
FreeProduct Composition & Available Strengths
We manufacture Amiodarone in standard, internationally recognized strengths to allow for the intensive loading phase and lower maintenance doses required in cardiology.
Active Ingredient Standard Strengths Primary Clinical Target Amiodarone HCl BP / IP / USP 100 mg Low-Dose Maintenance: For fine-tuned long-term rhythm control and geriatric titration. Amiodarone HCl BP / IP / USP 200 mg Standard Therapy: Used for initial institutional oral loading phases and standard daily maintenance. Amisulpride Tablets
FreeProduct Composition & Strength
We supply this product in a full range of strengths to facilitate both low-dose “Disthymia” protocols and high-dose “Schizophrenia” maintenance.
Active Ingredient Strength Primary Clinical Function Amisulpride USP/BP 50 mg / 100 mg The Negative Symptom Unit: Used to treat social withdrawal, depression, and lack of initiative. Amisulpride USP/BP 200 mg The Transition Anchor: Used for moderate psychosis or as a step-up dose during titration. Amisulpride USP/BP 400 mg The Positive Symptom Payload: High-potency dose for acute psychotic episodes and hallucinations. Amitriptyline & Chlordiazepoxide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Amitriptyline (as HCl) USP/BP 12.5 mg / 25 mg The Antidepressant Anchor: Elevates mood and energy levels by modulating neurotransmitter reuptake. Chlordiazepoxide USP/BP 5 mg / 10 mg The Anxiolytic Shield: Provides rapid relief from nervousness, agitation, and muscle tension. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid onset of the anxiolytic effect while the antidepressant effect builds over time. Amitriptyline Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often Blue, Yellow, or Orange depending on strength) to mask the intensely bitter taste of the API.
Active Ingredient Strength (Standard) Primary Role Amitriptyline HCl IP/BP/USP 10 mg Neuropathic Pain / Migraine / Sleep Amitriptyline HCl IP/BP/USP 25 mg Pain / Depression Initiation Amitriptyline HCl IP/BP/USP 50 mg Major Depression (Maintenance) Amitriptyline HCl IP/BP/USP 75 mg High Potency / Severe Depression Amlodipine & Enalapril Maleate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets to protect the Enalapril Maleate from moisture-induced degradation and to ensure the physical integrity of the combination.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker (CCB) Enalapril Maleate BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Sodium Stearyl Fumarate / Lactose Lubricant & Stabilizer Amlodipine & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Amlodipine (as Besylate) USP/BP 5 mg / 10 mg The Vasodilator: Reduces the resistance of blood vessels to lower systemic pressure. Hydrochlorothiazide USP/BP 12.5 mg / 25 mg The Volume Reducer: Excretes excess sodium and water to reduce circulatory load. Excipients Proprietary Matrix Steady-State System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Amlodipine Besylate & Losartan Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The formulation is optimized for 24-hour efficacy, allowing for convenient once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine Besylate BP/USP 5 mg Calcium Channel Blocker (CCB) Losartan Potassium BP/USP 50 mg Angiotensin Receptor Blocker (ARB) Excipients Q.S. Microcrystalline Cellulose / Starch Stabilizing Core Matrix Amlodipine Tablet
FreeAmlodipine Tablets IP 5 mg
Each Uncoated tablet contains :
Amlodipine Besylate IP
Eq to Amlodipine 5 mgAmlodipine Tablets IP 10 mg
Each Uncoated Tablet Contains :
Amlodipine Besylate IP
Eq To Amlodipine 10 mgAmlodipine Besylate Tablets IP 2.5 mg
Each uncoated tablet contains :
Amlodipine Besylate IP
Eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 2.5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 5 mgAMLODIPINE & ENALAPRIL MALEATE TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Enalapril Maleate 5 mg
Excipients q.sAMLODIPINE & LISINOPRIL TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Lisinopril dihydrate
Eq. To Lisinopril 5 mg
Excipients q.sTRIPPLEACE AMLODIPINE -10 / AMLODIPINE
TABLETS 10 MG
Each uncoated tablet contains:
Amlodipine Besilate BP
Equivalent to Amlodipine 10 mg
Excipients Q.S.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – hypertensive, Cardiovascular Agent,
Amlodipine With Lisinopril Dehydrate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The use of Lisinopril in its Dihydrate form ensures superior stability and predictable dissolution profiles.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker Lisinopril (as Dihydrate) BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Calcium Phosphate / Mannitol Stabilizing Agents Amodiaquine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Yellow) or Film Coated Tablets. The strength is typically expressed in terms of the Amodiaquine Base.
Active Ingredient Strength (Base Equivalent) Salt Content (Approx) Role Amodiaquine HCl USP/BP 67.5 mg ~ 90 mg Pediatric (ACT Component) Amodiaquine HCl USP/BP 153 mg / 150 mg ~ 200 mg Adolescent / Co-blistered Amodiaquine HCl USP/BP 200 mg ~ 260 mg Standard Adult Dose Excipients Q.S. Microcrystalline Cellulose / Magnesium Stearate Direct Compression Amoxapine Tablets
FreeProduct Composition & Strength
We supply this product in a full range of strengths to allow for precise clinical titration, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amoxapine USP/BP 25 mg / 50 mg The Titration Unit: Used for gradual dose escalation to minimize initial sedative effects. Amoxapine USP/BP 100 mg The Standard Anchor: The primary maintenance dose for outpatients with moderate depression. Amoxapine USP/BP 150 mg The High-Potency Payload: For hospitalized patients with severe psychotic or endogenous depression. Amoxicillin & Potassium Clavulanate Dispersible Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized 7:1 ratio, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Clavulanate.
Active Ingredient Strength Primary Clinical Function Amoxicillin (as Trihydrate) USP/BP 200 mg / 400 mg The Growth Inhibitor: Destroys the bacterial cell wall across a broad range of pathogens. Potassium Clavulanate USP/BP 28.5 mg / 57 mg The Resistance Shield: Neutralizes bacterial enzymes, allowing Amoxicillin to function. Excipients Sweetened Matrix Pediatric-Friendly System: Engineered with pleasant fruit flavors to ensure 100% child compliance. Amoxicillin & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, ultra-low moisture Alu-Alu blister strips (often containing integrated desiccants) to ensure the absolute stability of the incredibly hygroscopic Clavulanate salt.
Active Ingredient Strength Primary Clinical Function Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.500 mg
125 mg
(Total: 625 mg)Standard Adult Dose: Therapy for moderate RTIs, dental infections, and skin infections. Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.875 mg
125 mg
(Total: 1000 mg)High-Dose Adult Therapy: Aggressive intervention for severe pneumonia, severe sinus infections, and bite wounds. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Moisture Scavenger (Engineered for immediate gastric dissolution) *Pack Sizes: 1×6 or 1×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-7 day acute antibiotic regimens).
Amoxicillin Trihydrate Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Fruit-Flavored Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Amoxicillin (as Trihydrate) USP/BP 125 mg The Pediatric Starter: Ideal for infants and toddlers requiring low-dose respiratory or ear infection therapy. Amoxicillin (as Trihydrate) USP/BP 250 mg The Junior Anchor: The standard dose for older children and adolescents for broad-spectrum anti-infective coverage. Excipients Sweetened Matrix Taste-Masking System: Engineered with pleasant flavors (Strawberry/Pineapple/Orange) to overcome the natural bitterness of the antibiotic. Amoxycillin , Cloxacillin And Lactic Acid Bacillus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet or Capsule, packed in high-barrier Alu-Alu blister strips to ensure the stability of the live probiotic spores.
Active Ingredient Strength Primary Clinical Function Amoxycillin (as Trihydrate) USP/BP 250 mg The Growth Inhibitor: Destroys the bacterial cell wall across a broad range of pathogens. Cloxacillin (as Sodium) USP/BP 250 mg The Defense Breaker: Specifically neutralizes bacterial enzymes, making the treatment effective against “Staph” infections. Lactic Acid Bacillus (LAB) 1.5 Billion Spores The Biological Shield: Replenishes healthy gut bacteria to prevent diarrhea and boost immunity. Amoxycillin & Dicloxacillin Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dispersible Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.
Active Ingredient Strength Primary Clinical Function Amoxycillin (as Trihydrate) USP/BP 125 mg / 250 mg The Growth Inhibitor: Destroys the bacterial cell wall across a broad range of common pathogens. Dicloxacillin (as Sodium) USP/BP 125 mg / 250 mg The Enzyme Bodyguard: Specifically neutralizes bacterial defenses, making the treatment effective against “Staph” infections. Excipients Sweetened Matrix Pediatric-Friendly System: Engineered with non-bitter, pleasant flavors (Pineapple/Orange) to ensure child compliance. Amoxycillin Dispersible Kid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Fruit-Flavored Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Amoxycillin (as Trihydrate) USP/BP 125 mg The Pediatric Starter: Ideal for infants and toddlers requiring low-dose respiratory or ear infection therapy. Amoxycillin (as Trihydrate) USP/BP 250 mg The Junior Anchor: The standard dose for older children and adolescents for broad-spectrum anti-infective coverage. Excipients Sweetened Matrix Taste-Masking System: Engineered with pleasant flavors (Strawberry/Pineapple/Orange) to overcome the natural bitterness of the antibiotic. Anastrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Anastrozole USP/Ph.Eur. 1 mg The Standard Oncology Anchor: The globally validated dose for both adjuvant and first-line treatment of advanced breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust, ensuring safety for healthcare workers. Antacid & Anti-Ulcerant Tablets
FreeTechnical & Logistics Specifications
Parameter Specifications & Standards HS Code 3004.90.99 (Medicaments acting on the alimentary tract and metabolism) Pharmacopeia Compliance IP / BP / USP / EP Dosage Formats Enteric-Coated, Delayed-Release, Film-Coated, and Chewable Tablets Export Packaging 10 / 14 / 15 Tablets per Blister packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) or thick PVC/PVDC matrixes to protect against moisture ingress in Zone IVb tropical climates. Shelf-Life Stability Fully validated 36-Month real-time stability metrics Apixaban Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Apixaban USP/Ph.Eur. 2.5 mg The Dose-Reduction Unit: Used for patients with specific risk factors (Age ≥80, Weight ≤60kg, or high Creatinine) to minimize bleeding. Apixaban USP/Ph.Eur. 5 mg The Therapeutic Anchor: The standard maintenance dose for stroke prevention in Atrial Fibrillation and DVT treatment. Excipients Proprietary Matrix Rapid-Dissolution System: Engineered to ensure a consistent $T_{max}$ of approx. 3 to 4 hours for reliable protection. Apremilast tablets
FreeProduct Composition & Strength
We supply this product in a standardized titration pack format or individual strengths to ensure patient safety during the initial phase.
Active Ingredient Strength Primary Clinical Function Apremilast USP/Ph.Eur. 10 mg / 20 mg The Titration Unit: Used during the first 5 days of therapy to minimize gastrointestinal side effects. Apremilast USP/Ph.Eur. 30 mg The Therapeutic Anchor: The standard maintenance dose for long-term control of Psoriasis and Psoriatic Arthritis. Excipients Proprietary Matrix Bio-Synchronized Release: Engineered to ensure a consistent $T_{max}$ of approx. 2.5 hours for steady-state immune modulation. Aripipralzole Tablets
FreeProduct Composition & Strength
We supply this product in a wide range of strengths to allow for precise clinical titration, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Aripiprazole USP/Ph.Eur. 2 mg / 5 mg The Titration/Adjunct Unit: Used for initial dosing or as an add-on for Major Depressive Disorder. Aripiprazole USP/Ph.Eur. 10 mg / 15 mg The Standard Anchor: The primary maintenance dose for Schizophrenia and Bipolar Disorder. Aripiprazole USP/Ph.Eur. 20 mg / 30 mg The High-Potency Payload: For acute manic episodes or treatment-resistant cases under specialist care Artemether & Lumefantrine Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Yellow) or Dispersible Tablets (Sweetened for Pediatrics). The standard regimen is a fixed ratio of 1:6.
Strength Variant Artemether Content Lumefantrine Content Target Patient Standard / Pediatric 20 mg 120 mg Infants & Children (5kg–35kg) Double Strength (DS) 40 mg 240 mg Adolescents / Simplified Dosing Adult Forte (80/480) 80 mg 480 mg Adults (>35kg) – High Compliance Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Artesunate & Mefloquine Tablet
FreeProduct Composition & Compliance Configurations
We supply this combination in both co-formulated Fixed-Dose Combination (FDC) single tablets and customized, color-coded co-blistered kits calibrated for adult and pediatric treatment regimens.
Product Packaging Format Active Ingredient Mix (per Dose) Target Patient Cohort Primary Clinical Function Pediatric Compliance FDC 25 mg Artesunate + 55 mg Mefloquine Infants & Children (6 months to less than 7 years) Micro-Dose Accuracy: Optimized for easy pediatric disintegration and ingestion. Adolescent Strength FDC 100 mg Artesunate + 220 mg Mefloquine Youth & Teenagers (7 years to less than 14 years) Intermediate Titration: Ensures balanced dosing without neuro-toxicity risks. Adult Potency FDC / Kit 100 mg + 220 mg (2 Tablets/Day for 3 days) or 200 mg + 440 mg Adults & Children over 14 years Full Strength Treatment: Maximizes biomass eradication in multi-drug resistant zones. Artesunate & Sulphadoxine-Pyrimethamine Tablets
FreeProduct Composition & Kit Configuration
We supply this product in standardized, age-titrated Fixed-Dose Combination (FDC) Blister Strips, commonly containing a 3-day course of Artesunate tablets alongside a single-dose treatment of Sulfadoxine-Pyrimethamine.
Component Tablet Type Active Ingredient Mix Standard Strengths (per Tablet) Primary Clinical Function Artesunate Tablet Artesunate 50 mg / 100 mg / 200 mg The Fast Cleaver: Clears parasite biomass over 3 consecutive days. Sulfadoxine-Pyrimethamine Tablet Sulfadoxine + Pyrimethamine 500 mg + 25 mg The Extended Shield: Single-dose companion to prevent recrudescence. Artesunate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. Stability is a key factor in our formulation.
Active Ingredient Strength (Standard) Role Artesunate IP/BP 50 mg Pediatric / Initial Dose Artesunate IP/BP 100 mg Adult Standard Dose Artesunate IP/BP 200 mg High Strength (Combination Protocols) Ascorbic Acid Tablet
FreeProduct Composition & Strength
We supply this product as Chewable Tablets (Sugar/Sugar-Free) or Film Coated Tablets (Swallowable).
Active Ingredient Strength (Standard) Form Role Ascorbic Acid IP/BP/USP 100 mg Uncoated / Coated Pediatric / Maintenance Ascorbic Acid IP/BP/USP 500 mg Chewable (Orange) Standard Adult Dose Ascorbic Acid IP/BP/USP 1000 mg Chewable / Effervescent High Potency / Immunity Sodium Ascorbate Var. Buffered Salt Reduced Acidity Variant Aspirin Tablets
FreeProduct Composition & Strength
We supply this product in various formats, including Gastro-resistant (Enteric-coated), Dispersible, and standard Film-coated tablets.
Active Ingredient Strength Primary Clinical Function Aspirin (Acetylsalicylic Acid) 75 mg / 81 mg The Cardiac Shield: Low-dose daily therapy for the prevention of heart attack and stroke. Aspirin (Acetylsalicylic Acid) 150 mg Post-Surgical Maintenance: Used for patients with stents or high-risk vascular profiles. Aspirin (Acetylsalicylic Acid) 300 mg / 500 mg The Analgesic Anchor: High-dose relief for acute pain, migraine, and rheumatic fever. Atazanavir & Ritonavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour viral suppression.
Active Ingredient Strength Primary Clinical Function Atazanavir (as Sulfate) USP/BP 300 mg The Antiviral Anchor: Blocks the maturation of HIV, preventing the spread of infection to CD4 cells. Ritonavir USP/BP 100 mg The Pharmacokinetic Booster: Inhibits liver metabolism to maintain high Atazanavir levels for 24 hours. Excipients Proprietary Matrix Bio-Enhancement System: Engineered to ensure maximum intestinal absorption, which is critical for PI-class medications. Atenolol & Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The combination is engineered to maintain therapeutic plasma levels over a 24-hour period, supporting once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Atenolol BP/USP 50 mg / 100 mg Cardioselective Beta-Blocker Chlorthalidone BP/USP 12.5 mg / 25 mg Long-acting Diuretic Excipients Q.S. Magnesium Stearate / Povidone Stabilizing Core Matrix Atenolol & Indapamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 50 mg The Heart Rate Regulator: Controls cardiac output and myocardial oxygen demand. Indapamide USP/BP 2.5 mg The Metabolic-Neutral Diuretic: Reduces blood volume and provides direct vascular relaxation. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Atenolol & S-Amlodipine Besylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, utilizing high-purity S-Amlodipine Besylate to ensure stability.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 25 mg / 50 mg The Heart Rate Regulator: Controls the “Pump” by reducing heart rate and myocardial oxygen demand. S-Amlodipine (as Besylate) USP/BP 2.5 mg / 5 mg The Vessel Relaxant: Pure chiral isomer for maximum vasodilation with minimum side effects (edema). Excipients Proprietary Matrix Chiral-Stability System: Engineered to ensure the S-enantiomer remains stable and does not racemize during the shelf-life. Atenolol Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (often scored for dosage adjustment).
Active Ingredient Strength (Standard) Role Atenolol IP/BP/USP 25 mg Low Dose / Renal Impairment Atenolol IP/BP/USP 50 mg Standard Adult Dose Atenolol IP/BP/USP 100 mg High Potency / Angina Excipients Q.S. Binder / Disintegrant Atorvastatin & Aspirin and Clopidogrel Tablets
FreeProduct Composition & Strength
We supply this product typically in a Capsule-in-Capsule or Multi-Particulate Tablet format to ensure the chemical stability of the three distinct APIs.
Active Ingredient Strength Primary Clinical Function Atorvastatin (as Calcium) USP 10 mg / 20 mg The Lipid Stabilizer: Lowers cholesterol and prevents the growth of arterial blockages. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Primary Blood Thinner: Prevents initial platelet activation via the COX pathway. Clopidogrel (as Bisulphate) USP 75 mg The Secondary Blood Thinner: Provides high-level protection against stent thrombosis and recurrent stroke. Atorvastatin & Asprin Tablets
FreeProduct Composition & Strength
We supply this product as a Bi-Layered or Film-Coated Tablet, often utilizing specialized enteric coating for the Aspirin component to protect the stomach lining.
Active Ingredient Strength Primary Clinical Function Atorvastatin Calcium USP/BP 10 mg / 20 mg The Lipid Regulator: Controls cholesterol synthesis in the liver and stabilizes arterial walls. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Anti-Platelet Anchor: Provides low-dose blood thinning to prevent clot formation. Excipients Proprietary Matrix Gastro-Protective System: Engineered to ensure Aspirin dissolves only in the small intestine, minimizing gastric irritation. Atorvastatin Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The active ingredient is used in the amorphous or crystalline form depending on bioavailability requirements.
Active Ingredient Strength (Standard) Role Atorvastatin Calcium IP/BP/USP 10 mg Primary Prevention / Maintenance Atorvastatin Calcium IP/BP/USP 20 mg Standard Therapeutic Dose Atorvastatin Calcium IP/BP/USP 40 mg High Intensity Therapy Atorvastatin Calcium IP/BP/USP 80 mg Acute Coronary Syndrome Azathioprine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Yellow/Pale Yellow) in blister packs or bulk containers.
Active Ingredient Strength (Standard) Role Azathioprine USP/BP 50 mg Standard Adult Dose Azathioprine USP/BP 25 mg Low Dose / Renal Adjustment Excipients Q.S. Binder / Coating Agent Azilsartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the Medoxomil ester.
Active Ingredient Strength Primary Clinical Function Azilsartan Medoxomil Potassium 40 mg The Standard Initiation Unit: The primary starting dose for most adult patients with hypertension. Azilsartan Medoxomil Potassium 80 mg The High-Potency Payload: For patients requiring additional blood pressure lowering beyond the 40 mg dose. Excipients Proprietary Matrix Hydrolysis-Stable System: Engineered to prevent premature breakdown of the prodrug before it reaches the gastrointestinal tract. Azithromycin & Cefixime tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to prevent the degradation of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/BP 200 mg The Gram-Negative Specialist: Targets the cell walls of stubborn bacteria, highly effective in Typhoid and Bronchitis. Azithromycin (as Dihydrate) USP/BP 250 mg / 500 mg The Tissue-Penetrating Anchor: Provides prolonged activity in the lungs and soft tissues to eliminate intracellular pathogens. Excipients Proprietary Matrix Dual-Release System: Engineered to ensure synchronized absorption of both antibiotics despite their different chemical solubilities. Azithromycin Dispersible Tablet
FreeProduct Composition & Strength
We supply this product as Dispersible Tablets (DT) with advanced taste-masking technology.
Active Ingredient Strength Flavor Profile Role Azithromycin IP/BP/USP 100 mg Orange / Peppermint Pediatric Low Dose Azithromycin IP/BP/USP 250 mg Orange / Peppermint Pediatric Standard / Adult Excipients Q.S. Sweeteners Disintegrant / Flavor Azithromycin Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is essential to mask the extremely bitter taste and facilitate swallowing.
Active Ingredient Strength (Standard) Standard Regimen Primary Role Azithromycin Dihydrate USP/BP 250 mg 6 Tablets (3-5 Days) Step-down Therapy / Pediatric Azithromycin Dihydrate USP/BP 500 mg 3 Tablets (3 Days) Respiratory Infections / Typhoid Azithromycin Dihydrate USP/BP 1000 mg (1 g) 1 Tablet (Single Dose) STI (Chlamydia / Gonorrhea) Excipients Q.S. Pregelatinized Starch / HPMC Disintegration / Coating Baclofen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Baclofen USP/BP/Ph.Eur. 10 mg The Standard Titration Unit: The primary dose used for gradual escalation to determine patient tolerance and efficacy. Baclofen USP/BP/Ph.Eur. 20 mg The Maintenance Payload: High-potency dose for patients with severe spasticity from chronic spinal cord injuries. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure a predictable $T_{max}$ (time to peak concentration) of 1 to 2 hours for fast relief. Baricitinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Baricitinib USP/Ph.Eur. 2 mg The Standard RA Anchor: The primary maintenance dose for adult patients with moderate-to-severe Rheumatoid Arthritis. Baricitinib USP/Ph.Eur. 4 mg The Dermatology/Severe Payload: High-potency dose utilized for Alopecia Areata and severe Atopic Dermatitis protocols. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure a consistent pharmacokinetic profile (Tmax of approx. 1 hour) for predictable immune suppression. Benfotiamine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu or Alu-PVC blister strips.
Active Ingredient Strength Primary Clinical Function Benfotiamine USP/Ph.Eur. 100 mg / 150 mg The Neuropathy Anchor: Standard daily dose for the prevention of diabetic complications and nerve maintenance. Benfotiamine USP/Ph.Eur. 300 mg The Therapeutic Max-Payload: High-potency dose for clinical management of established Peripheral Neuropathy and Retinopathy. Excipients Proprietary Matrix Lipid-Enhanced System: Engineered to ensure maximum intestinal uptake and stable plasma concentrations. Benzhexol Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets. The chemical name Benzhexol and Trihexyphenidyl refer to the exact same molecule.
Active Ingredient Strength (Standard) Role Trihexyphenidyl HCl (Benzhexol) 2 mg Initial Dose / Mild EPS Trihexyphenidyl HCl (Benzhexol) 5 mg Forte / Maintenance Dose Excipients Q.S. Binder / Filler Benzthiazide & Triamterene Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Benzthiazide USP/BP 25 mg The Thiazide Payload: The primary driver for sodium and water excretion to lower blood pressure. Triamterene USP/BP 50 mg The Potassium Guardian: Physically prevents the loss of Potassium (K+) during the diuretic process. Excipients Proprietary Matrix Bio-Balance System: Engineered to ensure synchronized dissolution of both active APIs for maximum clinical synergy. Betahistine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active dihydrochloride salt.
Active Ingredient Strength Primary Clinical Function Betahistine Dihydrochloride USP/Ph.Eur. 8 mg / 16 mg The Standard Maintenance Anchor: Ideal for long-term management of vertigo and tinnitus. Betahistine Dihydrochloride USP/Ph.Eur. 24 mg / 48 mg The Therapeutic Payload: High-potency dose for acute phases of Meniere’s Disease and severe vestibular dysfunction. Excipients Proprietary Matrix Gastric-Gentle System: Engineered to ensure rapid absorption while minimizing the common “histamine-like” gastric irritation. Betamethasone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Soluble Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive sodium phosphate salt.
Active Ingredient Strength Primary Clinical Function Betamethasone Sodium Phosphate BP/USP 0.5 mg The Maintenance Anchor: Standard dose for chronic inflammatory conditions and pediatric allergy management. Betamethasone Sodium Phosphate BP/USP 1 mg (Forte) The Crisis Payload: High-potency therapeutic dose for acute asthma, severe eczema, and drug reactions. Excipients Proprietary Matrix Instant-Dispersible System: Engineered to dissolve in seconds, ensuring maximum bioavailability and ease of administration. Bethanecol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in secure Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Bethanechol Chloride USP/BP 10 mg The Pediatric & Titration Unit: Ideal for initial dosing or mild cases of gastric atony. Bethanechol Chloride USP/BP 25 mg The Urology Anchor: The standardized therapeutic dose for managing post-operative urinary retention. Excipients Proprietary Matrix Acid-Stable Formulation: Engineered to survive the gastric environment for consistent intestinal absorption. Betnesol forte 1mg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Soluble Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive sodium phosphate salt.
Active Ingredient Strength Primary Clinical Function Betamethasone Sodium Phosphate BP/USP 1 mg The Crisis Anchor: High-potency therapeutic dose for short-term management of acute asthma, severe eczema, and drug reactions. Excipients Proprietary Matrix Instant-Dispersible System: Engineered to dissolve in seconds, ensuring maximum bioavailability and ease of administration for all age groups Bicalutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bicalutamide USP/Ph.Eur. 50 mg The Metastatic Anchor: Used in combination with a LHRH analogue (medical castration) for advanced metastatic disease. Bicalutamide USP/Ph.Eur. 150 mg The Monotherapy Payload: Utilized as a standalone treatment for locally advanced, non-metastatic prostate cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Biotin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Biotin USP/BP (Vitamin H) 5 mg The Standard Maintenance Unit: The definitive therapeutic dose for treating brittle nails and mild hair thinning. Biotin USP/BP (Vitamin H) 10 mg The Therapeutic Max-Payload: High-potency dose utilized for severe deficiency, advanced dermatology protocols, and metabolic support. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure 100% water solubility for immediate intestinal absorption. Biperiden Tablets
FreeProduct Composition & Strength
We supply this product as Tablets (usually White, scored). The 2 mg strength is the global standard for titration.
Active Ingredient Strength (Standard) Primary Role Biperiden Hydrochloride USP/BP 2 mg Standard Therapeutic Dose Excipients Q.S. Lactose Monohydrate / Maize Starch Filler / Binder Bisacodyl Tablets
FreeProduct Composition & Strength
We supply this product as Enteric Coated Tablets (Gastro-resistant). The specialized coating is non-negotiable to prevent gastric irritation.
Active Ingredient Strength (Standard) Formulation Type Primary Role Bisacodyl USP/BP 5 mg Enteric Coated (Sugar or Film) Standard Adult Dose Bisacodyl USP/BP 10 mg Enteric Coated Strong Dose / Bowel Prep Excipients Q.S. Methacrylic Acid Copolymer (Enteric) pH-Dependent Release Bisoprolol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (distinctively shaped/scored). The low-dose range is critical for the “Start Low, Go Slow” titration required in heart failure.
Active Ingredient Strength (Standard) Shape/Color Primary Role Bisoprolol Fumarate USP/BP 2.5 mg White (Scored) Heart Failure Initiation Bisoprolol Fumarate USP/BP 5 mg Yellow/Pink (Scored) Standard Hypertension Bisoprolol Fumarate USP/BP 10 mg Orange/White High Dose Maintenance Excipients Q.S. Microcrystalline Cellulose / Hypromellose Filler / Coating Bosentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bosentan (as Monohydrate) USP/Ph.Eur. 62.5 mg The Initiation Unit: Utilized for the first 4 weeks of therapy to assess patient tolerance and liver response. Bosentan (as Monohydrate) USP/Ph.Eur. 125 mg The Maintenance Payload: The standardized therapeutic dose for long-term management of PAH and exercise capacity improvement. Excipients Proprietary Matrix Controlled Disintegration System: Engineered to ensure a predictable pharmacokinetic profile, matching the innovator brand’s $T_{max}$ (time to peak concentration). Bromhexine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Bromhexine Hydrochloride BP/USP 8 mg The Respiratory Anchor: The standardized therapeutic unit for adults and children over 12 for the treatment of productive cough. Excipients Proprietary Matrix Rapid Dissolution System: Engineered to ensure the tablet shatters instantly in the stomach for rapid systemic absorption and lung-tissue penetration. Bromocriptin Tablets
FreeBromocriptin Mesylate Tablets IP 2.5 MG
Each uncoated tablet contains
Bromocriptin Mesylate IP
eq.to Bromocriptine 2.5 mgUsage: – high levels of a natural substance prolactin in the body
Category: – Anti Parkinson drugs
Therapeutic category: – Anti Parkinson
Buclizine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Fast-Acting Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Buclizine Hydrochloride BP/USP 25 mg The Universal Anchor: The standardized therapeutic unit for both appetite stimulation (adults/pediatrics) and motion sickness prevention. Excipients Proprietary Matrix High-Disintegration System: Engineered to ensure the tablet dissolves rapidly in the gastric environment for a fast onset of action (typically within 30–60 minutes). Buprenorphine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed Sublingual Tablet, engineered for rapid mucosal absorption.
Active Ingredient Strength Primary Clinical Function Buprenorphine HCl USP/Ph.Eur. 0.4 mg / 2 mg The Pain & Induction Anchor: Low-dose format for chronic pain or the initial phase of addiction treatment. Buprenorphine HCl USP/Ph.Eur. 8 mg The Maintenance Payload: High-strength dose for long-term stabilization in Opioid Use Disorder. Excipients Sublingual Matrix Rapid Dissolution System: Engineered to dissolve completely under the tongue in < 2 minutes for maximum transmucosal bioavailability. Bupropion tablets
FreeProduct Composition & Strength
We supply this product in three distinct Release Profiles, packed in moisture-resistant Alu-Alu or HDPE containers to protect the stability of the hydrochloride salt.
Release Profile Strength Primary Clinical Function Bupropion XL (Extended Release) 150 mg / 300 mg The Depression Anchor: Once-daily dosing (24-hour release) for MDD and Seasonal Affective Disorder. Bupropion SR (Sustained Release) 150 mg The Smoking Cessation Specialist: Twice-daily dosing (12-hour release) for smoking cessation and MDD. Bupropion IR (Immediate Release) 75 mg / 100 mg The Titration Unit: Immediate-release format for precise dose escalation under specialist supervision. Cabergoline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed, Micro-Dose Tablet, packed in high-barrier Alu-Alu blister strips or specialized glass vials to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Cabergoline USP/Ph.Eur. 0.5 mg The Standard Specialty Anchor: The definitive therapeutic unit for managing prolactin-related infertility and pituitary tumors. Excipients Proprietary Matrix Micro-Gram Content Uniformity: Engineered utilizing Geometric Dilution techniques to ensure every 0.5 mg tablet contains the exact clinical dose across the entire batch. Calcium & Calcitriol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Softgel or Tablet, packed in high-barrier Alu-Alu or Blister strips to protect the light-sensitive Calcitriol.
Active Ingredient Strength Primary Clinical Function Calcium Carbonate USP/BP 500 mg (200 mg Elemental) The Mineral Substrate: Provides the high-density elemental calcium needed for skeletal reinforcement. Calcitriol USP/BP 0.25 mcg The Active Hormone: The potent, pre-activated Vitamin D that drives 100% absorption efficiency. Excipients Oil-Based Matrix Softgel Stability: For softgel formats, we utilize a specialized oil-base to ensure the fat-soluble Calcitriol remains fully dissolved and bioavailable. Calcium & Chloecalciferol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Swallowable) or Chewable Tablets (Flavor masked). The chewable format is popular due to the large size of calcium tablets.
Component Strength (Standard) Strength (High Potency) Role Elemental Calcium
(from Calcium Carbonate)500 mg
(1250 mg Salt)500 mg
(1250 mg Salt)Bone Mineralization Vitamin D3
(Cholecalciferol)250 IU 500 IU / 1000 IU Absorption Enhancer Excipients Q.S. Starch / Povidone Binding Agent Calcium Acetate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in moisture-resistant Alu-Alu or HDPE bottles.
Active Ingredient Strength Primary Clinical Function Calcium Acetate USP/Ph.Eur. 667 mg The Dialysis Anchor: Each 667mg tablet provides 169mg of elemental calcium, the standardized dose for maximum phosphate binding. Excipients Proprietary Matrix Rapid Dissolution System: Engineered to ensure the tablet shatters instantly in the stomach to maximize contact with dietary phosphorus during a meal. Calcium Carbonate & Vitamin D3 Tablets
FreeProduct Composition & Common Strengths
We supply this combination in standard, clinically calibrated ratios designed to optimize daily absorption thresholds without overwhelming intestinal transit.
Active Ingredient Components Standard Strengths (per Tablet) Elemental Yield / Biological Activity Primary Clinical Function Calcium Carbonate IP / BP / USP 1250 mg Yields 500 mg Elemental Calcium The Scaffold: Provides the physical structural block for bone density. Vitamin D3 (Cholecalciferol) IP/BP/USP 250 IU / 400 IU Equivalent to 6.25 mcg / 10.0 mcg The Catalyst: Chemically drives intestinal transport channels. Excipients Pharma Grade Modified Matrix Adjusters The Carrier: Ensures fast disintegration or chewable palatability. Calcium Citrate With Vitamin D3 Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White or Off-White, Oblong/Caplet shape). The coating makes the large tablet easier to swallow.
Active Ingredient Strength (Standard) Therapeutic Role Calcium Citrate USP/BP 1000 mg (Eq. to 210 mg Elemental Ca) Bone Mineralization Vitamin D3 (Cholecalciferol) USP/BP 200 IU / 400 IU / 1000 IU Absorption Enhancer (High Strength Variant) 1200 mg Citrate + 1000 IU D3 Severe Osteoporosis Excipients Q.S. Starch / Magnesium Stearate / HPMC Disintegrant / Coating Calcium Citrate, Vitamin D3, Methylcobalamin, Folic Acid & Pyridoxine HCl Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in moisture-resistant Alu-Alu or Alu-PVC blister strips to protect the sensitive B-vitamins.
Active Ingredient Strength Primary Clinical Function Calcium Citrate USP/BP 1000 mg The Structural Payload: Provides elemental calcium for bone mineral density (BMD) restoration. Vitamin D3 (Cholecalciferol) IP 200 IU / 400 IU The Absorption Catalyst: Facilitates active intestinal transport of calcium. Methylcobalamin USP/JP 1500 mcg The Nerve Restorer: Active B12 for nerve fiber regeneration and red blood cell formation. Folic Acid USP/BP 1.5 mg The DNA/Heme Synthesis Anchor: Essential for cell division and lowering homocysteine. Pyridoxine HCl (Vit B6) USP 3 mg The Metabolic Co-factor: Supports neurotransmitter synthesis and protein metabolism. Calcium Citrate,Vitamin D3, Magnesium, Zinc Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White or Blue, Oblong). The coating masks the metallic taste of Zinc and Magnesium.
Active Ingredient Strength (Standard) Therapeutic Role Calcium Citrate USP/BP 1000 mg (Eq. to 210 mg Elemental Ca) Bone Mineralization Vitamin D3 (Cholecalciferol) 200 IU / 400 IU Absorption Enhancer Magnesium Hydroxide USP/BP 100 mg (Eq. to Elemental Mg) D3 Activation / Bone Structure Zinc Sulphate Monohydrate USP/BP 4 mg / 10 mg (Eq. to Elemental Zn) Collagen Synthesis Excipients Q.S. Croscarmellose Sodium / HPMC Disintegrant / Coating Calcium Gluconate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets or Chewable Tablets in bulk jars or blisters.
Active Ingredient Strength Elemental Calcium Role Calcium Gluconate IP/BP/USP 500 mg ~ 45 mg Pediatric / Maintenance Calcium Gluconate IP/BP/USP 1000 mg (1g) ~ 90 mg Adult Therapeutic Dose Excipients Q.S. — Binder / Sweetener Calcium Pantothanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed, High-Purity Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to prevent the hygroscopic vitamin from degrading.
Active Ingredient Strength Primary Clinical Function D-Calcium Pantothenate USP/BP 50 mg / 100 mg The Wellness & Hair Anchor: Standard daily dose for nutritional support and maintenance of hair/skin health. D-Calcium Pantothenate USP/BP 250 mg / 500 mg The Therapeutic Payload: High-dose intervention for clinical B5 deficiency, acne management, and post-surgical wound healing. Excipients Proprietary Matrix Moisture-Lock Formulation: Engineered utilizing specialized binders to protect the vitamin from atmospheric humidity, ensuring a 36-year shelf life in Zone IVb tropical climates. Canagliflozin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Stability Tablet, packed in secure, moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Canagliflozin (Hemi-hydrate) USP 100 mg The Metabolic Anchor: Standard starting dose for glycemic control and cardio-renal protection. Canagliflozin (Hemi-hydrate) USP 300 mg The High-Efficacy Payload: Utilized for patients requiring maximal HbA1c reduction with preserved renal function. Excipients Proprietary Matrix Lactose-Optimized Blend: Engineered to ensure rapid disintegration and 100% bioequivalence to the innovator brand. Candesartan Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored). The wide range of strengths allows for precise titration in heart failure patients.
Active Ingredient Strength (Standard) Primary Role Candesartan Cilexetil USP/BP 4 mg Heart Failure Initiation / Hepatic Impairment Candesartan Cilexetil USP/BP 8 mg Standard Hypertension Start Candesartan Cilexetil USP/BP 16 mg Standard Maintenance Candesartan Cilexetil USP/BP 32 mg High Dose / Resistant Hypertension Capecitabine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Capecitabine USP/Ph.Eur. 150 mg The Precision Titration Anchor: Utilized for accurate dose adjustments based on Body Surface Area (BSA). Capecitabine USP/Ph.Eur. 500 mg The Oncology Macrodose: The primary therapeutic unit for standard cycles in Colorectal and Breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Carbamazepine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (White, scored). We also offer Controlled Release (CR) variants upon request.
Active Ingredient Strength (Standard) Primary Role Carbamazepine USP/BP 100 mg Pediatric / Initiation Dose Carbamazepine USP/BP 200 mg Standard Adult Dose Carbamazepine USP/BP 400 mg High Dose / CR Formulation Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Carbidopa and Levodopa Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (often scored/mottled). The ratios are designed to minimize nausea while maximizing brain dopamine levels.
Carbidopa (Anhydrous) Levodopa Ratio Primary Role 10 mg 100 mg 1:10 Low Dose Initiation 25 mg 100 mg 1:4 Standard Maintenance (Best Nausea Control) 25 mg 250 mg 1:10 High Dose / Advanced Disease Excipients Q.S. Microcrystalline Cellulose / Starch / Dye Filler / Colorant Carbimazole Tablets
FreeProduct Composition & Available Strengths
We manufacture Carbimazole in exact, internationally recognized strengths to facilitate precise dosage titration based on periodic patient blood chemistry.
Active Ingredient Standard Strengths Primary Clinical Target Carbimazole BP/IP/USP 5 mg Maintenance Titration: For long-term control once stable thyroid levels are chemically achieved. Carbimazole BP/IP/USP 10 mg Initial Suppression: High-dose intervention to rapidly bring down severely elevated $T_{3}$/$T_{4}$ levels. Carvedilol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Because therapy for Heart Failure requires very precise “low dose” initiation, we offer the full titration range.
Active Ingredient Strength (Standard) Color Code (Typical) Role Carvedilol USP/BP 3.125 mg White/Pink CHF Initiation (Critical) Carvedilol USP/BP 6.25 mg Yellow Titration Step 1 Carvedilol USP/BP 12.5 mg Tan/Peach Titration Step 2 Carvedilol USP/BP 25 mg White Target Maintenance Dose Cefadroxil 500 mg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the beta-lactam ring.
Active Ingredient Strength Primary Clinical Function Cefadroxil Monohydrate USP/Ph.Eur. 500 mg (Equivalent to anhydrous Cefadroxil) Global Standard: Twice-daily adult therapy for pharyngitis, skin infections, and UTIs. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol / Magnesium Stearate Diluent / Superdisintegrant / Film-Coating (Engineered for rapid gastric dissolution and high bioavailability) Cefadroxil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Cefadroxil (as Monohydrate) USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections in adolescents. Cefadroxil (as Monohydrate) USP/Ph.Eur. 500 mg The Dermatology & UTI Payload: High-efficacy therapeutic dose for Cellulitis, Impetigo, and bladder infections. Excipients Proprietary Matrix High-Density Granulation: Engineered to manage the bulk of the 500mg payload while ensuring rapid disintegration and consistent absorption. Cefdinir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Cefdinir USP/Ph.Eur. 300 mg The Respiratory & Skin Anchor: The definitive therapeutic unit utilized for CAP, Sinusitis, and Skin/Soft Tissue Infections (SSTI). Excipients Proprietary Matrix Crystalline Form Stability: Engineered utilizing specialized binders to maintain the Crystalline Form I of Cefdinir, ensuring maximum shelf-life and predictable intestinal absorption. Cefixime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Linezolid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Gram-Negative Anchor: Broad-spectrum bactericidal activity against H. influenzae, E. coli, and Salmonella. Linezolid USP/Ph.Eur. 600 mg The Gram-Positive Powerhouse: Bacteriostatic activity against multi-drug resistant Staphylococci and Streptococci. Excipients Proprietary Matrix Advanced Disintegration System: Engineered utilizing Super-Disintegrants to manage the large 800mg+ active payload, ensuring the tablet shatters rapidly for maximum absorption. Cefixime and Ofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Extracellular Specialist: Targets the bacterial cell wall; highly effective against Gram-negative enteric pathogens. Ofloxacin USP/Ph.Eur. 200 mg The Intracellular Specialist: Targets DNA replication; excellent tissue penetration into the lungs, prostate, and urinary tract. Excipients Proprietary Matrix Bilayer Technology: Engineered to prevent physical interaction between the two APIs, ensuring maximum stability and a synchronized release profile in the gut. Cefixime Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime Trihydrate USP/Ph.Eur. 100 mg / 200 mg The Pediatric & Enteric Anchor: Dispersible format for easy administration in children and patients with dysphagia. Excipients Sweetening & Flavoring Agents Compliance Engineering: Formulated with high-grade fruit flavors and non-cariogenic sweeteners to mask the bitter antibiotic taste, ensuring 100% pediatric compliance. Disintegrants Super-Disintegrant Blend Instant-Dispersible Matrix: Engineered to shatter and form a smooth, grit-free suspension in < 45 seconds when placed in 5-10 mL of water. Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the trihydrate salt.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Standard Primary Care Anchor: Utilized for uncomplicated UTIs, Otitis Media, and Pharyngitis. Cefixime (as Trihydrate) USP/Ph.Eur. 400 mg The Enteric & Gonorrhea Payload: High-efficacy therapeutic dose for Typhoid Fever and uncomplicated Gonorrhea. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing Laser Micronization of the API to ensure rapid dissolution and 100% bioequivalence to the innovator brand. Cefopodoxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 100 mg The Pediatric & Titration Anchor: Ideal for Pharyngitis, Tonsillitis, and uncomplicated UTIs in adolescents and adults. Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The Respiratory Macrodose: High-efficacy payload for Community-Acquired Pneumonia and Sinusitis. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing micronized API and specialized surfactants to overcome the naturally poor solubility of the Proxetil salt. Cefpodoxime & Clavulanic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefpodoxime Proxetil Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 50 mg / 100 mg The Pediatric & Titration Anchor: Dispersible format for easy administration in children and elderly patients with swallowing difficulties. Excipients Sweetening & Flavoring Agents Bitter-Shield Technology: Engineered with molecular masking agents (e.g., Cyclodextrins) to neutralize the intense bitterness of the API, ensuring 100% pediatric compliance. Disintegrants Croscarmellose Sodium / SSG Instant-Dispersible Matrix: Engineered to shatter and form a uniform suspension in < 60 seconds when placed in 5-10 mL of water. Cefpodoxime-Potassium-Clavulanate-Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefprozil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-Alu blister strips to prevent hydrolytic degradation.
Active Ingredient Strength Primary Clinical Function Cefprozil USP/Ph.Eur. 250 mg The Pediatric & Mild Infection Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections. Cefprozil USP/Ph.Eur. 500 mg The Respiratory & SSTI Macrodose: Utilized for Acute Sinusitis, secondary infections of Bronchitis, and complicated skin infections. Excipients Proprietary Matrix Hydrolysis-Resistant Formulation: Engineered utilizing high-density granulation to protect the monohydrate API from environmental moisture. Cefuroxime Axetil Tablets
FreeProduct Composition & StrengthWe supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Utilized for Acute Otitis Media, Pharyngitis, and uncomplicated UTIs. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: Utilized for Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Proprietary Matrix Amorphous Solid Dispersion Technology: Engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates. Cefuroxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips to ensure the stability of the hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur.
(Equivalent to Cefuroxime)250 mg The Pediatric & ENT Anchor: The definitive unit utilized for the treatment of Acute Otitis Media, Pharyngitis, and uncomplicated Urinary Tract Infections. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: The high-efficacy therapeutic payload required for the management of Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Colloidal Silicon Dioxide / Premium Polymeric Film Diluent / Superdisintegrant / Solubilizer / Glidant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion Technology. Because crystalline Cefuroxime Axetil has near-zero bioavailability, our tablets are engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates). *Pack Sizes: 1×6, 1×10, or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-10 day acute curative regimens).
Cetrizine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (White/scored). The tablets are scored to facilitate dose splitting for pediatric use.
Active Ingredient Strength (Standard) Primary Role Cetirizine HCl USP/BP/IP 5 mg Pediatric / Mild Allergy Cetirizine HCl USP/BP/IP 10 mg Standard Adult Dose Excipients Q.S. Lactose Monohydrate / Maize Starch Chlorambucil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Cytotoxic Tablet, packed exclusively in light-shielded, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the sensitive aromatic mustard payload.
Active Ingredient Strength Primary Clinical Function Chlorambucil USP/Ph.Eur. 2 mg The Standard Hematology Anchor: The definitive unit utilized for chronic, daily maintenance and precise titration in CLL and low-grade lymphomas. Chlorambucil USP/Ph.Eur. 5 mg The Pulse-Dosing Payload: High-efficacy therapeutic payload utilized for “Pulse” therapy regimens or initial aggressive induction phases. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Magnesium Stearate / Hypromellose / Titanium Dioxide / Premium Polymeric Film Diluent / Glidant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing an impenetrable film coat. This ensures the highly toxic, mutagenic API never comes into contact with the skin of the pharmacist or caregiver handling the medication). *Pack Sizes: 25-Tablet or 30-Tablet Bottles/Blisters (Optimized for oncology-specific treatment cycles).
Chlordiazepoxide Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (often Green or Yellow). The robust coating is essential to mask the intensely bitter taste of the API and protect the light-sensitive drug.
Active Ingredient Strength (Standard) Therapeutic Role Chlordiazepoxide HCl USP/BP 10 mg Mild Anxiety / Elderly / Taper End Chlordiazepoxide HCl USP/BP 25 mg Severe Anxiety / Alcohol Detox Loading Excipients Q.S. Sucrose / Talc / Calcium Carbonate Sugar Coating (Light Barrier) Chlordiazepoxide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (typically Green/Black or Green/White). The coating is essential to mask the intensely bitter taste of the HCl salt.
Active Ingredient Strength (Standard) Therapeutic Role Chlordiazepoxide HCl USP/BP 10 mg Mild Anxiety / Geriatric Chlordiazepoxide HCl USP/BP 25 mg Severe Anxiety / Alcohol Withdrawal Excipients Q.S. Lactose / Talc / Sucrose Filler / Coating Chlorine Tablets
FreeProduct Specifications & Strength
We supply these tablets in High-Density Industrial Configurations, packed in moisture-proof, UV-stabilized HDPE drums to ensure the stability of the active chlorine content during international transit.
Chemical Grade Available Strength Primary Application Calcium Hypochlorite (Tablets) 65% Available Chlorine The Standard Industrial Grade: Primarily utilized for commercial swimming pool sanitation and general environmental disinfection. Calcium Hypochlorite (High-Purity) 70% Available Chlorine The Municipal Water Anchor: The elite-tier concentration required for large-scale potable water treatment and disaster-relief water purification kits. Physical Form 20g (Small Tabs) / 200g (Giant Tabs) Engineered specifically utilizing High-Tonnage Hydraulic Pressing to ensure the tablets do not crumble during transport, maintaining a consistent surface area for uniform dissolution. *Pack Sizes: 2kg/5kg Pails or 25kg/45kg/50kg Industrial HDPE Drums.
Chloroquine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets or Uncoated Tablets. The strength is often labeled by the salt weight or the base equivalent.
Active Ingredient Salt Strength Base Equivalent (Active) Primary Role Chloroquine Phosphate USP/BP 250 mg 150 mg Base Pediatric / Prophylaxis Chloroquine Phosphate USP/BP 500 mg 300 mg Base Standard Adult Dose Excipients Q.S. Maize Starch / Magnesium Stearate Binder / Lubricant Chloroquine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is critical to mask the intensely bitter taste of the drug. Note: Dosing is often calculated based on the “Base” content.
Active Ingredient (Salt) Equivalent Base Primary Role Chloroquine Phosphate USP/BP 250 mg ~ 155 mg Base Prophylaxis / Maintenance Chloroquine Phosphate USP/BP 500 mg ~ 310 mg Base Acute Malaria Treatment Excipients Q.S. Starch / Magnesium Stearate Chlorpheniramine Tablets
FreeProduct Composition & Strength
We supply this product in the globally accepted standard strength for adult dosing, ensuring safe and effective treatment cycles.
Active Ingredient Strength (per Tablet) Primary Clinical Function Chlorpheniramine Maleate IP/BP/USP 4 mg The H1 Blocker: Rapidly controls acute allergic flares. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid dissolution. Chlorpromazine and Trihexyphenidyl Tablets
FreeProduct Composition & Strength
We supply this product in Precision-Blended configurations, often customized for institutional titration, packed in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips.
Active Ingredient Common Strengths Primary Clinical Function Chlorpromazine HCl USP/Ph.Eur. 25 mg / 50 mg / 100 mg The Antipsychotic Anchor: High-potency D2 blockade to control positive symptoms of psychosis and induce behavioral calm. Trihexyphenidyl HCl USP/Ph.Eur. 2 mg The Anti-Tremor Shield: Centrally acting anticholinergic required to neutralize drug-induced Parkinsonism and muscle rigidity. Excipients Lactose Monohydrate / Maize Starch / Povidone K-30 / Magnesium Stearate / Polymeric Film Coat Diluent / Binder / Disintegrant / Lubricant (Engineered specifically utilizing High-Shear Wet Granulation to ensure 100% uniformity of the 2mg Trihexyphenidyl payload alongside the larger Chlorpromazine dose, guaranteeing consistent motor protection). *Pack Sizes: 10×10 Blisters or Bulk Jars of 1000 (Optimized specifically for high-volume psychiatric hospital dispensing).
Chlorpromazine Tablets
FreeProduct Composition & Available Strengths
We provide this therapeutic in a versatile range of strengths to allow for the precise dose titration required in specialized psychiatric medicine.
Active Ingredient Standard Strengths Primary Clinical Target Chlorpromazine HCl IP/BP/USP 25 mg Low-Dose Titration: For anxiety, pediatric hiccups, or elderly care. Chlorpromazine HCl IP/BP/USP 50 mg Maintenance Therapy: For stable outpatient management of schizophrenia. Chlorpromazine HCl IP/BP/USP 100 mg Acute Crisis Control: High-potency dosing for acute manic or psychotic states. Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.
Active Ingredient Strength Primary Clinical Function Chlorthalidone USP/BP 6.25 mg / 12.5 mg The Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss. Chlorthalidone USP/BP 25 mg The High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis. Excipients Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized Starch Diluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch). Chlorzoxazone ,Ibuprofen & Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as a High-Density, Precision-Compressed Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the large multi-API payload.
Active Ingredient Strength Primary Clinical Function Chlorzoxazone USP/BP 250 mg The Muscle Relaxant Anchor: Targets the spinal cord to inhibit the reflexes driving the muscle spasm. Ibuprofen USP/BP 400 mg The Anti-Inflammatory Payload: Blocks prostaglandin synthesis to reduce tissue swelling and peripheral pain. Paracetamol (Acetaminophen) USP/BP 325 mg The Central Analgesic Booster: Synergistically raises the pain threshold for rapid symptomatic relief. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Polymeric Film Coat Diluent / Superdisintegrant / Binder / Lubricant (Engineered specifically utilizing High-Pressure Rotary Compression to manage the massive ~1000mg tablet weight while ensuring the tablet remains swallowable and shatters instantly in gastric fluid). *Pack Sizes: 10×10 Blisters (Optimized specifically for 5-day to 10-day acute injury recovery cycles).
Cholecalciferol Granules Sachet
FreeProduct Composition & Strength
We supply this product as Free-Flowing Granules in 1-gram sachets (Single Dose). The granules are flavored (Orange/Lemon) to ensure palatability.
Active Ingredient Strength Formulation Base Role Cholecalciferol (Vitamin D3) IP/BP/USP 60,000 IU Stabilized Powder Deficiency Correction Excipients Q.S. to 1 gm Sucrose / Mannitol / Flavor Diluent / Taste Masking Chymotrypsin Tablets
FreeProduct Composition & Enzyme Potency
We supply this product as a synergistic Trypsin-Chymotrypsin Fixed-Dose Combination (FDC), calibrated in Armour Units (AU) for maximum biological activity.
Active Ingredient Mixture Enzyme Ratio Standard Potency Options Primary Clinical Function Trypsin & Chymotrypsin IP/BP/USP 6:1 50,000 Armour Units (AU) Maintenance Recovery: For standard soft-tissue trauma and mild post-operative edema. Trypsin & Chymotrypsin IP/BP/USP 6:1 100,000 Armour Units (AU) High-Intensity Therapy: For major orthopedic adjustments, dental extractions, and large hematomas. CILNIDIPINE & TELMISARTAN TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed exclusively in secure, high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Telmisartan and light-sensitive Cilnidipine.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg The Hormonal Stabilizer: Blocks the RAAS system to provide 24-hour systemic pressure control and metabolic benefits (PPAR-gamma activation). Cilnidipine USP/Ph.Eur. 10 mg The Vascular Relaxant: Provides immediate N-type and L-type calcium channel blockade to lower peripheral resistance without edema. Excipients Meglumine / Sorbitol / Sodium Hydroxide / Magnesium Stearate / Titanium Dioxide (Opaque Coating) Solubilizer / Diluent / PH Modifier / Light Shield (Engineered specifically utilizing Alkaline Matrix Solubilization. Telmisartan requires a highly alkaline environment to dissolve, while Cilnidipine is light-sensitive. Our bilayer technology ensures each API is released at its peak kinetic window). Cilostazol Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White, circular). Precise formulation is required to manage its solubility profile.
Active Ingredient Strength (Standard) Primary Role Cilostazol USP/BP 50 mg Initiation / Renal Adjustment Cilostazol USP/BP 100 mg Standard Maintenance Dose Excipients Q.S. Microcrystalline Cellulose / CMC Calcium Cimetidine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Green or Blue). The coating masks the characteristic bitter taste and sulfur-like odor of the drug.
Active Ingredient Strength (Standard) Primary Role Cimetidine USP/BP 200 mg Prophylaxis / Maintenance Cimetidine USP/BP 400 mg Standard Therapeutic Dose Cimetidine USP/BP 800 mg Once-Daily (Bedtime) Excipients Q.S. Povidone / Magnesium Stearate CINITAPRIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Gastric Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hydrogen tartrate salt.
Active Ingredient Strength Primary Clinical Function Cinitapride Hydrogen Tartrate 1 mg The Global Prokinetic Anchor: The definitive therapeutic unit utilized to accelerate gastric emptying and increase esophageal tone in patients with chronic GERD or dyspepsia. Excipients Lactose Monohydrate / Maize Starch / Povidone K-30 / Magnesium Stearate / Hypromellose / Titanium Dioxide (Film Coat) Diluent / Binder / Lubricant / Protective Barrier (Engineered specifically utilizing High-Shear Wet Granulation to ensure 100% uniformity of the microscopic 1mg payload. The premium film coat protects the tablet from atmospheric moisture and masks the bitter taste of the tartrate salt). *Pack Sizes: 10×10 Blisters (Optimized specifically for 15-day to 30-day chronic GI dispensing regimens).
Cinnarizine & Dimenhydrinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active antihistamine salts.
Active Ingredient Strength Primary Clinical Function Cinnarizine BP/USP 20 mg The Peripheral Stabilizer: Stops the influx of calcium into the inner ear hair cells to dampen the physical sensation of vertigo. Dimenhydrinate BP/USP 40 mg The Central Antiemetic: Blocks H1 and muscarinic receptors in the brain to prevent nausea and motion-induced vomiting. Excipients Microcrystalline Cellulose / Maize Starch / Talc / Magnesium Stearate / Croscarmellose Sodium Diluent / Binder / Glidant / Superdisintegrant (Engineered specifically utilizing High-Shear Dry Blending to ensure 100% uniformity of the active APIs, providing a rapid disintegration profile that delivers relief within 30 minutes of ingestion). *Pack Sizes: 10×10 Blisters (Optimized specifically for short-course acute vertigo regimens).
Cinnarizine Tablets
FreeTechnical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
Technical Metric Specification Standard Active Ingredient Cinnarizine BP / USP / IP Dosage Form Immediate Release Tablets Available Strengths 25 mg (Vestibular) / 75 mg (Cerebrovascular) HS Code 3004.90.39 (Other CNS drugs) / 2933.59.90 Stability Validated for Zone IVb (Tropical) export markets Ciprofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is non-negotiable due to the extreme bitterness of the API and its light sensitivity.
Active Ingredient Strength (Standard) Primary Role Ciprofloxacin HCl USP/BP 250 mg Uncomplicated UTI / Mild Infection Ciprofloxacin HCl USP/BP 500 mg Typhoid / Respiratory / Abdominal Ciprofloxacin HCl USP/BP 750 mg Severe / Bone & Joint / Pseudomonas Excipients Q.S. Titanium Dioxide (Opacifier) / Hypromellose Ciprofloxacin Tinidazole Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Oblong/Caplet shape). The coating is critical to mask the intense bitterness of both APIs.
Active Ingredient 1 Active Ingredient 2 Strength Combination Primary Role Ciprofloxacin HCl Tinidazole 500 mg + 500 mg Standard Adult Dose Ciprofloxacin HCl Tinidazole 500 mg + 600 mg High Potency / Amoebiasis Excipients Q.S. Microcrystalline Cellulose / Opadry (Coating) Disintegration & Taste Masking Citalopram Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the chemical stability of the hydrobromide salt.
Active Ingredient Strength Primary Clinical Function Citalopram Hydrobromide USP/Ph.Eur. 10 mg / 20 mg The Primary Care Anchor: The definitive starting and maintenance doses utilized for the vast majority of patients with moderate depression or panic disorder. Citalopram Hydrobromide USP/Ph.Eur. 40 mg The Severe Refractory Payload: The maximum therapeutic dose utilized for severe depression. (Note: Doses above 40mg are strictly avoided due to cardiac risks). Excipients Lactose Monohydrate / Maize Starch / Croscarmellose Sodium / Magnesium Stearate / Hypromellose / Titanium Dioxide (Film Coat) Diluent / Binder / Superdisintegrant / Lubricant / Opaque Coating (Engineered specifically utilizing High-Shear Wet Granulation to ensure 100% uniformity of the active API, providing a smooth, fast-acting dissolution profile that matches the originator brand). *Pack Sizes: 10×10 Blisters or 28-Tablet Calendar Packs (Optimized for monthly psychiatric compliance).
Citicoline Tablets
FreeProduct Composition & Strength
We supply this product as Controlled Release (CR) Tablets (Film Coated). The matrix formulation is critical to extend the biological half-life.
Active Ingredient Strength Release Profile Primary Indication Citicoline Sodium USP/IP 500 mg Controlled Release Mild Cognitive Impairment / Maintenance Citicoline Sodium USP/IP 1000 mg Controlled Release Acute Stroke Recovery / Severe Dementia Excipients Q.S. HPMC (Release Retardant) / Magnesium Stearate Matrix System Clarithromycin Tablets
FreeClarithromycin Tablets USP 500 mg
Each Filmcoated tablet contains :
Clarithromycin USP 500 mgUsage: – Chest infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Clindamycin & clotrimazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Non-Greasy Vaginal Tablet (V-Tab), packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips, often accompanied by a specialized applicator for sterile insertion.
Active Ingredient Strength Primary Clinical Function Clindamycin Phosphate USP/Ph.Eur. 100 mg The Antibacterial Anchor: The definitive therapeutic unit utilized to eradicate anaerobic bacteria and restore the natural vaginal flora (Lactobacilli). Clotrimazole USP/Ph.Eur. 200 mg The Antifungal Payload: The massive imidazole payload required to penetrate deep into the mucosal layers and destroy recurrent yeast colonies. Excipients Adipic Acid / Sodium Bicarbonate / Lactose / Maize Starch / Magnesium Stearate Effervescent Matrix / Diluent / Disintegrant / Lubricant (Engineered specifically utilizing an Effervescent Vaginal Base. Upon contact with minimal vaginal moisture, the tablet releases microscopic amounts of CO2 to rapidly disperse the active APIs across the entire vaginal vault, ensuring no “untreated zones” remain) *Pack Sizes: 3-Tablet or 7-Tablet Strips (Optimized specifically for the strict, short-course clinical curative regimens).
Clindipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Cardiovascular Tablet, packed exclusively in highly secure, opaque Alu-Alu blister strips to ensure the absolute chemical stability of the highly photosensitive active ingredient.
Active Ingredient Strength Primary Clinical Function Cilnidipine USP/Ph.Eur. 5 mg The Geriatric & Titration Anchor: The definitive starting dose utilized for elderly patients or those with mild essential hypertension to prevent sudden hypotensive episodes. Cilnidipine USP/Ph.Eur. 10 mg The Global Maintenance Standard: The standardized daily therapeutic payload utilized for the vast majority of adult patients requiring chronic 24-hour blood pressure control. Cilnidipine USP/Ph.Eur. 20 mg The Severe Refractory Macrodose: Utilized strictly for severe, uncontrolled hypertension where the 10mg dose has failed to achieve target blood pressure metrics. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Opaque Polymeric Film (Titanium Dioxide base) Diluent / Densifier / Superdisintegrant / Binder / Lubricant / Protective Light Shield (Engineered specifically utilizing a dense, titanium dioxide-heavy film coat. Cilnidipine is intensely sensitive to UV and visible light; this opaque coating guarantees 100% of the active molecule survives to reach the patient’s systemic circulation) *Pack Sizes: 10×10 Opaque Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Clobazam Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). The score line is critical for precise titration, especially in pediatric patients.
Active Ingredient Strength (Standard) Primary Role Clobazam USP/BP 5 mg Pediatric Initiation / Titration Clobazam USP/BP 10 mg Standard Maintenance Clobazam USP/BP 20 mg High Dose / Adult Refractory Excipients Q.S. Lactose / Maize Starch / Talc Clofazimine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micronized Lipid-Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive phenazine dye.
Active Ingredient Strength Primary Clinical Function Clofazimine USP/Ph.Eur. 50 mg The Standard MDT Maintenance Unit: The globally standardized daily dose utilized in the WHO Multi-Drug Therapy (MDT) regimen for Multibacillary Leprosy. Clofazimine USP/Ph.Eur. 100 mg The MDR-TB & Acute ENL Macrodose: The heavy therapeutic payload utilized for the aggressive suppression of acute ENL reactions or as a core component of the standardized short-course MDR-TB regimen. Excipients Microcrystalline Cellulose / Propylene Glycol / Gelatin / Sodium Lauryl Sulfate / Magnesium Stearate / Heavy Opaque Polymeric Film Diluent / Lipid-Solvent Matrix / Binder / Surfactant / Lubricant / Protective Light Shield (Engineered specifically utilizing Advanced API Micronization & Solid-Lipid Tableting. Because Clofazimine is practically insoluble in water, the API is micro-milled and suspended in a specialized surfactant matrix to ensure it absorbs perfectly in the gut without requiring a soft-gelatin encapsulation process) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, continuous, multi-year infectious disease dispensing regimens).
Clomifene citrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Fertility Tablet, packed exclusively in highly secure, opaque Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the photosensitive SERM.
Active Ingredient Strength Primary Clinical Function Clomifene Citrate USP/Ph.Eur. 50 mg The Standard Ovulatory Anchor: The definitive starting dose utilized for the first cycle of ovulation induction to assess ovarian response and minimize the risk of dangerous hyperstimulation. Clomifene Citrate USP/Ph.Eur. 100 mg The Refractory Macrodose: The heavy therapeutic payload utilized strictly for subsequent cycles in patients who failed to ovulate (clomifene-resistant PCOS) on the 50mg dose. Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate / Opaque Polymeric Film (Titanium Dioxide base) Diluent / Binder / Disintegrant / Lubricant / Protective Light Shield (Engineered specifically utilizing a dense, titanium dioxide-heavy film coat. Clomifene degrades under direct UV/visible light; this opaque coating guarantees 100% of the active hormone modulator survives from the blister pack to the patient’s stomach) *Pack Sizes: 10-Tablet or 5-Tablet Blisters (Optimized specifically for the strict, 5-day cyclical dosing regimen utilized in reproductive endocrinology).
Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Clonidine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Small, White). Note: Clonidine is extremely potent and dosed in micrograms (mcg), not milligrams.
Active Ingredient Strength (Metric) Strength (Common) Primary Role Clonidine HCl USP/BP/IP 100 mcg 0.1 mg Initiation / Mild Hypertension Clonidine HCl USP/BP/IP 200 mcg 0.2 mg Standard Maintenance Clonidine HCl USP/BP/IP 300 mcg 0.3 mg High Dose / Crisis Management Excipients Q.S. Lactose / Corn Starch Filler / Binder Clopidogrel Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (usually Pink or Red). We offer both the standard maintenance dose and the high-dose loading unit.
Active Ingredient Strength (Standard) Primary Role Clopidogrel Bisulfate USP/BP 75 mg Daily Maintenance Clopidogrel Bisulfate USP/BP 300 mg Emergency Loading Dose Excipients Q.S. Mannitol / Hydrogenated Castor Oil Clopidogrel, Aspirin Tablets Clopidogrel, Aspirin Tablets
FreeA Clopidogrel + Aspirin tablet is a dual antiplatelet therapy (DAPT) used primarily to prevent serious cardiovascular events like heart attacks and strokes
Clotrimazole Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Vaginal Tablets (bullet or almond shaped) with or without an applicator, offering flexible treatment durations.
Active Ingredient Strength Treatment Course Patient Convenience Clotrimazole USP/BP 100 mg 6 Nights Standard Therapy Clotrimazole USP/BP 200 mg 3 Nights Short Course Clotrimazole USP/BP 500 mg 1 Night Single Dose (“One Shot”) Excipients Q.S. Lactose / Adipic Acid / Starch Rapid Disintegration Clozapine Tablets
FreeProduct Composition & Available Titration Strengths
Because Clozapine demands highly delicate, low-dose initial titration to protect the patient’s cardiovascular profile, we manufacture the full compendial strength spectrum.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clozapine USP / BP / IP 25 mg Oral Solid Uncoated Micro-Tablet Introductory Safety Titration: Mandatory low-dose baseline format utilized exclusively for the initial day 1 and day 2 dose-escalation phase to prevent orthostatic shock. Clozapine USP / BP / IP 50 mg Oral Solid Uncoated Micro-Tablet Intermediate Dose Step-Up: Mid-tier titration strength engineered to scale up systemic tolerance during weeks 1 and 2. Clozapine USP / BP / IP 100 mg Oral Solid Compressed Tablet The Core Commercial Volume: First-line international standard target maintenance strength for adult refractory schizophrenia management. Co -Trimoxazole Tablets Tablet
FreeCo- Trimoxazole Tablets IP
Trimethoprime & Sulphamethoxazole Tablets IP
Each Uncoated tablet contains :
Trimethoprime IP 20 mg
Sulphamethoxazole IP 100 mgTrimethoprim & sulphamethoxazole tablets IP Co -trimoxazole Tablets IP
Each film coated tablets : Excipients q.s
Trimethoprim IP 80 mg
Sulphamethoxazole IP 400 mgTrimethoprim & sulphamethoxazole tablets IP
Each film coated tablets :
Trimethoprim IP 160 mg
Sulphamethoxazole IP 800 mgCo – Trimoxazole Tablets BP
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated Tablet contains :
Trimethoprim BP 80 mg
Sulfamethoxazole BP 400 mgTACOT – DS
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated tablet contains :
Trimethoprim BP 160 mg
Sulphamethoxazole BP 800 mgUsage: – Traveler’s diarrhea
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Codeine Phosphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Narcotic Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the alkaloid salt and to strictly prevent diversion.
Active Ingredient Strength Primary Clinical Function Codeine Phosphate USP/Ph.Eur. 15 mg / 30 mg The Standard Analgesic / Antitussive Anchor: The definitive unit utilized for the suppression of severe, dry coughs and the management of mild-to-moderate acute somatic pain. Codeine Phosphate USP/Ph.Eur. 60 mg The Severe Trauma Macrodose: The heavy therapeutic payload utilized strictly for moderate-to-severe refractory pain, often in post-operative or palliative oncology settings. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Densifier / Superdisintegrant / Lubricant / Glidant (Engineered utilizing Strict Geometric Dilution to ensure the opiate payload is flawlessly uniform across every batch, preventing toxic “hot spots” that could trigger accidental respiratory depression) *Pack Sizes: 10×10 Tamper-Evident Blisters (Optimized specifically for strict, closely monitored acute pain dispensing regimens).
Collagen Peptide , Sodium Hyaluronate , Chondroitin Sulfate and Vitamin C Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the intensely sensitive biological payloads.
Active Ingredient Strength Primary Clinical Function Hydrolyzed Collagen Peptides (Type I & II) 150 mg – 500 mg
(Customizable per monograph)The Structural Foundation: The massive, highly bioavailable amino acid payload required to stimulate chondrocyte proliferation and rebuild the physical cartilage matrix. Chondroitin Sulfate Sodium USP/Ph.Eur. 200 mg The Cartilage Hydrator & Shield: Prevents enzymatic cartilage degradation and draws essential water into the articular matrix for compression resistance. Sodium Hyaluronate (Hyaluronic Acid) 30 mg The Synovial Lubricant: Restores the high-viscosity, shock-absorbing properties of the joint capsule fluid. Vitamin C (Ascorbic Acid) USP/Ph.Eur. 35 mg The Biosynthetic Cofactor: The absolute mandatory catalyst required to cross-link the newly formed collagen fibers into a strong, unified matrix. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Glidant / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced Cold-Process High-Shear Granulation. Fluffy collagen peptides are heavily densified without using destructive heat that would instantly oxidize and destroy the Vitamin C payload) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30/60 (Optimized specifically for premium retail presentation and chronic daily compliance).
Cyclophosphamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Prodrug Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the sensitive nitrogen mustard derivative and to physically protect caregivers from API exposure.
Active Ingredient Strength Primary Clinical Function Cyclophosphamide USP/Ph.Eur.
(as Cyclophosphamide Monohydrate)50 mg The Oncology & Autoimmune Macrodose: The definitive oral therapeutic unit utilized for chronic, daily continuous “metronomic” chemotherapy regimens and severe immunosuppressive maintenance. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Starch / Magnesium Stearate / Heavy Sucrose or Polymeric Film-Coat Diluent / Densifier / Disintegrant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing a thick, impenetrable sugar or film coat to ensure the highly toxic API never comes into contact with the skin of the patient, pharmacist, or caregiver handling the pill) *Pack Sizes: Bottles of 50/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic oncology and rheumatology dispensing regimens).
Cyclosporine tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, SMEDDS Liquid-Filled Soft Gelatin Capsule, packed exclusively in highly secure, moisture-resistant heavy-gauge Alu-Alu blister strips to ensure the absolute chemical and physical stability of the volatile microemulsion.
Active Ingredient Strength Primary Clinical Function Cyclosporine USP/Ph.Eur. (Modified) 25 mg / 50 mg The Micro-Titration Anchor: The definitive units utilized for extremely precise, weight-based dose adjustments during the critical early post-transplant phase, or for pediatric dosing. Cyclosporine USP/Ph.Eur. (Modified) 100 mg The Transplant Macrodose: The heavy therapeutic payload required to minimize the total pill burden for adult patients maintaining long-term solid organ graft survival. Excipients (SMEDDS Matrix) Polyoxyl 40 Hydrogenated Castor Oil / Polysorbate 80 / Propylene Glycol / Corn Oil Mono-di-triglycerides / Alpha-Tocopherol Microemulsion Vehicles & Surfactants / Co-Solvent / Lipophilic Carrier / Antioxidant (Engineered specifically to keep the massive lipophilic peptide fully dissolved inside the gelatin shell, instantly forming nanometer-sized droplets upon contact with stomach acid for maximum bioavailability) *Pack Sizes: 5×10 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, lifelong immunosuppressive dispensing regimens).
Cyproheptadine Tablets
FreeProduct Composition & Configuration
We supply Cyproheptadine Hydrochloride in the globally standardized 4 mg therapeutic dosage configuration, engineered to optimize absorption kinetics and support highly flexible pediatric-to-adult dose fractioning.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Cyproheptadine Hydrochloride USP / BP / IP 4 mg Oral Solid Immediate-Release Uncoated Tablet Dual-Action Therapy: Alleviation of allergic rhinitis, chronic urticaria, pruritus, and medical management of appetite stimulation / underweight stabilization. Excipients Pharma Grade Lactose Monohydrate, Microcrystalline Cellulose, Maize Starch, Magnesium Stearate The Disintegration Scaffold: High-compressibility matrix optimized to maintain core hardness during transit while facilitating rapid gastric dissolution. Dabigatran Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Tartaric Acid-Cored Pellet Formulation, packed exclusively in highly specialized, moisture-blocking Alu-Alu blister strips with integrated desiccants to ensure the absolute chemical survival of the intensely hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Dabigatran Etexilate Mesylate USP/Ph.Eur. 75 mg / 110 mg The Renal & Geriatric Anchor: The strictly mandated dose reductions utilized for elderly patients (over 80 years old), patients with moderate renal impairment, or those at an elevated risk of hemorrhagic bleeding. Dabigatran Etexilate Mesylate USP/Ph.Eur. 150 mg The Cardiovascular Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily prevention of stroke and systemic embolism in Non-Valvular Atrial Fibrillation (NVAF). Excipients Tartaric Acid (Core) / Hypromellose / Talc / Hydroxypropyl Cellulose / Dimethicone Acidic Microenvironment Generator / Polymer Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced Fluid-Bed Pellet Coating. The tartaric acid core is isolated with a polymer layer, then coated with the Dabigatran API, and sealed again. This prevents the acid from prematurely degrading the drug before it reaches the patient’s stomach) *Pack Sizes: 10×10 Specialized Alu-Alu Blisters or Heavy-Gauge HDPE Bottles with Desiccant Caps (Optimized specifically for absolute moisture defense).
Daclatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dihydrochloride Salt Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the active virological agent.
Active Ingredient Strength Primary Clinical Function Daclatasvir Dihydrochloride USP/Ph.Eur. 60 mg The Standard Eradication Macrodose: The definitive, globally standardized daily therapeutic payload utilized for the vast majority of patients to achieve a Sustained Virologic Response (SVR12 – Clinical Cure). Daclatasvir Dihydrochloride USP/Ph.Eur. 30 mg The CYP3A4 Titration Unit: The strict, mandatory dose-reduction unit utilized for patients who are co-infected with HIV and taking strong CYP3A inhibitors (like Ritonavir or Atazanavir). Excipients Anhydrous Lactose / Microcrystalline Cellulose / Croscarmellose Sodium / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film (Opadry Green) Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced dissolution-enhancing matrices to ensure the Dihydrochloride salt separates perfectly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Heavy-Gauge HDPE Bottles of 28 (Optimized exactly for a 4-week supply in strict 12-week or 24-week curative regimens).
Dapagliflozin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.
Active Ingredient Strength Primary Clinical Function Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 5 mg The Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension). Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 10 mg The Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).
Dapsone Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White). The range of strengths allows for precise dosing in both leprosy programs and dermatological maintenance.
Active Ingredient Strength (Standard) Primary Role Dapsone USP/BP 25 mg Pediatric / Initiation Dapsone USP/BP 50 mg Intermediate Dose Dapsone USP/BP 100 mg Standard Adult MDT Dose Excipients Q.S. Magnesium Stearate / Starch Darifenacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Deferasirox Tablets
FreeProduct Composition & Strength
We supply this product across two distinct, Precision-Blended Engineering Platforms, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical and chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength & Form Primary Clinical Function Deferasirox USP/Ph.Eur. 125 mg / 250 mg / 500 mg (Dispersible) The Pediatric Suspension Standard: Engineered with micro-crystalline disintegrants to rapidly dissolve in water or apple juice for precise, weight-based pediatric dosing. Deferasirox USP/Ph.Eur. 90 mg / 360 mg (Film-Coated) The High-Compliance Macrodose: The highly densified, lactose-free therapeutic payload designed to be swallowed whole, minimizing GI distress for adult patients. (Note: 360mg FCT is clinically equivalent to 500mg DT). Excipients (FCT Matrix) Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Poloxamer 188 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Solubilizer / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced High-Shear Wet Granulation and Poloxamer Solubilization. Because the FCT tablet is highly densified, it requires elite surfactants to guarantee instantaneous release and absorption in the gastrointestinal tract without the need for pre-dispersion) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for strict, 30-day chronic hematology dispensing regimens).
Deferiprone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, heavy-gauge HDPE bottles to ensure the absolute physical and chemical stability of the massive active pharmaceutical payload.
Active Ingredient Strength Primary Clinical Function Deferiprone USP/Ph.Eur. 500 mg The Standard Titration Unit: The baseline therapeutic dose utilized for precise, weight-based titration in pediatric and lower-weight thalassemia patients. Deferiprone USP/Ph.Eur. 1000 mg The Hematology Macrodose: The massive therapeutic payload required to minimize the total daily pill burden for adult patients suffering from severe, refractory iron overload. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced High-Shear Wet Granulation. Because a 1000mg tablet is inherently massive, it must be highly densified to remain swallowable, heavily coated to mask its severe bitterness, and packed with elite disintegrants to ensure it shatters instantly in the stomach) *Pack Sizes: Heavy-Gauge HDPE Bottles of 50 or 100 (Optimized specifically for massive, multi-pill daily chronic dispensing regimens).
Deflazacort Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Steroidal Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the glucocorticoid prodrug.
Active Ingredient Strength Primary Clinical Function Deflazacort USP/Ph.Eur. 6 mg The Pediatric & Titration Standard: The definitive unit utilized for weight-based dosing in pediatric Duchenne Muscular Dystrophy, slow tapering protocols, and chronic low-dose maintenance for rheumatoid arthritis. Deflazacort USP/Ph.Eur. 30 mg The Acute Flare-Up Macrodose: High-efficacy therapeutic payload utilized for the immediate, aggressive suppression of severe allergic anaphylaxis, acute asthma exacerbations, and violent autoimmune flare-ups. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Binder / Superdisintegrant / Lubricant / Glidant (Engineered utilizing Extreme Multi-Stage Geometric Dilution to ensure the steroidal payload is flawlessly uniform, manufactured under strict OEB 4 containment protocols to prevent cross-contamination and protect facility operators) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict titration, tapering, and chronic immunological dispensing regimens).
Desloratidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Dissolution Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent API.
Active Ingredient Strength Primary Clinical Function Desloratadine USP/Ph.Eur. 5 mg The Global Allergy & Dermatology Anchor: The definitive once-daily therapeutic unit utilized for the continuous, 24-hour baseline control of Allergic Rhinitis (Hay Fever) and severe Chronic Urticaria. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Maize Starch / Talc / Premium Polymeric Film Diluent / Densifier / Disintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing elite rapid-burst disintegrants to ensure the tablet shatters instantly in gastric fluid. The dense polymer coating masks the inherent bitterness of the API, ensuring a flawless patient experience) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, 30-day chronic allergy and dermatology dispensing regimens).
Desmopressin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose Peptide Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical stability of the fragile acetate salt.
Active Ingredient Strength Primary Clinical Function Desmopressin Acetate USP/Ph.Eur.
(Equivalent to Desmopressin base)0.1 mg The Titration & Pediatric Anchor: The definitive starting dose utilized for primary nocturnal enuresis in children or baseline control of Central Diabetes Insipidus. Desmopressin Acetate USP/Ph.Eur. 0.2 mg The Maintenance Macrodose: High-efficacy therapeutic payload utilized for severe, refractory polyuria and nocturia in adults. Excipients Lactose Monohydrate / Potato Starch / Povidone K-30 / Magnesium Stearate Diluent / Disintegrant / Binder / Lubricant (Engineered specifically utilizing Strict Geometric Dilution to ensure the microscopic peptide payload is flawlessly uniform, manufactured under stringent low-moisture conditions to prevent hydrolytic degradation of the fragile peptide bonds) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic endocrine dispensing regimens).
Desvenlafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base)50 mg (ER) The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. Desvenlafaxine Succinate USP/Ph.Eur. 100 mg (ER) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).
Dexamethasone Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (typically White, Round, Scored). The scoring allows for precise dose tapering.
Active Ingredient Strength (Standard) Therapeutic Role Dexamethasone USP/BP 0.5 mg Standard Low Dose / Pediatric Dexamethasone USP/BP 4 mg High Dose / Pulse Therapy Dexamethasone USP/BP 8 mg Critical Care / Oncology Excipients Q.S. Lactose / Corn Starch / Magnesium Stearate Diluent / Lubricant Dexamethasone Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White/scored). The range of strengths caters to everything from mild allergy management to high-dose chemotherapy support.
Active Ingredient Strength (Standard) Primary Role Dexamethasone USP/BP 0.5 mg Pediatric / Maintenance / Diagnostic (DST) Dexamethasone USP/BP 2 mg Standard Anti-Inflammatory Dexamethasone USP/BP 4 mg Severe Allergy / Cerebral Edema Dexamethasone USP/BP 6 mg / 8 mg COVID-19 / Chemotherapy Anti-emetic DI Calcium Phosphate with Vitamin D3 Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (typically White, Round/Oval). The formulation is optimized for disintegration to prevent the “gritty” sensation often associated with phosphate salts.
Active Ingredient Strength (Standard) Therapeutic Role Dibasic Calcium Phosphate IP/USP 500 mg / 1000 mg Source of Calcium & Phosphorus Vitamin D3 (Cholecalciferol) IP/USP 200 IU / 400 IU Absorption Enhancer Excipients Q.S. Maize Starch / Gelatin / Talc Binder / Glidant Diacerein & Glucosamine Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic Glucosamine salt.
Active Ingredient Strength Primary Clinical Function Diacerein USP/Ph.Eur. 50 mg The IL-1β Inhibitor: The potent, slow-acting anti-inflammatory anchor required to halt the enzymatic digestion of joint cartilage. Glucosamine Sulphate Potassium Chloride USP/Ph.Eur.
(Equivalent to Glucosamine Sulphate 750mg)750 mg The Cartilage Substrate: The massive amino-sugar payload required to stimulate proteoglycan synthesis and rebuild the articular matrix. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced Low-Humidity Granulation Technology to process the sticky, highly hygroscopic Glucosamine, sealed with a dense polymer film to block environmental moisture and ensure rapid gastric dissolution of the highly insoluble Diacerein) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, continuous, long-term chronic dispensing regimens).
Diazepam Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). The score line allows for flexible dosing.
Active Ingredient Strength (Standard) Primary Indication Diazepam USP/BP 2 mg Geriatric / Mild Muscle Spasm Diazepam USP/BP 5 mg Standard Anxiety Dose Diazepam USP/BP 10 mg Severe Spasm / Alcohol Withdrawal Excipients Q.S. Lactose / Maize Starch Diclofenac Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (Red/Brown) or Film Coated Tablets. Sugar coating is traditional to effectively mask the bitter taste of the API.
Active Ingredient Strength (Standard) Primary Indication Diclofenac Potassium USP/BP 25 mg Pediatric (Older) / Mild Pain Diclofenac Potassium USP/BP 50 mg Standard Adult Acute Dose Diclofenac Potassium USP/BP 75 mg Severe Acute Pain (Post-Op) Excipients Q.S. Sucrose (Coating) / Maize Starch Diclofenac Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (typically Reddish-Brown or White). The coating is essential to mask the intensely bitter and metallic taste of the potassium salt.
Active Ingredient Strength (Standard) Therapeutic Role Diclofenac Potassium USP/BP 25 mg Pediatric (Older Children) / Mild Pain Diclofenac Potassium USP/BP 50 mg Standard Acute Adult Dose Excipients Q.S. Maize Starch / Povidone / Sucrose Disintegrant / Coating Agent Diclofenac Sodium & Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Multi-Particulate or Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the sensitive biological enzyme.
Active Ingredient Strength Primary Clinical Function Diclofenac Sodium USP/Ph.Eur. 50 mg Potent peripheral NSAID for sustained localized pain and inflammation blockade. Serratiopeptidase IP/Ph.Eur. 10 mg or 15 mg (Enteric-Coated) Proteolytic enzyme engineered to drain localized post-surgical/traumatic edema. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Enteric Coating Polymer for Serratiopeptidase / Diluent / Lubricant *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for 7-to-14 day post-operative or orthopedic recovery regimens).
Diclofenac Sodium Paracetamol Serratiopeptidase Tablets
FreeA tablet containing Diclofenac Sodium + Paracetamol + Serratiopeptidase is a triple-action medication formulated to provide comprehensive relief from pain, fever, and inflammation. It is widely used for musculoskeletal disorders, post-surgical recovery, and dental pain.
Diclofenac Tablets
FreeProduct Composition & Strength
We supply this product as Enteric Coated (Gastro-Resistant) Tablets or Sustained Release (SR) Tablets.
Active Ingredient Strength (Standard) Formulation Role Diclofenac Sodium USP/BP 25 mg Enteric Coated Pediatric / Mild Pain Diclofenac Sodium USP/BP 50 mg Enteric Coated Standard Acute Dose Diclofenac Sodium USP/BP 75 mg Enteric Coated / SR Intermediate / Injection Switch Diclofenac Sodium USP/BP 100 mg Sustained Release (SR) Once Daily (Chronic Pain) Dicyclomine & Mefenic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Dicyclomine Hydrochloride USP/Ph.Eur. 10 mg The Anticholinergic Anchor: The potent antimuscarinic payload required to rapidly force smooth muscle relaxation and dry up hyper-secretions in the gut. Mefenamic Acid USP/Ph.Eur. 250 mg The Gynecological Analgesic Payload: The dual-action fenamate NSAID required to crush radiating inflammatory pain and block uterine prostaglandin receptors. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Enteric-Like Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing Bi-Layer Compression Technology to physically separate the highly reactive Dicyclomine from the bulky Mefenamic Acid, ensuring rapid, synchronized gastric dissolution without the APIs degrading each other) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute gynecological and GI dispensing regimens).
Dicyclomine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (usually small, white or blue). The dosage allows for flexible titration based on the severity of spasms.
Active Ingredient Strength (Standard) Primary Role Dicyclomine HCl USP/BP/IP 10 mg Pediatric / Mild Cramps Dicyclomine HCl USP/BP/IP 20 mg Adult Standard / IBS Therapy Excipients Q.S. Lactose / Magnesium Stearate Dienogest Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent steroidal API.
Active Ingredient Strength Primary Clinical Function Dienogest USP/Ph.Eur. 2 mg The Global Endometriosis Standard: The definitive therapeutic micro-dose utilized globally for the continuous, long-term suppression of pelvic pain, dysmenorrhea, and dyspareunia caused by endometriosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the 2mg steroidal payload is flawlessly uniform, finished with an opaque film-coat to seal the potent hormone safely away from factory handlers) *Pack Sizes: 14/28-Tablet Calendar Blisters (Optimized specifically for daily, uninterrupted, long-term gynecological dispensing).
Diethyl Carbamazine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White, circular). The formulation is designed for rapid disintegration to support mass dosing campaigns.
Active Ingredient Strength (Standard) Primary Role Diethylcarbamazine Citrate USP/BP/IP 50 mg Pediatric / Titration Diethylcarbamazine Citrate USP/BP/IP 100 mg Standard Adult Unit Diethylcarbamazine Citrate USP/BP/IP 300 mg (Forte) High Dose / TPE Therapy Excipients Q.S. Dibasic Calcium Phosphate / Starch Digoxin Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). Due to the potency (measured in micrograms), precise titration options are essential.
Active Ingredient Strength (Standard) Target Patient Digoxin USP/BP/IP 0.0625 mg (62.5 mcg) Pediatric / Severe Renal Failure Digoxin USP/BP/IP 0.125 mg (125 mcg) Geriatric / Maintenance Digoxin USP/BP/IP 0.25 mg (250 mcg) Standard Adult Dose Excipients Q.S. Lactose / Maize Starch Diloxanide Furoate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Luminal-Dispersion Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the anti-parasitic ester.
Active Ingredient Strength Primary Clinical Function Diloxanide Furoate USP/Ph.Eur. 500 mg The Global Anti-Parasitic Standard: The definitive therapeutic macrodose utilized globally for the total luminal eradication of amoebic cysts in asymptomatic carriers and post-dysentery patients. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced high-shear granulation and elite superdisintegrants to ensure the massive 500mg tablet shatters and disperses uniformly across the intestinal lining, maximizing physical contact with the embedded cysts) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, 10-day acute parasitology eradication regimens).
Diltiazem Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Immediate Release) or Sustained Release (SR) Tablets (Matrix Technology).
Active Ingredient Strength Formulation Role Diltiazem HCl USP/BP 30 mg Immediate Release Initial Titration / Angina Diltiazem HCl USP/BP 60 mg Immediate Release Standard Maintenance Diltiazem HCl USP/BP 90 mg / 120 mg Sustained Release (SR) Twice Daily Control Excipients Q.S. HPMC (Release Matrix) / Lactose Controlled Diffusion Diphenoxylate & Atropine Sulfate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both the opioid and the anticholinergic alkaloid.
Active Ingredient Strength Primary Clinical Function Diphenoxylate Hydrochloride USP/Ph.Eur. 2.5 mg The Anti-Diarrheal Anchor: The potent mu-opioid agonist required to physically halt hyperactive intestinal peristalsis. Atropine Sulfate USP/Ph.Eur. 0.025 mg (25 mcg) The Abuse Deterrent (Ultra-Microdose): The anticholinergic alkaloid engineered strictly to prevent deliberate opioid overdosage. Excipients Microcrystalline Cellulose / Sucrose / Maize Starch / Magnesium Stearate / Purified Talc Diluent / Binder / Disintegrant / Lubricant / Glidant (Engineered utilizing Extreme Multi-Stage Geometric Dilution to guarantee the microscopic 25 microgram Atropine payload is flawlessly distributed throughout the tablet, preventing lethal anticholinergic “hot spots”) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute gastrointestinal dispensing regimens).
Diphenylhydantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dissolution-Optimized Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive sodium salt.
Active Ingredient Strength Primary Clinical Function Diphenylhydantoin (Phenytoin) Sodium USP/Ph.Eur. 100 mg The Global Epilepsy Standard: The definitive therapeutic unit utilized globally for the chronic, daily maintenance and suppression of tonic-clonic and psychomotor seizures. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant / Lubricant (Engineered specifically utilizing Strict Particle-Size Distribution (PSD) Control. Because the drug is highly insoluble, the API is micro-milled to an exact, mathematically defined micron size to guarantee a highly predictable, extended dissolution profile in the gut, preventing toxic “dose dumping”) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict chronic neurology dispensing regimens and therapeutic drug monitoring protocols).
Disulfiram Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored). The tablets are formulated to dissolve rapidly to ensure quick systemic coverage.
Active Ingredient Strength (Standard) Role Disulfiram USP/BP 250 mg Standard Maintenance Disulfiram USP/BP 500 mg Induction Dose Excipients Q.S. Microcrystalline Cellulose / Starch Divalproex Sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.
Active Ingredient Strength Primary Clinical Function Divalproex Sodium USP/Ph.Eur. 250 mg (DR / ER) The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy. Divalproex Sodium USP/Ph.Eur. 500 mg (DR / ER) The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania. Excipients (Enteric DR Formulation) Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium Dioxide Diluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).
Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.
Active Ingredient Strength Primary Clinical Function Dolutegravir (as Sodium) USP/Ph.Eur. 50 mg The Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load. Excipients D-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Domperidone & Famotidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Release FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Antiemetic/Prokinetic Anchor: The micro-dose peripheral D2 antagonist required to halt nausea and rapidly accelerate gastric emptying. Famotidine USP/Ph.Eur. 20 mg The Acid Suppressor (NDMA-Free): The highly potent, structurally stable H2-receptor antagonist required to crush basal and food-stimulated gastric acid secretion. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced rapid-burst disintegrants to ensure the tablet dissolves instantly in the stomach for fast relief, heavily coated to protect the APIs from environmental degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-volume, rapid-turnover acute GI dispensing).
Domperidone & Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Antiemetic/Prokinetic Anchor: The micro-dose peripheral D2 antagonist required to halt vomiting and rapidly accelerate gastric emptying. Paracetamol (Acetaminophen) USP/Ph.Eur. 500 mg The Central Analgesic Payload: The massive therapeutic payload required to elevate the central pain threshold and crush acute migraine pain. Excipients Microcrystalline Cellulose / Crospovidone / Maize Starch / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 510mg active core shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste of the APIs) *Pack Sizes: 10×10 Blisters (Optimized specifically for rapid-response outpatient pain management and acute neurology dispensing).
Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Release / MD Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability and instantaneous dissolution of the active ingredient.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Global Antiemetic Standard: The definitive rapid-acting unit utilized globally for the immediate suppression of acute nausea and the acceleration of delayed gastric emptying. Excipients (MD Formulation) Microcrystalline Cellulose / Crospovidone / Mannitol / Aspartame / Peppermint Flavor / Magnesium Stearate Diluent / Superdisintegrant / Cooling Agent / Sweetener / Flavoring (Engineered specifically using elite “Rapid-Burst” superdisintegrants to ensure the Mouth Dissolving tablet shatters in saliva within seconds. This is critical because a vomiting patient physically cannot swallow water or a hard pill without instantly throwing it back up) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, short-term gastrointestinal dispensing regimens).
Donepezil Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White for 5mg and Yellow for 10mg). The film coating aids in swallowing and identification.
Active Ingredient Strength (Standard) Role Donepezil HCl USP/BP 5 mg Initial Titration Dose Donepezil HCl USP/BP 10 mg Standard Maintenance Dose Donepezil HCl USP/BP 23 mg High Dose (Sustained Release – Special Order) Excipients Q.S. Lactose Monohydrate / Starch Dothiepin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Heavy-Coated Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure absolute chemical stability and patient safety.
Active Ingredient Strength Primary Clinical Function Dothiepin (Dosulepin) Hydrochloride USP/Ph.Eur. 25 mg The Titration & Geriatric Standard: The definitive low-dose unit utilized for careful initial titration, daytime anxiety management, or for elderly patients highly sensitive to anticholinergic side effects. Dothiepin (Dosulepin) Hydrochloride USP/Ph.Eur. 75 mg The Nighttime Maintenance Macrodose: High-efficacy therapeutic payload utilized strictly at bedtime to induce heavy sleep and drive profound, long-term monoamine receptor down-regulation. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Maize Starch / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opaque Polymeric Film Diluent / Binder / Disintegrant / Glidant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. Dothiepin hydrochloride is profoundly bitter and can cause local oral anesthesia if it dissolves in the mouth; our elite coating guarantees seamless swallowing and zero taste disruption) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, heavily monitored 30-day psychiatric dispensing regimens).
Doxofylline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the xanthine derivative.
Active Ingredient Strength Primary Clinical Function Doxofylline USP/Ph.Eur. 400 mg The Global Pulmonology Standard: The definitive therapeutic macrodose utilized globally for the rapid and sustained reversal of severe bronchoconstriction in adult asthma and COPD patients. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced rapid-burst disintegrants to ensure the massive 400mg tablet dissolves quickly in the stomach, while the heavy film-coat completely masks the intensely bitter taste characteristic of all xanthine alkaloids) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict chronic respiratory dispensing regimens).
Doxycycline Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets or Dispersible Tablets. The film coating is essential to prevent esophageal irritation.
Active Ingredient Strength (Standard) Primary Role Doxycycline Hyclate USP/BP 100 mg Standard Adult Dose Doxycycline Monohydrate USP/BP 100 mg Esophageal Safety Variant Excipients Q.S. Microcrystalline Cellulose / Titanium Dioxide Doxylamine Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Release Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the succinate salt.
Active Ingredient Strength Primary Clinical Function Doxylamine Succinate USP/Ph.Eur. 25 mg The Global OTC Sleep Standard: The definitive therapeutic unit utilized globally for the immediate induction of sleep in patients suffering from transient or short-term insomnia. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / Densifier / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically utilizing a dense, rapid-dissolving polymeric film to completely mask the notoriously bitter, metallic taste of the succinate salt, while guaranteeing the tablet shatters in the stomach within minutes for fast sleep onset) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for high-volume, over-the-counter retail distribution).
Dried Aluminium Hydroxide & Magnesium Trisilicate Tablet
FreeProduct Composition & Strength
We supply this product as Chewable Tablets (Mint or Orange Flavor) to ensure rapid disintegration and palatability.
Active Ingredient Strength (Standard) Role Dried Aluminium Hydroxide Gel IP/BP/USP 250 mg Acid Neutralizer / Constipating Agent Magnesium Trisilicate IP/BP/USP 500 mg Acid Neutralizer / Adsorbent Excipients Q.S. Sweeteners / Flavoring Agents Dried Aluminium Hydroxide Gel, Magnesium Hydroxide & Dimethylpolysiloxane Tablets
FreeProduct Composition & Strength
We supply this product as Chewable Tablets (typically White or Pink, Mint/Orange Flavored). The chewable format is critical for increasing the surface area for acid neutralization and gas dispersion.
Active Ingredient Strength (Standard) Therapeutic Role Dried Aluminium Hydroxide Gel USP/BP 250 mg / 400 mg Sustained Antacid Magnesium Hydroxide USP/BP 250 mg / 400 mg Rapid Antacid Activated Dimethylpolysiloxane (Simethicone) USP/BP 50 mg / 25 mg Antiflatulent (Gas Relief) Excipients Q.S. Mannitol / Sorbitol / Flavor Sweetener / Coolant Dried Aluminium Hydroxide Gel, Magnesium Trisilicate & Peppermint Oil Tablets
FreeProduct Composition & Strength
We supply this product as Chewable Tablets (typically White, Round, Mint-Flavored). The chewable format is essential to increase the surface area for rapid acid neutralization.
Active Ingredient Strength (Standard) Therapeutic Role Dried Aluminium Hydroxide Gel USP/BP 250 mg Antacid / Adsorbent Magnesium Trisilicate USP/BP 500 mg Antacid / Mucosal Protectant Peppermint Oil USP/BP Q.S. (e.g., 2-5 mg) Carminative / Flavor Excipients Q.S. Mannitol / Sucrose / Menthol Sweetener / Coolant Dried Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Tablets
FreeProduct Composition & Strength
We supply this product as Chewable Tablets, which is the optimal delivery format to ensure the active ingredients are finely dispersed before reaching the stomach.
Active Ingredient Strength Primary Clinical Function Dried Aluminium Hydroxide Gel 250 mg / 300 mg The Sustained Buffer: Provides long-lasting acid neutralization and forms a protective coating on the stomach lining. Magnesium Hydroxide 250 mg The Rapid Neutralizer: Provides immediate relief from heartburn and balances the digestive transit time. Simethicone 25 mg / 50 mg The Defoaming Agent: Physically breaks down gas bubbles to relieve bloating and abdominal discomfort. Flavors Mint / Fruit / Orange Palatability Matrix: Engineered to be pleasant-tasting to ensure high patient compliance for OTC use. Dried Ferrous Sulfate & Folic Acid Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (typically Red or Brown). The coating masks the metallic taste and protects the iron from oxidation.
Active Ingredient Strength (Standard) Therapeutic Role Dried Ferrous Sulfate USP/BP 200 mg (Eq. to 65 mg Elemental Iron) Standard WHO Prophylaxis Dried Ferrous Sulfate USP/BP 335 mg (Eq. to 100 mg Elemental Iron) Therapeutic / Treatment Dose Folic Acid USP/BP 0.4 mg / 0.5 mg / 1.5 mg DNA Synthesis / Neural Tube Protection Excipients Q.S. Maize Starch / Titanium Dioxide / Red Oxide Disintegrant / Colorant Dried Ferrous Sulphate, Elemental Iron, Folic Acid Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (typically Red, Brown, or Maroon). The coating acts as an oxidation barrier.
Active Salt Equivalent Elemental Iron Therapeutic Role Dried Ferrous Sulphate IP/BP 200 mg 65 mg Elemental Iron WHO Standard Prophylaxis Dried Ferrous Sulphate IP/BP 335 mg 100 mg Elemental Iron Therapeutic Anemia Treatment Folic Acid IP/BP 0.4 mg / 0.5 mg / 1.5 mg Neural Tube Protection Excipients Q.S. Cellulose / Titanium Dioxide / Oxide Colors Filler / Colorant Drotaverine & Aceclofenac Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Drotaverine Hydrochloride USP/Ph.Eur. 80 mg The Spasmolytic Anchor (Forte Dose): The massive isoquinoline payload required to rapidly force smooth muscle relaxation in the ureters, biliary tract, and uterus. Aceclofenac USP/Ph.Eur. 100 mg The Anti-Inflammatory Payload: The potent COX-2 preferential NSAID required to crush the radiating inflammatory pain and tissue swelling. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Enteric-Like Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing Bi-Layer Compression Technology to physically separate the two highly reactive APIs, guaranteeing maximum shelf-life and ensuring rapid, simultaneous gastric dissolution without the APIs degrading each other) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, short-term acute emergency dispensing regimens).
Drotaverine & Mefenamic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Drotaverine Hydrochloride USP/Ph.Eur. 80 mg The Spasmolytic Anchor (Forte Dose): The massive isoquinoline payload required to rapidly force smooth muscle relaxation in the uterus, biliary tract, and intestines. Mefenamic Acid USP/Ph.Eur. 250 mg The Gynecological Analgesic Payload: The potent, dual-action fenamate NSAID required to crush radiating inflammatory pain and block uterine prostaglandin receptors. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Enteric-Like Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Heavy Film-Coating (Engineered specifically utilizing Bi-Layer Compression Technology to physically separate the two active APIs, guaranteeing maximum shelf-life and ensuring rapid gastric dissolution without the APIs chemically degrading each other) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute gynecological and emergency dispensing regimens).
Drotaverine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly bitter hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Drotaverine Hydrochloride USP/Ph.Eur. 40 mg The Standard GI/Gynecology Anchor: The definitive therapeutic unit utilized for irritable bowel syndrome (IBS), routine dysmenorrhea, and mild gastrointestinal cramping. Drotaverine Hydrochloride USP/Ph.Eur. 80 mg (Forte) The Acute Colic Macrodose: Massive therapeutic payload utilized for the immediate, aggressive suppression of agonizing renal colic (kidney stones), biliary colic (gallstones), and severe cervical spasms during labor. Excipients Lactose Monohydrate / Maize Starch / Crospovidone / Talc / Magnesium Stearate / Premium Polymeric Film Diluent / Disintegrant / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the tablet shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the intense, bitter taste of the API) *Pack Sizes: 10×10 Blisters (Optimized specifically for rapid-response acute ward dispensing and outpatient pain management).
Duloxetine Tablets
FreeProduct Composition & Strength
We supply this product as Gastro-Resistant Tablets or Delayed-Release Capsules (containing enteric-coated pellets). Both forms ensure optimal bioavailability.
Active Ingredient Strength (Standard) Primary Role Duloxetine HCl USP/BP 20 mg Geriatric / Initial Dose Duloxetine HCl USP/BP 30 mg Standard Maintenance (Pain/Anxiety) Duloxetine HCl USP/BP 40 mg High Strength (Specific Mkts) Duloxetine HCl USP/BP 60 mg High Strength (Depression/Neuropathy) Dydrogesterone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the retro-steroidal API.
Active Ingredient Strength Primary Clinical Function Dydrogesterone USP/Ph.Eur. 10 mg The Global Fertility & Maternal Standard: The definitive therapeutic unit utilized globally for luteal phase support, miscarriage prevention, and chronic endometriosis management. Excipients Lactose Monohydrate / Hypromellose / Maize Starch / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Disintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing high-shear wet granulation to ensure the 10mg steroidal payload is flawlessly uniform, finished with an opaque film-coat to lock the teratogen/hormone safely away from factory handlers) *Pack Sizes: 10×10 Blisters or Calendar Blisters of 14/28 (Optimized specifically for precise tracking during the menstrual cycle and IVF protocols).
Ebastine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Dissolution Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the piperidine derivative API.
Active Ingredient Strength Primary Clinical Function Ebastine USP/Ph.Eur. 10 mg The Standard Allergy Anchor: The definitive once-daily unit utilized for the baseline control of Seasonal and Perennial Allergic Rhinitis (Hay Fever). Ebastine USP/Ph.Eur. 20 mg The Dermatology Macrodose: High-efficacy therapeutic payload utilized strictly for severe, refractory Chronic Idiopathic Urticaria (hives) or intensely severe allergic rhinitis. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered utilizing elite rapid-burst disintegrants to ensure the tablet dissolves instantly in gastric fluid, expediting the hepatic conversion to Carebastine for the fastest possible onset of clinical relief) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, 30-day chronic allergy and dermatology dispensing regimens).
Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression. Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg The Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Efavirenz Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.
Active Ingredient Strength Primary Clinical Function Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg
(Eq. to 245 mg Tenofovir Disoproxil)The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry) Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Enalapril Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration). The wide range of strengths allows for the “Start Low, Go Slow” dosing strategy essential for heart failure.
Active Ingredient Strength (Standard) Primary Role Enalapril Maleate USP/BP 2.5 mg Heart Failure Initiation Enalapril Maleate USP/BP 5 mg Hypertension Initiation Enalapril Maleate USP/BP 10 mg Maintenance Dose Enalapril Maleate USP/BP 20 mg High Strength Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Epalrestat Sustained Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable SR Matrix Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of the intensely photolabile molecule.
Active Ingredient Strength Primary Clinical Function Epalrestat USP/Ph.Eur. 150 mg (SR) The Global Diabetology Standard: The definitive macrodose engineered for 24-hour continuous aldose reductase suppression, dramatically improving patient adherence over standard 50mg TID dosing. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Titanium-Dioxide Film Rate-Controlling Polymer / Diluent / Glidant / Lubricant / UV-Barrier Film (Engineered utilizing elite viscosity-grade HPMC to form a gel-matrix in the gut for sustained drug release, finished with a heavy, opaque film-coat to act as an absolute UV/Light barrier) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 3-to-6 month chronic diabetic dispensing regimens).
Ergometrine Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets. The coating is critical to protect the active ingredient from oxidation and light.
Active Ingredient Strength (Standard) Primary Role Ergometrine Maleate USP/BP 0.2 mg (200 mcg) PPH Prevention / Subinvolution Ergometrine Maleate USP/BP 0.5 mg (500 mcg) High Potency (Specific Mkts) Excipients Q.S. Tartaric Acid (Stabilizer) Ergotamine & Caffeine ,Paracetamol & Prochlorperazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Quad-API Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive ergot alkaloid and phenothiazine components.
Active Ingredient Strength Primary Clinical Function Ergotamine Tartrate USP/Ph.Eur. 1 mg The Vascular Terminator (Micro-Dose): The foundational ergot alkaloid required to aggressively constrict pulsing cranial arteries. Caffeine Anhydrous USP/Ph.Eur. 100 mg The Absorption Catalyst: Enhances Ergotamine bioavailability and accelerates onset of action. Paracetamol (Acetaminophen) USP/Ph.Eur. 250 mg The Central Analgesic (Macro-Dose): Provides immediate, broad-spectrum relief from accompanying head and neck pain. Prochlorperazine Maleate USP/Ph.Eur. 2.5 mg The Antiemetic Anchor (Ultra-Micro-Dose): Lethally blocks the CTZ to prevent vomiting and ensure full gastrointestinal absorption of the FDC. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant (Engineered utilizing extreme multi-stage geometric dilution to flawlessly blend a microscopic 1mg and 2.5mg payload into a massive 250mg/100mg base, guaranteeing absolute content uniformity and zero toxic ‘hot spots’) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, heavily limited acute neurology dispensing to prevent ergot toxicity).
Erlotinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic API.
Active Ingredient Strength Primary Clinical Function Erlotinib (as Hydrochloride) USP/Ph.Eur. 100 mg The Pancreatic Oncology Standard: The definitive daily maintenance dose utilized globally in combination with Gemcitabine for advanced, unresectable, or metastatic pancreatic cancer. Erlotinib (as Hydrochloride) USP/Ph.Eur. 150 mg The Thoracic Oncology Standard: Massive therapeutic payload utilized as a first-line, maintenance, or second-line daily monotherapy for EGFR-mutated Non-Small Cell Lung Cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize dissolution of this highly insoluble compound while locking the potent cytotoxic API safely inside the tablet, completely preventing handler exposure to carcinogenic dust) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Erythromycin Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Pink/Red). The coating is essential to mask the intensely bitter taste of the API.
Active Ingredient Strength (Standard) Primary Role Erythromycin Stearate USP/BP
(Equivalent to Erythromycin Base)250 mg Pediatric / Mild Infection Erythromycin Stearate USP/BP
(Equivalent to Erythromycin Base)500 mg Adult Standard Dose Excipients Q.S. Maize Starch / Povidone Escitalopram Oxalate & Clonazepam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Escitalopram (as Oxalate) USP/Ph.Eur. 5 mg / 10 mg The Serotonin Anchor (Macro-Dose): The foundational, highly selective SSRI required to cure the underlying clinical depression and generalized anxiety. Clonazepam USP/Ph.Eur. 0.25 mg / 0.5 mg The Anxiolytic Bridge (Micro-Dose): The highly potent, long-acting benzodiazepine required to suppress acute panic attacks and SSRI-induced activation syndrome. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 0.25mg/0.5mg micro-dose of Clonazepam is flawlessly distributed throughout the Escitalopram matrix, preventing toxic “hot spots”) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 2-to-4 week short-term bridging regimens before stepping down to Escitalopram monotherapy).
Esomeprazole Tablets
FreeProduct Composition & Strength
We supply this product as Gastro-Resistant (Enteric Coated) Tablets. The drug is acid-labile and must pass through the stomach intact to be absorbed in the intestine.
Active Ingredient Strength (Standard) Role Esomeprazole Magnesium Trihydrate USP/BP 20 mg Maintenance / Mild GERD Esomeprazole Magnesium Trihydrate USP/BP 40 mg Erosive Esophagitis / Zollinger-Ellison Excipients Q.S. Enteric Polymers (Methacrylic Acid) Ethambutol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often Gray or White). Coating is essential as the API is hygroscopic and has a bitter taste.
Active Ingredient Strength (Standard) Primary Role Ethambutol HCl USP/BP/IP 200 mg Pediatric / Renal Adjustment Ethambutol HCl USP/BP/IP 400 mg Standard Adult Unit Ethambutol HCl USP/BP/IP 600 mg High Strength (Daily Regimen) Ethambutol HCl USP/BP/IP 800 mg Intensive Phase Loading Ethambutol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is essential as Ethambutol HCl is highly hygroscopic (absorbs moisture) and has a bitter taste.
Active Ingredient Strength (Standard) Role in DOTS Therapy Ethambutol HCl USP/BP 200 mg Pediatric / Renal Adjustment Ethambutol HCl USP/BP 400 mg Standard Adult Unit Ethambutol HCl USP/BP 600 mg / 800 mg High Weight Band / Forte Ethambutol HCl USP/BP 1000 mg High Dose (Special Order) Excipients Q.S. Sorbitol / Magnesium Stearate Ethamsylate tablets
FreeAn Ethamsylate tablet is a hemostatic (antihemorrhagic) medication used to prevent and control excessive bleeding, particularly from small blood vessels (capillaries).
Ethamsylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Oxidation-Resistant Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical survival of the highly reactive active ingredient.
Active Ingredient Strength Primary Clinical Function Ethamsylate USP/Ph.Eur. 250 mg The Prophylactic Surgical Standard: Base therapeutic unit utilized for pre-operative dosing to prevent excessive capillary oozing during delicate ENT (tonsillectomy) or dental procedures. Ethamsylate USP/Ph.Eur. 500 mg The Acute Gynecology Macrodose: Massive therapeutic payload utilized for the aggressive, immediate suppression of severe menorrhagia (heavy menstrual bleeding) and acute trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Metabisulfite / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Antioxidant / Film-Coating (Engineered specifically incorporating powerful antioxidants and a heavy moisture-barrier film to completely shield the API from atmospheric oxygen, preventing the tablet from degrading and turning black/pink on the shelf) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 5-to-10 day acute surgical and gynecological dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Ethinylestradiol & Levonorgestrel Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant “Calendar Blister” packs to ensure absolute daily patient compliance and chemical stability.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.03 mg (30 mcg) The Estrogenic Anchor: The synthetic estrogen required to suppress FSH release and stabilize the uterine lining to prevent irregular breakthrough bleeding. Levonorgestrel USP/Ph.Eur. 0.15 mg (150 mcg) The Progestin Powerhouse: The highly potent, second-generation progestin required to suppress the LH surge and thicken the cervical mucus. Excipients Lactose Monohydrate / Maize Starch / Povidone K-30 / Magnesium Stearate / Premium Sugar/Film Coating Diluent / Disintegrant / High-Shear Binder / Lubricant (Engineered specifically using elite multi-stage geometric dilution to guarantee the microscopic 30 mcg and 150 mcg payloads are flawlessly distributed, preventing lethal hormonal drops that cause contraceptive failure) *Pack Sizes: 21-Day Active Blisters OR 28-Day Calendar Blisters (21 Active Hormonal Tablets + 7 Placebo/Iron Tablets to enforce daily habit-forming compliance).
Ethionamide Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Yellow/Orange). Effective coating is mandatory as the drug causes significant gastric irritation and has a metallic taste.
Active Ingredient Strength (Standard) Target Patient Ethionamide USP/BP/IP 250 mg Standard Adult / Pediatric Unit Excipients Q.S. Microcrystalline Cellulose / Hypromellose Etizolam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the ultra-low-dose API.
Active Ingredient Strength Primary Clinical Function Etizolam JP/Ph.Eur. 0.25 mg The Geriatric & Daytime Standard: The definitive ultra-low-dose unit utilized for daytime anxiety suppression without severe sedation, or for highly sensitive elderly patients. Etizolam JP/Ph.Eur. 0.5 mg / 1 mg The Panic & Insomnia Standard: High-efficacy therapeutic payload utilized for the immediate termination of acute panic attacks and the induction of sleep in severe insomnia. Excipients (MD Formulation) Mannitol / Crospovidone / Aspartame / Peppermint Flavor / Magnesium Stearate Diluent / Superdisintegrant / Sweetener / Flavoring (Engineered specifically using elite “Rapid-Burst” superdisintegrants to ensure the tablet shatters and dissolves in saliva within seconds, masking the chemical taste for maximum patient compliance during severe distress) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, short-term psychiatric dispensing regimens).
Etofylline Theophylline Tablets
FreeProduct Composition & Strength
We supply this product as Prolonged Release (PR/Retard) Tablets or standard Film Coated Tablets.
Formulation Variant Etofylline Strength Theophylline Strength Total Potency Role Standard Tablet 77 mg 23 mg 100 mg Acute / Pediatric Retard 150 115 mg 35 mg 150 mg Mild Maintenance Retard 300 231 mg 69 mg 300 mg Adult Standard (BID) Retard 450 346.5 mg 103.5 mg 450 mg High Dose (OD) Etoricoxib Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (distinctively colored by strength). The coating masks the bitter taste and ensures stability.
Active Ingredient Strength (Standard) Color (Typical) Primary Indication Etoricoxib USP/BP 60 mg Green Osteoarthritis / Chronic Pain Etoricoxib USP/BP 90 mg White Rheumatoid Arthritis / Dental Pain Etoricoxib USP/BP 120 mg Pale Green Acute Gout (Short Term) Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Famotidine & Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density Alu-PVC blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Famotidine USP/Ph.Eur. 20 mg Global Clinical Standard: Safe, NDMA-free H2 antagonist for baseline acid suppression. Domperidone Maleate BP/Ph.Eur. 10 mg (Base Equivalent) Peripheral prokinetic and anti-emetic to accelerate gastric emptying and prevent reflux. Excipients Microcrystalline Cellulose / Maize Starch / Crospovidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered for immediate gastric dissolution and synchronized absorption) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover retail OTC and acute gastroenterology dispensing).
Famotidine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Square or Round). The film coating masks the bitter taste and protects the API from moisture.
Active Ingredient Strength (Standard) Role Famotidine USP/BP 20 mg GERD / Heartburn / Maintenance Famotidine USP/BP 40 mg Ulcer Healing / Hypersecretory States Excipients Q.S. Starch (Disintegrant) / Hypromellose Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
Ferrous Acorbate & Folic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Hematinic FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive iron complex.
Active Ingredient Strength Primary Clinical Function Ferrous Ascorbate USP/Ph.Eur.
(Equivalent to Elemental Iron)100 mg The Hemoglobin Anchor: Massive, highly bioavailable elemental iron payload required to rapidly reverse severe maternal anemia without inducing dose-limiting gastric toxicity. Folic Acid (Vitamin B9) USP/Ph.Eur. 1.5 mg The DNA Synthesizer: Critical micro-dose required to drive red blood cell proliferation and guarantee fetal neurodevelopmental safety. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Film-Coating (Engineered specifically using a heavy, dark-colored polymeric film-coat to completely mask the violent, metallic taste of the iron and prevent the tablet from rapidly oxidizing on the shelf) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, daily 9-month prenatal dispensing regimens).
Ferrous Folic Tablets
FreeProduct Composition & Strength
We supply this product primarily as Sugar Coated Tablets (Red/Maroon) to mask the metallic taste, or Film Coated Tablets.
Component Strength (Standard) Strength (Therapeutic) Role Dried Ferrous Sulphate 200 mg
(~60-65 mg Elemental Iron)200 mg
(~60-65 mg Elemental Iron)Hemoglobin Synthesis Folic Acid 0.4 mg (400 mcg) 1.5 mg / 5 mg DNA Synthesis / NTD Prevention Color Red / Maroon Red / Brown Identification Ferrous Fumarate with Folic Acid Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is essential to mask the metallic taste of iron and prevent the oxidation of the ferrous salt during storage.
Active Ingredient Strength (Standard) Therapeutic Role Ferrous Fumarate BP/USP 200 mg / 300 mg Hematinic (Iron Supplement) Folic Acid BP/USP 0.4 mg / 0.5 mg / 1 mg / 5 mg Vitamin B9 (Folates) Excipients Q.S. Povidone / Talc / Magnesium Stearate Stabilizing Core Matrix Ferrous Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (Red/Brown) or Film Coated Tablets. The sugar coating is critical to mask the strong, astringent metallic taste and prevent gastric nausea.
Active Ingredient Strength Elemental Iron Primary Role Dried Ferrous Sulphate USP/BP 200 mg ~ 65 mg Standard Adult Therapy Dried Ferrous Sulphate USP/BP 300 mg ~ 100 mg High Dose Treatment Excipients Q.S. Sucrose (Coating) / Talc Taste Masking Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Finasteride USP/Ph.Eur. 1 mg The Global Dermatology Standard: The definitive micro-dose engineered specifically for the lifelong, daily maintenance of Androgenetic Alopecia (Male Pattern Hair Loss). Finasteride USP/Ph.Eur. 5 mg The Global Urology Standard: High-efficacy macro-dose utilized for the aggressive shrinkage of the prostate gland in symptomatic Benign Prostatic Hyperplasia (BPH). Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Docusate Sodium / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Opadry Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the teratogenic API, ensuring absolute safety for female pharmacists and caregivers handling the medication) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strict, lifelong chronic urology and dermatology dispensing regimens).
Flavoxate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Flavoxate Hydrochloride USP/Ph.Eur. 200 mg The Global Urological Standard: The definitive macrodose therapeutic unit utilized for rapid, acute suppression of agonizing bladder spasms and chronic overactive bladder maintenance. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 200mg tablet shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-4 times daily acute dispensing regimens).
Fluconazole & Ivermectin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Fluconazole USP/Ph.Eur. 150 mg The Antifungal Anchor (Macro-Dose): The foundational triazole payload required to systematically eradicate widespread dermatophytes and yeasts. Ivermectin EP/USP 6 mg / 12 mg The Antiparasitic Assassin (Micro-Dose): The highly potent, targeted neurotoxin required to paralyze burrowing mites, lice, and severe helminthic infections. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 6mg micro-dose of Ivermectin is flawlessly distributed throughout the massive Fluconazole matrix, preventing toxic “hot spots”) *Pack Sizes: Single-Dose Blister Packs (1×1 or 1×2) or 10×10 Blisters (Optimized specifically for rapid NGO deployment and “stat” dosing protocols).
Fluconazole Tablets
FreeFLUCONAZOLE TABLETS IP 150 MG
Each uncoated tablet contains:
Fluconazole IP 150 mg Excipients q.s.Nuflucon – 200
Fluconazole Tablets IP 200 mg
Each Uncoated Tablet contains :
Fluconazole IP 200 mgUsage: – Prevent and treat a variety of fungal and yeast infections
Category: – Antifungal Drugs
Therapeutic category: – Antifungal
Flunarazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the dihydrochloride salt.
Active Ingredient Strength Primary Clinical Function Flunarizine (as Dihydrochloride) USP/Ph.Eur. 5 mg The Pediatric & Geriatric Standard: The definitive low-dose unit required for migraine prophylaxis in children or for treating vertigo in elderly patients who are highly sensitive to drug accumulation. Flunarizine (as Dihydrochloride) USP/Ph.Eur. 10 mg The Global Adult Migraine Standard: High-efficacy adult maintenance dose utilized for maximum suppression of chronic, refractory migraine attacks. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant / Lubricant (Engineered utilizing elite low-dose geometric dilution to guarantee that the 5mg or 10mg micro-dose is flawlessly distributed, preventing accidental drug-accumulation spikes) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, heavily monitored 3-to-6 month neurology dispensing regimens).
Flupentixol & Melitracen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, light-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly photolabile thioxanthene derivative.
Active Ingredient Strength Primary Clinical Function Flupentixol (as Dihydrochloride) USP/Ph.Eur. 0.5 mg The Anxiolytic Activator (Ultra-Micro-Dose): The foundational presynaptic autoreceptor antagonist required to rapidly resolve apathy, fatigue, and physical tension. Melitracen (as Hydrochloride) USP/Ph.Eur. 10 mg The Mood Elevator (Micro-Dose): The highly tolerable TCA required to lift the baseline depressive neurosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opaque Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / UV-Barrier Film (Engineered utilizing elite multi-stage geometric dilution to guarantee the lethal 0.5mg micro-dose of Flupentixol is flawlessly distributed throughout the matrix, finished with a heavy, opaque coat to prevent UV degradation) *Pack Sizes: 10×10 Blisters (Optimized specifically for rapid-response, short-to-medium term psychiatric and general medicine dispensing regimens).
Flutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antiandrogen API.
Active Ingredient Strength Primary Clinical Function Flutamide USP/Ph.Eur. 250 mg Global Uro-Oncology Standard: The definitive therapeutic unit utilized for chronic, 8-hourly maintenance in Maximum Androgen Blockade (MAB) protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the potent antiandrogen API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous hormonal dust) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic oncology dispensing regimens).
Fluvoxamine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the maleate salt.
Active Ingredient Strength Primary Clinical Function Fluvoxamine Maleate USP/Ph.Eur. 50 mg (Scored) Psychiatric Titration Standard: The definitive base unit required for the slow, highly monitored initiation of therapy to prevent severe nausea and activation syndrome in hyper-anxious patients. Fluvoxamine Maleate USP/Ph.Eur. 100 mg (Scored) Global OCD Maintenance Standard: High-efficacy adult maintenance dose. OCD frequently requires massive dosing (up to 300 mg/day), requiring dense, easily swallowable macrodose tablets. Excipients Mannitol / Microcrystalline Cellulose / Pregelatinized Starch / Sodium Stearyl Fumarate / Premium Hypromellose Film Diluent / Binder / Disintegrant / Lubricant / Slipper-Coating (Engineered specifically to compress the active API securely while utilizing a heavy, slick film-coat to completely mask the intensely bitter taste of Fluvoxamine, ensuring long-term patient compliance) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 3-to-6 month chronic psychiatric dispensing regimens).
Folic Acid Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Yellow/Orange) in standard therapeutic and prophylactic strengths.
Active Ingredient Strength (Standard) Primary Role Folic Acid USP/BP 400 mcg (0.4 mg) Pre-conception / Prophylaxis Folic Acid USP/BP 1 mg High Risk Prophylaxis Folic Acid USP/BP 5 mg Therapeutic / Anemia Treatment Excipients Q.S. Lactose (Filler) / Starch Folic Acid, Niacinamide Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated or Sugar Coated Tablets (typically Yellow or White). The coating protects the photosensitive vitamins from degradation.
Active Ingredient Strength (Standard) Therapeutic Role Folic Acid USP/BP 1.5 mg / 5 mg DNA Repair / Anemia Prevention Niacinamide USP/BP 20 mg / 50 mg / 100 mg Metabolic Support / Skin Barrier Excipients Q.S. Dibasic Calcium Phosphate / Starch Filler / Disintegrant Frusemide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White/Light Sensitive). We offer a wide range of strengths, including high-dose variants for renal failure.
Active Ingredient Strength (Standard) Primary Indication Frusemide USP/BP/IP 20 mg Geriatric / Mild Edema Frusemide USP/BP/IP 40 mg Standard Adult Dose Frusemide USP/BP/IP 500 mg Severe Renal Failure (Dialysis Support) Excipients Q.S. Lactose / Starch / Talc Furazolidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Tablet, packed exclusively in highly secure, opaque Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical survival of the intensely photolabile (light-sensitive) nitrofuran molecule.
Active Ingredient Strength Primary Clinical Function Furazolidone USP/Ph.Eur. 100 mg Global Outbreak & Dysentery Standard: The definitive therapeutic unit utilized for rapid, massive-dose eradication of intestinal protozoa and severe bacterial enteritis. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Opacifying Film-Coat Diluent / Superdisintegrant / Binder / Lubricant / UV-Barrier Film (Engineered specifically using heavy Titanium Dioxide film-coating to block ultraviolet light, preventing the yellow Furazolidone powder from oxidizing and degrading into a useless brown paste before ingestion) *Pack Sizes: 10×10 Blisters (Optimized specifically for rapid NGO deployment and short-course 5-to-7 day dysentery eradication protocols).
Furosemide & Spironolactone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Furosemide USP/Ph.Eur. 20 mg The Loop Diuretic (Fluid Clearance): Rapidly eliminates severe fluid buildup (edema) from the lungs, abdomen, and peripheral tissues. Spironolactone USP/Ph.Eur. 50 mg The Potassium-Sparing Shield: Blocks aldosterone, prevents toxic cardiac fibrosis, and heavily protects the patient against lethal hypokalemia. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Slipper-Coating (Engineered utilizing advanced wet-granulation to ensure both the rapid-acting Furosemide and the slower-acting Spironolactone dissolve at precise, synchronized rates to guarantee the electrolyte-sparing synergy) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict chronic cardiology and hepatology dispensing regimens).
Gabapentin & Amitriptyline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Gabapentin USP/Ph.Eur. 300 mg / 400 mg The Neuromodulator (Macro-Dose): The foundational calcium-channel inhibitor required to stabilize hyperactive nerve terminals. Amitriptyline (as Hydrochloride) USP/Ph.Eur. 10 mg The Synaptic Enhancer (Micro-Dose): The highly potent TCA required to amplify descending pain inhibition and restore sleep patterns. Excipients Microcrystalline Cellulose / Crospovidone / Copovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 10mg micro-dose of Amitriptyline is flawlessly distributed throughout the massive Gabapentin matrix, preventing toxic “hot spots”) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic neurology dispensing regimens).
Gabapentin & Methylcobalamin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable FDC Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of the ultra-fragile B12 molecule.
Active Ingredient Strength Primary Clinical Function Gabapentin USP/Ph.Eur. 300 mg / 400 mg The Neuromodulator (Macro-Dose): The foundational calcium-channel inhibitor required to stabilize hyperactive nerve terminals and stop the shooting pain. Methylcobalamin (Mecobalamin) JP/USP 500 mcg / 1500 mcg The Myelin Regenerator (Micro-Dose): The highly potent, biologically active B12 analogue required to stimulate axonal growth and rebuild the damaged myelin sheath. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Copovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Titanium-Dioxide Film Diluent / Superdisintegrant / Binder / Glidant / Film-Coating (Engineered utilizing strictly segregated blending or Bilayer technology to prevent the massive Gabapentin dose from degrading the microscopic Methylcobalamin, finished with a heavy, opaque film-coat to act as an absolute UV/Light barrier) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 3-to-6 month chronic diabetic and neurology dispensing regimens).
Gabapentin & Nortriptyline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Gabapentin USP/Ph.Eur. 400 mg The Neuromodulator (Macro-Dose): The foundational calcium-channel inhibitor required to stabilize hyperactive nerve terminals. Nortriptyline (as Hydrochloride) USP/Ph.Eur. 10 mg The Synaptic Enhancer (Micro-Dose): The highly potent TCA required to amplify descending pain inhibition and restore sleep patterns. Excipients Microcrystalline Cellulose / Crospovidone / Copovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 10mg micro-dose of Nortriptyline is flawlessly distributed throughout the massive 400mg Gabapentin matrix, preventing toxic “hot spots”) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic neurology dispensing regimens).
Gabapentine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the heavily compressed active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Gabapentin USP/Ph.Eur. 600 mg Global Neuropathy Standard: The definitive high-dose unit utilized for the aggressive, long-term maintenance of severe diabetic peripheral neuropathy and postherpetic neuralgia. Gabapentin USP/Ph.Eur. 800 mg Max-Dose Seizure & Refractory Pain Standard: Massive therapeutic payload utilized for high-dose titration (up to 3600 mg/day) in refractory partial-onset seizures and extreme nerve pain. Excipients Copovidone / Crospovidone / Microcrystalline Cellulose / Magnesium Stearate / Premium Polymeric Film High-Shear Binder / Superdisintegrant / Diluent / Slipper-Coating (Engineered specifically utilizing advanced wet-granulation to compress the massive, fluffy 800mg API into a dense, smooth, swallowable tablet, preventing the pill from becoming a dangerous choking hazard for elderly patients) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for chronic, high-volume daily dispensing regimens).
Ganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Ganciclovir USP/Ph.Eur. 250 mg Renal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance). Ganciclovir USP/Ph.Eur. 500 mg Global Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).
Gefitinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Gefitinib USP/Ph.Eur. 250 mg Global Adult Oncology Standard: The definitive, highly precise daily maintenance dose required to maintain constant, paralyzing pressure on the mutated EGFR protein to keep the lung cancer in deep molecular remission. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize the dissolution of this poorly soluble compound while locking the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Ginkgo Biloba Extract ,Piracetam & Vinpocetine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the combined phyto-synthetic payloads.
Active Ingredient Strength Primary Clinical Function Piracetam USP/Ph.Eur. 400 mg / 800 mg The Nootropic Anchor: Massive synthetic payload required to force neuroplasticity, enhance membrane fluidity, and restore memory function in damaged neural networks. Ginkgo Biloba Extract (Standardized) 60 mg The Microcirculatory Botanical: Standardized extract to prevent capillary clotting and shield the brain from oxidative stress. Vinpocetine USP/Ph.Eur. 5 mg The Cerebral Oxygenator (Micro-Dose): Targeted vasodilation of cerebral arteries to immediately restore oxygen delivery to ischemic tissues. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Polyvinylpyrrolidone (PVP) / Magnesium Stearate / Premium Moisture-Barrier Film Diluent / Superdisintegrant / Binder / Slipper-Coating (Engineered specifically to compress the incredibly bulky Piracetam alongside the sticky herbal extract into a single, dense, swallowable pill, heavily coated to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic 3-to-6 month neurology dispensing regimens).
Ginkgo Biloba Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Pharmaceutical-Grade Botanical Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic herbal extract.
Active Ingredient Strength Primary Clinical Function Standardized Ginkgo Biloba Extract (Leaves) 40 mg The Tinnitus & Vertigo Standard: Base therapeutic unit frequently prescribed three times daily for the management of inner-ear microcirculatory disorders (tinnitus and dizziness). Standardized Ginkgo Biloba Extract (Leaves)
*Strictly Standardized to 24% Ginkgo Flavone Glycosides & 6% Terpene Lactones (EGb 761 Equivalent)80 mg / 120 mg The Cognitive & Vascular Standard: High-efficacy adult macro-doses utilized for the targeted treatment of vascular dementia, Alzheimer’s disease adjunct therapy, and intermittent claudication. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Anhydrous Silica / Magnesium Stearate / Premium Moisture-Barrier Film Diluent / Superdisintegrant / Glidant / Lubricant (Engineered utilizing strictly climate-controlled dry-granulation to prevent the intensely sticky botanical extract from agglomerating, heavily coated to lock out humidity and prevent the characteristic pungent botanical odor) *Pack Sizes: 10×10 Blisters or Bottles of 60 (Optimized specifically for chronic, lifelong neuro-vascular maintenance).
Glibenclamide & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Metformin HCl 400 mg / 500 mg The Foundation: Reduces glucose production. Glibenclamide (Glyburide) 2.5 mg / 5 mg The Stimulator: Enhances insulin secretion. Excipients Pharma Grade The Matrix: Ensures stability of the FDC. Glibenclamide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). The tablet is usually white or pink and scored to allow for precise dose titration.
Active Ingredient Strength (Standard) Role Glibenclamide USP/BP 1.25 mg Geriatric / Renal Impairment Glibenclamide USP/BP 2.5 mg Initial Dose / Mild Diabetes Glibenclamide USP/BP 5 mg Standard Therapeutic Dose Excipients Q.S. Lactose (Diluent) / Maize Starch Glibenclamide, Metformin & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.
Active Ingredient Strength Primary Clinical Function Glibenclamide USP/Ph.Eur. 5 mg The Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes. Pioglitazone (as Hydrochloride) USP/Ph.Eur. 15 mg The Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue. Metformin Hydrochloride USP/Ph.Eur. 500 mg (IR or ER) The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).
Gliclazide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Immediate Release) or Modified Release (MR) Tablets (Once Daily).
Active Ingredient Strength Formulation Role Gliclazide BP/EP 80 mg Immediate Release Standard Divided Dose Gliclazide BP/EP 30 mg Modified Release (MR) Once Daily (Start) Gliclazide BP/EP 60 mg Modified Release (MR) Once Daily (Maintenance) Excipients Q.S. HPMC (Matrix) / Lactose Release Control Glimepiride & Metformin Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Bilayered Tablets or Film Coated Tablets. The bilayered technology is often used to manage the different release profiles and physical characteristics of the two APIs.
Active Ingredient Strength (Standard) Therapeutic Role Glimepiride USP/BP/IP 1 mg / 2 mg Sulfonylurea (Insulin Secretagogue) Metformin HCl USP/BP/IP 500 mg / 1000 mg Biguanide (Insulin Sensitizer) Excipients Q.S. Povidone / Magnesium Stearate Stabilizing Core Matrix Glimepiride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (often color-coded by strength). This allows for precise titration from very low doses.
Active Ingredient Strength (Standard) Color Code (Typical) Role Glimepiride USP/BP/IP 1 mg Pink Initial Dose Glimepiride USP/BP/IP 2 mg Green Titration Step 1 Glimepiride USP/BP/IP 3 mg Yellow Titration Step 2 Glimepiride USP/BP/IP 4 mg Blue Maintenance / High Dose Glimepiride, Pioglitazone & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Common Strength Primary Clinical Function Metformin HCl (SR/IR) 500 mg / 1000 mg The Foundation: Reduces glucose production. Glimepiride 1 mg / 2 mg The Stimulator: Enhances insulin secretion. Pioglitazone 15 mg The Sensitizer: Fixes insulin resistance. Glipizide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Immediate Release) or Extended Release (XL/SR) Tablets using osmotic pump or matrix technology.
Active Ingredient Strength Formulation Role Glipizide USP/BP 5 mg Immediate Release Standard Initial Dose Glipizide USP/BP 10 mg Immediate Release High Potency Maintenance Glipizide USP/BP 5 mg / 10 mg Extended Release (XL) Once Daily (24hr Control) Excipients Q.S. Lactose / Stearic Acid Binder / Lubricant Glucosamine ,Chondroitin & Diacerein Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Oblong Caplet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic sulfate salts.
Active Ingredient Strength Primary Clinical Function Glucosamine Sulfate Potassium Chloride USP/Ph.Eur. 750 mg The Structural Foundation: Massive therapeutic payload required to stimulate raw cartilage synthesis. Chondroitin Sulfate Sodium USP/Ph.Eur. 200 mg / 250 mg The Hydraulic Restorer: Pulls water into the joint matrix to restore physical shock-absorption and elasticity. Diacerein USP/Ph.Eur. 50 mg The Biochemical Brake: Direct Interleukin-1 (IL-1) inhibition to halt the enzymatic degradation of the joint space. Excipients Microcrystalline Cellulose / Povidone K-30 / Croscarmellose Sodium / Magnesium Stearate / Premium Moisture-Barrier Film Diluent / High-Shear Binder / Superdisintegrant / Lubricant / Slipper-Coating (Engineered specifically to compress over 1000mg of bulky, powdery API into a single, dense, swallowable “caplet” without crumbling, heavily coated to mask the bitter taste and lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 3-to-6 month chronic orthopedic dispensing regimens).
Glucosamine Sulphate Chondroitin Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Large Oval/Caplet shape). The formulation is optimized for high bioavailability and stability.
Active Ingredient Strength Source/Form Glucosamine Sulphate
(as Glucosamine Sulphate Potassium Chloride)500 mg Marine (Shellfish) Exoskeletons Chondroitin Sulphate Sodium 400 mg Bovine / Shark Cartilage (High Purity) Excipients Q.S. PVP K-30 (Binder) / Titanium Dioxide Glyceryl Trinitrate Tablets
FreeProduct Composition & Strength
We supply this product as Sublingual Tablets (Dissolve under tongue) or Sustained Release (SR) Tablets (Swallow whole for prevention).
Active Ingredient Strength Formulation Role Diluted Glyceryl Trinitrate USP 0.5 mg (500 mcg) Sublingual (SL) Acute Attack Rescue Diluted Glyceryl Trinitrate USP 2.6 mg Sustained Release (SR) Angina Prophylaxis Diluted Glyceryl Trinitrate USP 6.4 mg Sustained Release (SR) High Dose Maintenance Excipients Q.S. Lactose (Adsorbent) / Stearates Stability Matrixt Griseofulvin Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored). Critical to its efficacy is the particle size; we strictly use Micronized API to ensure adequate absorption.
Active Ingredient Strength (Standard) Form Role Griseofulvin USP/BP 125 mg Micronized Pediatric (Tinea Capitis) Griseofulvin USP/BP 250 mg Micronized Standard Adult Dose Griseofulvin USP/BP 500 mg Micronized High Dose / Resistant Cases Excipients Q.S. Povidone / Maize Starch Binder / Disintegrant Haloperidol Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (often small, white or yellow). We offer a wide range of strengths for precise titration.
Active Ingredient Strength (Standard) Primary Role Haloperidol USP/BP 1.5 mg Geriatric / Maintenance Haloperidol USP/BP 5 mg Standard Acute Dose Haloperidol USP/BP 10 mg Severe Psychosis / Mania Haloperidol USP/BP 20 mg Treatment Resistant Cases HP Kit (Pantoprazole,Metronidazole & Clarithromycin Tablets)
FreeProduct Composition & Strength
We supply this product as a Precision-Packed, Multi-Component Combi-Kit, packed exclusively in highly secure, day-labeled Alu-Alu blister strips to ensure the absolute chemical stability of all three distinct APIs while forcing flawless patient compliance.
Active Component (Per Daily Blister) Strength & Form Primary Clinical Function Pantoprazole Sodium USP/Ph.Eur.
(2 Tablets per kit)40 mg (Gastro-Resistant / Enteric Coated) The Environmental Modulator: Suppresses acid, heals the ulcer, and creates the required pH for antibiotic survival. (Must be heavily enteric-coated to survive the stomach and absorb in the duodenum). Clarithromycin USP/Ph.Eur.
(2 Tablets per kit)500 mg (Film-Coated) The Primary Bacteriostatic: Halts bacterial protein synthesis. Heavy film-coating masks the intensely bitter, metallic macrolide taste. Metronidazole USP/Ph.Eur.
(2 Tablets per kit)400 mg / 500 mg (Film-Coated) The Bactericidal Finisher: Destroys bacterial DNA. Crucial alternative to Amoxicillin for penicillin-allergic demographics or regions with high amoxicillin resistance. *Pack Sizes: 1 Day Kit (containing 6 tablets total: 1 of each for Morning, 1 of each for Evening). Generally supplied in 7-Day or 14-Day Full Therapy Cartons.
Hydralazine Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (often Yellow or Orange). Uncoated tablets are avoided due to stability issues.
Active Ingredient Strength (Standard) Role Hydralazine HCl USP/BP 25 mg Initial Dose / Titration Hydralazine HCl USP/BP 50 mg Maintenance Dose Excipients Q.S. Coating Agents / Stabilizers Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration). Accurate low-dose titration is critical for modern therapy.
Active Ingredient Strength (Standard) Role Hydrochlorothiazide USP/BP 12.5 mg Initial Dose / Combination Use Hydrochlorothiazide USP/BP 25 mg Standard Therapeutic Dose Hydrochlorothiazide USP/BP 50 mg Edema / High Potency Excipients Q.S. Lactose (Filler) / Starch Hydrocortisone Oromucosal Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Mucoadhesive Pellet/Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the highly hygroscopic polymers do not prematurely swell from atmospheric humidity.
Active Ingredient Strength Primary Clinical Function Hydrocortisone (as Sodium Succinate or Acetate) USP/Ph.Eur. 2.5 mg Global Oral Pathology Standard: The definitive micro-dose engineered specifically for localized mucosal absorption, maximizing ulcer healing while neutralizing systemic exposure. Excipients Carbomer / Hypromellose (HPMC) / Lactose Monohydrate / Polycarbophil / Magnesium Stearate Bio-Adhesive Polymers / Matrix Former / Diluent / Lubricant (Engineered utilizing elite hydrophilic polymers that instantly cross-link upon contact with saliva, converting the hard tablet into an immovable, slow-release mucosal patch) *Pack Sizes: 10×10 Alu-Alu Blisters or Tubes of 20 (Optimized specifically for the short-term, acute treatment of cyclical ulcer outbreaks).
Hydrocortisone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micronized steroid payload.
Active Ingredient Strength Primary Clinical Function Hydrocortisone USP/Ph.Eur. 5 mg / 10 mg (Scored) Titration & Afternoon Standard: Highly precise, low-dose units engineered for pediatric CAH dosing and the critical “afternoon taper” in adult replacement therapy. Hydrocortisone USP/Ph.Eur. 20 mg (Scored) Morning Surge & Acute Flare Standard: High-efficacy dosing to replicate the natural morning cortisol spike, or for short-term suppression of acute severe allergic or inflammatory conditions. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered utilizing Micronized API—the steroid particles are milled to a microscopic size before blending to guarantee immediate, consistent gastric absorption, which is critical to avoid unpredictable hormone spikes) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict chronic, lifelong endocrinology dispensing regimens).
Hydroxy Chloroquine Sulfate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Heavy-Coated Tablet, packed exclusively in highly secure, light-blocking Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the photolabile active ingredient.
Active Ingredient Strength Primary Clinical Function Hydroxychloroquine Sulfate USP/Ph.Eur. 200 mg Global Rheumatology Standard: Base therapeutic unit for daily chronic maintenance in SLE and RA, allowing for exact mg/kg dosing based on ideal body weight to prevent toxicity. Excipients Dibasic Calcium Phosphate / Pregelatinized Starch / Magnesium Stearate / Polyethylene Glycol / Premium Titanium Dioxide Opadry Film Diluent / Binder / Lubricant / Heavy Opacifying Film-Coating (Engineered specifically to form an impenetrable light barrier against UV degradation, while completely masking the intensely bitter taste of the sulfate salt to ensure long-term patient compliance) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict 3-to-6 month chronic rheumatology dispensing regimens).
Hydroxyurea Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Film-Coated Tablet, packed exclusively in highly secure, handler-protective Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure absolute chemical stability and prevent accidental cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Hydroxyurea USP/Ph.Eur. 200 mg / 300 mg / 400 mg Pediatric Sickle Cell Standard: Specialized weight-based units designed for exact mg/kg titration in infants and children suffering from severe vaso-occlusive crises. Hydroxyurea USP/Ph.Eur. 500 mg (Scored) Global Adult Hematology Standard: High-efficacy adult maintenance dose for CML, Polycythemia Vera, and adult Sickle Cell Disease. Excipients Microcrystalline Cellulose / Sodium Citrate / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / pH Stabilizer / Superdisintegrant / Slipper-Coating (Engineered specifically with a heavy, durable film-coat to completely seal the highly toxic, mutagenic core away from nurses, parents, and pharmacists) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for massive-volume NGO procurement and chronic lifetime dispensing).
Hyoscine Butylbromide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets or Film Coated Tablets. The coating is essential to mask the naturally bitter taste of the active ingredient and ensure patient compliance.
Active Ingredient Strength (Standard) Therapeutic Role Hyoscine Butylbromide BP/USP 10 mg Muscarinic Antagonist (Antispasmodic) Excipients Q.S. Calcium Hydrogen Phosphate / Maize Starch Stabilizing Core Matrix Coating Agent Q.S. Sucrose / Talc / Acacia Traditional Sugar Coating Ibuprofen & Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating protects the gastric mucosa from direct contact with Ibuprofen and masks the bitter taste of the active ingredients.
Active Ingredient Strength (Standard) Therapeutic Role Ibuprofen BP/USP 200 mg NSAID (Anti-inflammatory/Analgesic) Paracetamol BP/USP 325 mg Analgesic & Antipyretic Excipients Q.S. Starch / Croscarmellose Sodium Disintegrant & Binder Ibuprofen Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated (Round/Pink) or Film Coated Tablets. Effective taste-masking is critical as Ibuprofen has a burning aftertaste.
Active Ingredient Strength (Standard) Role Ibuprofen IP/BP/USP 200 mg OTC Standard / Fever Ibuprofen IP/BP/USP 400 mg Prescription Strength / Dental Pain Ibuprofen IP/BP/USP 600 mg Rheumatoid Arthritis (High Dose) Ibuprofen IP/BP/USP 800 mg Severe Osteoarthritis / Acute Injury Ibuprofen with Paracetamol Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for maximum therapeutic synergy and patient safety.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Ibuprofen IP/BP/USP 200 mg / 400 mg The Anti-Inflammatory: Reduces physical swelling. Paracetamol IP/BP/USP 325 mg / 500 mg The Analgesic: Raises the chemical pain threshold. Excipients Pharma Grade The Matrix: Ensures stability and rapid release. Imatinib Mesylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the mesylate salt.
Active Ingredient Strength Primary Clinical Function Imatinib (as Mesylate) USP/Ph.Eur. 100 mg Pediatric & Titration Standard: Base therapeutic unit utilized for weight-based pediatric leukemia dosing, or for highly precise adult dose adjustments during acute hematological toxicity. Imatinib (as Mesylate) USP/Ph.Eur. 400 mg Global Adult Oncology Standard: High-efficacy adult maintenance dose, typically taken once daily for the chronic phase of CML, or twice daily for accelerated phases and GIST. Excipients Microcrystalline Cellulose / Crospovidone / Hypromellose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Iron-Oxide Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically to lock the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Imidapril Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for precise titration). The standard strengths are optimized for maintenance therapy.
Active Ingredient Strength (Standard) Role Imidapril HCl 5 mg Initial Dose / Renal Impairment Imidapril HCl 10 mg Standard Maintenance Dose Excipients Q.S. Lactose / Macrogol Imipramine Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (often Red or Blue) to effectively mask the intensely bitter and numbing taste of the API.
Active Ingredient Strength (Standard) Primary Role Imipramine HCl USP/BP 25 mg Pediatric Enuresis / Initial Dose Imipramine HCl USP/BP 50 mg Adult Maintenance Imipramine HCl USP/BP 75 mg High Potency (Hospital Use) Excipients Q.S. Sucrose / Talc (Coating) Indapamide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar/Film Coated Tablets (Immediate Release) or Sustained Release (SR) Tablets.
Active Ingredient Strength Formulation Role Indapamide USP/BP 1.5 mg Sustained Release (SR) Modern Standard Dose (24hr Control) Indapamide USP/BP 2.5 mg Immediate Release Classic Maintenance Dose Excipients Q.S. HPMC (Matrix) / Lactose Release Control Indomethacin Tablets
FreeProduct Composition & Strength
We supply this product as Hard Gelatin Capsules (Standard) or Sustained Release (SR) Tablets.
Active Ingredient Strength (Standard) Form Role Indomethacin USP/BP 25 mg Capsule Standard Adult Dose Indomethacin USP/BP 50 mg Capsule Acute Gout / Severe Pain Indomethacin USP/BP 75 mg SR Capsule / Tablet Once/Twice Daily (Maintenance) Iron Folic Acid Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (Red/Brown) or Film Coated Tablets. Sugar coating is traditional to mask the strong metallic taste of iron.
Iron Salt Salt Strength Elemental Iron Folic Acid Primary Use Dried Ferrous Sulphate 200 mg ~65 mg 0.4 mg / 400 mcg Standard Adult Prophylaxis Dried Ferrous Sulphate 200 mg ~65 mg 1 mg / 5 mg Therapeutic (Pregnancy) Ferrous Fumarate 200 mg ~65 mg 0.4 mg / 1.5 mg Sensitive Stomach / Maternal Ferrous Fumarate 300 mg ~100 mg 5 mg Severe Anemia Treatment Isoniazid & Pyridoxine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The ratio of Isoniazid to Pyridoxine is carefully calibrated to meet international clinical guidelines for neuroprotection.
Active Ingredient Strength (Standard) Therapeutic Role Isoniazid BP/USP 300 mg Primary Antitubercular (Bactericidal) Pyridoxine Hydrochloride BP/USP 10 mg / 25 mg / 50 mg Neuroprotective Vitamin (B6) Excipients Q.S. Starch / Lactose / Magnesium Stearate Tablet Core Matrix Isoniazid & Pyridoxine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The ratio of Isoniazid to Pyridoxine is carefully calibrated to meet international clinical guidelines for neuroprotection.
Active Ingredient Strength (Standard) Therapeutic Role Isoniazid BP/USP 300 mg Primary Antitubercular (Bactericidal) Pyridoxine Hydrochloride BP/USP 10 mg / 25 mg / 50 mg Neuroprotective Vitamin (B6) Excipients Q.S. Starch / Lactose / Magnesium Stearate Tablet Core Matrix Isoniazid Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White/Scored). It is often co-administered with Pyridoxine (Vitamin B6) to prevent nerve damage.
Active Ingredient Strength (Standard) Target Patient Isoniazid USP/BP/IP 100 mg Pediatric / Prophylaxis Isoniazid USP/BP/IP 300 mg Standard Adult Dose Excipients Q.S. Binder / Disintegrant Isosorbide Mononitrate Tablets
FreeProduct Composition & Strength
We supply this product as Immediate Release Tablets (20 mg). We also offer Extended Release (ER/SR) variants for once-daily dosing through our contract manufacturing division.
Active Ingredient Strength (Standard) Therapeutic Role Isosorbide Mononitrate BP/USP 20 mg Organic Nitrate / Vasodilator Excipients Q.S. Microcrystalline Cellulose / Lactose Stabilizing Matrix Isosorbide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Oral) or Sublingual Tablets (Dissolve under tongue).
Active Ingredient Strength Route / Type Role Isosorbide Dinitrate USP/BP 5 mg Sublingual (SL)/ regular Acute Angina Attack Isosorbide Dinitrate USP/BP 10 mg Oral (Swallow) Angina Prophylaxis Isosorbide Dinitrate USP/BP 20 mg Oral (Swallow) Heart Failure / Maintenance Excipients Q.S. Lactose (Diluent) Safety / Bulk Isosorbide Tablets
FreeProduct Composition & Variants
We supply both Mononitrate and Dinitrate forms in immediate and sustained-release formats.
Variant Type Standard Strengths Primary Clinical Use Isosorbide Mononitrate 10mg, 20mg, 40mg Prophylaxis: Long-term prevention of angina. Isosorbide Dinitrate 5mg, 10mg, 20mg Acute & Chronic: Short and long-term heart failure. Sustained Release (SR) 30mg, 60mg Once-Daily: For improved patient compliance. Isoxsuprine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Immediate-Release or Sustained-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Isoxsuprine Hydrochloride USP/Ph.Eur. 10 mg (IR) Acute Titration Standard: Immediate-release base unit used for the rapid initiation of therapy or carefully titrated maintenance in sensitive patients. Isoxsuprine Hydrochloride USP/Ph.Eur. 40 mg (SR) Obstetrics Maintenance Standard: High-efficacy, slow-release matrix designed specifically to provide 12-hour continuous tocolysis, vastly improving maternal compliance and protecting the cardiovascular system. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Lactose Monohydrate / Colloidal Silicon Dioxide / Magnesium Stearate ER Polymer / Diluent / Binder / Glidant / Lubricant (Engineered specifically utilizing premium Hypromellose matrices in the 40mg variant to form a robust hydrogel that slowly erodes in the gastrointestinal tract, ensuring steady-state plasma levels) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict obstetric and chronic vascular dispensing regimens).
Itopride Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White or Off-White) to mask the bitter taste.
Active Ingredient Strength (Standard) Role Itopride HCl 50 mg Standard Therapeutic Dose Itopride HCl 150 mg (SR) Sustained Release (Once Daily) Excipients Q.S. Lactose (Filler) / HPMC (Binder) Ivabradine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Ivabradine (as Hydrochloride) USP/Ph.Eur. 5 mg Initiation / Titration Standard: Base therapeutic unit utilized twice daily for the safe initiation of therapy, allowing the cardiologist to monitor resting heart rate before upward titration. Ivabradine (as Hydrochloride) USP/Ph.Eur. 7.5 mg Global Maintenance Standard: High-efficacy adult maintenance dose to strictly maintain the resting heart rate between 50 and 60 beats per minute. Excipients Lactose Monohydrate / Maize Starch / Maltodextrin / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Glidant / Lubricant / Film-Coating (Engineered specifically using precise geometric dilution to ensure the micro-dose API is flawlessly distributed, preventing accidental bradycardia from “hot spots” in a poorly blended generic tablet) *Pack Sizes: 10×10 Blisters or Bottles of 56 (Optimized specifically for strict 28-day chronic cardiology dispensing regimens).
Ivermectin Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). The dosage is strictly weight-based.
Active Ingredient Strength (Standard) Role Ivermectin USP/BP/EP 3 mg Pediatric / Low Body Weight Ivermectin USP/BP/EP 6 mg Standard Adult Unit Ivermectin USP/BP/EP 12 mg High Strength (Adult Dose) Excipients Q.S. Microcrystalline Cellulose (Filler) Ketoconazole Tablets
FreeProduct Composition & Available Specifications
We supply Ketoconazole in the internationally recognized 200 mg therapeutic dosage configuration, engineered to optimize plasma saturation kinetics and ensure maximum cellular bioavailability.
Active Ingredient Monograph Calibrated Strength Formulation Matrix Delivery System Primary Clinical Application Ketoconazole USP / BP / IP 200 mg Oral Solid Immediate-Release Uncoated Tablet Systemic Antifungal Care: First-line systemic management of blastomycosis, coccidioidomycosis, histoplasmosis, and severe recalcitrant tinea infections. Excipients Pharma Grade Lactose Monohydrate, Corn Starch, Povidone K-30, Magnesium Stearate The Disintegration Scaffold: Calibrated matrix for high mechanical core stability and rapid wicking in gastric fluids. Ketorolac Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (White/Round). The standard oral dosage is strictly limited due to potency.
Active Ingredient Strength (Standard) Role Ketorolac Tromethamine USP/BP 10 mg Standard Adult Dose Excipients Q.S. Microcrystalline Cellulose / Lactose L- ornithine-L-aspartate tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical and physical stability of the highly hygroscopic amino acid salt.
Active Ingredient Strength Primary Clinical Function L-Ornithine L-Aspartate (LOLA) 150 mg / 250 mg Hepatology Maintenance Standard: Base therapeutic units for long-term chronic management of severe Non-Alcoholic Fatty Liver Disease (NAFLD), alcoholic hepatitis, and mild hyperammonemia. L-Ornithine L-Aspartate (LOLA) 500 mg Acute Detoxification Standard: High-efficacy adult therapy utilized for immediate ammonia reduction and the step-down management of Hepatic Encephalopathy following hospital discharge. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Moisture-Barrier Film Diluent / Superdisintegrant / Glidant / Film-Coating (Engineered specifically to lock out atmospheric moisture, preventing the heavy 500mg amino acid tablet from swelling, cracking, or prematurely degrading before it reaches the patient’s stomach) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic hepatology dispensing regimens).
L-Methylfolate Calcium ,Pyridoxal-5-Phosphate & Mecobalamin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable Film-Coated Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of the three delicate coenzymes.
Active Ingredient Strength Primary Clinical Function L-Methylfolate Calcium USP/Ph.Eur. 1 mg Active Vitamin B9: Direct methyl-donor for homocysteine remethylation and massive neurotransmitter synthesis. Pyridoxal-5-Phosphate (P5P) USP/Ph.Eur. 0.5 mg Active Vitamin B6: Immediate catalyst for transsulfuration; drastically reduces the risk of paradoxical sensory neuropathy seen with cheap Pyridoxine. Mecobalamin (Methylcobalamin) USP/Ph.Eur. 1500 mcg Active Vitamin B12: Direct peripheral nerve repair, myelin synthesis, and essential co-factor for homocysteine neutralization. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Titanium Dioxide / Premium Opaque Opadry Film Diluent / Superdisintegrant / Lubricant / Heavy UV-Blocking Coating (Engineered specifically to form an impenetrable light barrier, completely preventing the photolabile degradation of the active B12 and folate components) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, 3-to-6 month chronic neurology and diabetic dispensing regimens).
Lactobacillus SporogenesTablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Moisture Matrix Tablet, packed exclusively in highly secure Alu-Alu blister strips or tightly sealed Alu-PVC blisters to prevent premature ambient moisture from triggering spore germination prior to ingestion.
Active Ingredient Strength Primary Clinical Function Lactobacillus sporogenes (Bacillus coagulans) Spores 60 Million Spores (CFU) Global Microbiome Standard: High-density, survival-guaranteed spore count to aggressively recolonize the intestinal lining, halt acute diarrhea, and outcompete opportunistic pathogens following heavy antibiotic therapy. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant / Lubricant (Engineered specifically utilizing ultra-low moisture excipients during dry-blending to ensure the dormant spores are not accidentally “woken up” and destroyed by water activity on the factory floor) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for massive-volume retail pharmacy and pediatric clinic dispensing).
Lamivudine & Zidovudine tablets
FreeProduct Composition & Strength
We supply this product in the internationally standardized Fixed-Dose Combination (FDC) required for therapeutic compliance.
Active Ingredient Strength (per Tablet) Primary Clinical Function Lamivudine (3TC) IP/BP/USP 150 mg The Chain Terminator: High potency, low toxicity. Zidovudine (AZT) IP/BP/USP 300 mg The Foundation: Proven efficacy in preventing replication. Excipients Pharma Grade The Matrix: Ensures stability of the sensitive FDC. Lamivudine Tablets
FreeProduct Composition & Available Portfolio strengths
We manufacture Lamivudine across the precise compendial strengths mandated to manage either targeted chronic hepatic monotherapy or high-potency systemic combination antiretroviral protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamivudine USP / BP / IP 100 mg Oral Solid Film-Coated Tablet Chronic Hepatitis B (HBV): Low-dose configuration optimized for standalone daily suppression of active hepatic viral replication. Lamivudine USP / BP / IP 150 mg Oral Solid Film-Coated Tablet Standard Antiretroviral (HIV): Baseline strength designed for twice-daily co-administration or integration into standard multi-drug ARV regimens. Lamivudine USP / BP / IP 300 mg Oral High-Potency Solid Tablet High-Compliance Antiretroviral (HIV): Standard adult once-daily high-dose format engineered to optimize long-term patient compliance. Lamivudine, Zidovudine & Nevirapine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often White or Off-White). This FDC is designed for patients who have successfully completed the Nevirapine “lead-in” phase.
Active Ingredient Strength (Standard) Class Lamivudine USP/BP 150 mg NRTI (Cytidine Analog) Zidovudine USP/BP 300 mg NRTI (Thymidine Analog) Nevirapine USP/BP 200 mg NNRTI Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Lamotrigine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Rapid-Dispersible (DT) Tablet, packed exclusively in highly secure Alu-PVC or Alu-Alu blister strips, frequently customized into highly regulated Titration Starter Kits.
Active Ingredient Strength Primary Clinical Function Lamotrigine USP/Ph.Eur. 25 mg (Starter Kit) The SJS-Prevention Standard: Mandatory base unit for the strict, slow titration schedule required to prevent fatal cutaneous reactions. Often formulated as a Dispersible Tablet (DT) for pediatric epilepsy. Lamotrigine USP/Ph.Eur. 50 mg / 100 mg / 200 mg Global Maintenance Standard: High-efficacy adult maintenance doses for lifelong seizure control and bipolar stabilization. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Sucralose & Flavoring (If DT) / Magnesium Stearate Diluent / Superdisintegrant / Binder / Sweetener (Engineered specifically to either swallow intact or disperse rapidly in a teaspoon of water for children or elderly psychiatric patients suffering from dysphagia) *Pack Sizes: 10×10 Blisters, Bottles of 100, or Dedicated 28-Day Titration Calendar Packs (Optimized specifically to eliminate caregiver dosing errors during the critical initiation phase).
Lansoprazole Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, MUPS-Based Dispersible Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the delicate, moisture-sensitive micro-pellets.
Active Ingredient Strength Primary Clinical Function Lansoprazole (as Enteric-Coated Micro-Pellets) USP/Ph.Eur. 15 mg Maintenance & Pediatric Standard: Base therapeutic unit for healing maintenance, pediatric GERD, and preventing NSAID-induced gastric ulcers. Lansoprazole (as Enteric-Coated Micro-Pellets) USP/Ph.Eur. 30 mg Acute Healing Standard: High-efficacy adult dosing for the rapid healing of erosive esophagitis, active duodenal ulcers, and H. pylori eradication protocols. Excipients Methacrylic Acid Copolymer (Enteric Coat) / Crospovidone / Microcrystalline Cellulose / Mannitol / Sucralose / Strawberry Flavor Acid-Resistant Shield / Superdisintegrant / Diluent / Sweetener (Engineered specifically to create a highly palatable, rapid-burst suspension that masks the bitter API, ensuring high pediatric compliance and smooth NG tube transit) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, highly monitored hospital and outpatient dispensing regimens).
Ledipasvir & Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
Leflunomide Tablets
FreeProduct Composition & Available Portfolio Strengths
We supply Leflunomide across the complete compendial strength matrix, enabling clinicians to manage both rapid initial loading cycles and long-term low-dose maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Leflunomide USP / BP / IP 10 mg Oral Solid Film-Coated Tablet Low-Dose Maintenance: Calibrated for mild-to-moderate maintenance blocks or patients exhibiting sensitive hepatic profiles. Leflunomide USP / BP / IP 20 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard daily maintenance dose for active Rheumatoid and Psoriatic Arthritis. Leflunomide USP / BP / IP 100 mg Oral High-Mass Solid Tablet Initial Loading Regimen: High-potency format utilized exclusively for the rapid 3-day initial tissue saturation phase. Letrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.
Active Ingredient Strength Primary Clinical Function Letrozole USP/Ph.Eur. 2.5 mg Global Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).
Levamisole Tablets
FreeProduct Composition & Available Strengths
We supply Levamisole Hydrochloride across the two primary compendial configurations required to execute precise pediatric deworming courses or adult high-mass therapeutic maintenance.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levamisole Hydrochloride USP / BP / IP 50 mg Oral Solid Uncoated / Chewable Tablet Pediatric Deworming & Titration: Low-dose format calibrated for exact mass titration in pediatric ascariasis or low-dose immunomodulatory courses. Levamisole Hydrochloride USP / BP / IP 150 mg Oral Solid Compressed Tablet The Core Commercial Volume: High-potency, single-dose adult baseline format optimized for rapid mass community deworming campaigns. Levocetirizine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The small, easy-to-swallow tablets are engineered for rapid disintegration to facilitate quick relief from acute allergic flares.
Active Ingredient Strength (Standard) Therapeutic Role Levocetirizine Dihydrochloride BP/USP 5 mg Potent H1-Receptor Antagonist Excipients Q.S. Microcrystalline Cellulose / Lactose Diluent & Disintegrant Coating Agent Q.S. Opadry® White Protective Film Coating Levofloxacin Tablets
FreeProduct Composition & Available Portfolio
We manufacture Levofloxacin across the complete, internationally standardized therapeutic spectrum to accommodate customized tissue-saturation requirements and specific treatment durations.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 250 mg Oral Solid Film-Coated Tablet Uncomplicated Infections: For standard low-dose management of uncomplicated urinary tract infections (UTIs) and acute bacterial sinusitis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 500 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard for community-acquired pneumonia (CAP), skin structures, and acute pyelonephritis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 750 mg Oral High-Potency Solid Tablet Intensive High-Dose Short-Course: Calibrated for nosocomial pneumonia, complicated skin infections, and advanced multi-drug resistant (MDR) regimens. Levonorgestrel Emergency Contraceptive Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Single-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroid molecule.
Active Ingredient Strength Primary Clinical Function Levonorgestrel USP/Ph.Eur. 1.5 mg Global Emergency Contraceptive Standard: A massive, single-dose payload designed to instantly halt ovulation within the critical 72-hour post-coital window. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced micronized API to ensure ultra-rapid gastric dissolution, guaranteeing the hormone hits the bloodstream fast enough to beat the LH surge) *Pack Sizes: 1-Tablet Blister Packs (Optimized specifically for discrete, over-the-counter (OTC) retail and single-dispense NGO crisis kits).
Levosulpiride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the benzamide derivative.
Active Ingredient Strength Primary Clinical Function Levosulpiride USP/Ph.Eur. 25 mg Global Gastroenterology Standard: Base therapeutic unit taken prior to meals for the rapid relief of functional dyspepsia, bloating, and mild gastroparesis. Levosulpiride USP/Ph.Eur. 50 mg / 75 mg Psychiatric & Severe Dysmotility Standard: High-efficacy adult therapy used for severe, treatment-resistant diabetic gastroparesis or utilized by psychiatrists for somatoform disorders and mild depression. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Binder / Glidant (Engineered specifically without heavy polymeric retardants to guarantee immediate, complete gastric dissolution within 10 to 15 minutes of ingestion, preparing the stomach for the incoming meal) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, meal-dependent acute and chronic dispensing regimens).
Levothyroxine Tablet
FreeProduct Composition & Comprehensive Portfolio Range
Because thyroid replacement demands hyper-specific, patient-tailored titrations, we manufacture the entire internationally recognized microgram ($\mu\text{g}$) matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levothyroxine Sodium USP / BP / IP 25 mcg / 50 mcg Oral Solid Uncoated Micro-Tablet Pediatric & Geriatric Initialization: For delicate low-dose titration in elderly cardiac profiles or initial pediatric replacement. Levothyroxine Sodium USP / BP / IP 75 mcg / 88 mcg / 100 mcg Oral Solid Uncoated Micro-Tablet The Core Commercial Volume: Standard adult maintenance strengths for matching routine daily baseline metabolic deficiencies. Levothyroxine Sodium USP / BP / IP 112 mcg / 125 mcg / 137 mcg Oral Solid Uncoated Micro-Tablet Precision Step-Up Adjustments: Calibrated strengths engineered to adjust plasma levels without requiring multiple or split tablets. Levothyroxine Sodium USP / BP / IP 150 mcg / 175 mcg / 200 mcg Oral High-Potency Micro-Tablet Advanced Suppression Maintenance: For severe profound hypothyroidism, total thyroidectomy recovery, and thyroid cancer suppression therapy. Linagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the highly hygroscopic combination.
Active Ingredient Strength Primary Clinical Function Linagliptin / Metformin HCl (IR) 2.5 mg / 500 mg
2.5 mg / 850 mg
2.5 mg / 1000 mgTwice-Daily Standard: Immediate-release units designed to be taken twice a day with meals to provide rapid, meal-time incretin spikes alongside baseline hepatic suppression. Linagliptin / Metformin HCl (ER) 5 mg / 1000 mg (ER) Once-Daily Premium Standard: High-efficacy Extended-Release therapy designed for ultimate patient compliance, delivering the full daily dose of Linagliptin while slowly trickling Metformin into the gut over 24 hours to prevent severe gastrointestinal side effects. Excipients Hypromellose (HPMC) / Copovidone / Microcrystalline Cellulose / Magnesium Stearate / Premium Moisture-Barrier Film ER Polymer / Binder / Diluent / Lubricant (Engineered utilizing elite Bilayer Rotary Presses to physically separate the delicate 2.5mg/5mg Linagliptin dose from the massive, moisture-drawing Metformin layer, preventing cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Linagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Film-Coated Tablet, packed exclusively in highly secure Alu-Alu blister strips to ensure the absolute chemical stability of the delicate API.
Active Ingredient Strength Primary Clinical Function Linagliptin USP/Ph.Eur. 5 mg The Universal Standard: A single, high-efficacy maintenance dose that applies to all adult patients, regardless of age, hepatic function, or severe renal impairment. Excipients Mannitol / Pregelatinized Starch / Copovidone / Magnesium Stearate / Premium Opadry Film Diluent / Disintegrant / Binder / Moisture-Barrier Coating (Engineered specifically without highly hygroscopic components to prevent moisture absorption, ensuring rapid disintegration and maximum bioavailability of the 5mg payload) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Linezolide Tablets
FreeLinezolide Tablets
Each Film Coated Tablet Contains
Linezolide 600 mgUsage: – Treat different types of bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotics
Lisinopril Tablet
FreeProduct Composition & Available Portfolio Range
We manufacture Lisinopril in exact, compendial strengths calibrated to support initial introductory titration up to high-potency cardioprotective maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lisinopril Anhydrous / Dihydrate USP / BP / IP 5 mg Oral Solid Uncoated Tablet Initial Titration: For low-dose introductory management, pediatric hypertension, or initial combination therapy initiation. Lisinopril Anhydrous / Dihydrate USP / BP / IP 10 mg Oral Solid Uncoated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Lisinopril Anhydrous / Dihydrate USP / BP / IP 20 mg Oral High-Potency Solid Tablet Advanced Cardioprotection: High-strength configuration calibrated for severe heart failure management and post-infarction survival optimization. Lithium Carbonate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Lithium Carbonate USP/Ph.Eur. 300 mg (IR) Acute Mania Standard: Immediate-release base unit used for the rapid, aggressive titration of serum lithium levels during an active, severe manic episode. Lithium Carbonate USP/Ph.Eur. 400 mg / 450 mg (ER/SR) Global Maintenance Standard: Extended-release therapy designed to flatten the pharmacokinetic curve, preventing toxic blood spikes and minimizing severe hand tremors and nausea during lifelong maintenance therapy. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Hydrophilic ER Polymer / Diluent / Disintegrant / Lubricant (Engineered specifically using high-shear wet granulation to form a highly reliable, slow-eroding matrix that trickles the elemental lithium into the bloodstream over 12 hours) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict, massive-volume lifelong psychiatric dispensing regimens).
Liv 52 tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Standardized Herbal Matrix Tablet, packed exclusively in highly secure, moisture-resistant PVC/PVDC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative botanical alkaloids.
Standardized Botanical Extract Target Biomarker Primary Clinical Function Milk Thistle Ext. (Silybum marianum) Standardized to 70% Silymarin (140 mg) The Antioxidant Anchor: Massive glutathione restoration and hepatocyte membrane stabilization. Andrographis paniculata (Kalmegh) Ext. Standardized to 10% Andrographolides The Choleretic Catalyst: Potent antiviral properties (Hepatitis) and violent stimulation of bile flow to flush out hepatic toxins. Phyllanthus niruri (Bhumyamalaki) Ext. Standardized Bitters The Viral Blocker: Clinically documented to suppress the replication of the Hepatitis B virus and protect against drug-induced liver injury (DILI). Boerhavia diffusa (Punarnava) Ext. Standardized Alkaloids The Hepatic Diuretic: Reduces liver enlargement (hepatomegaly) and flushes out excess fluid accumulation (ascites) caused by liver failure. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Moisture-Barrier Film Diluent / Superdisintegrant / Glidant / Film-Coating (Engineered specifically to lock out atmospheric moisture—which destroys botanical extracts—and completely mask the intensely bitter taste of Kalmegh and Silymarin) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict 3-to-6 month chronic hepatology dispensing regimens).
Loperamide Tablet
FreeProduct Composition & Configuration
We supply Loperamide Hydrochloride in the internationally standardized 2 mg therapeutic dosage configuration, engineered for rapid disintegration and fast symptomatic relief.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Loperamide Hydrochloride USP / BP / IP 2 mg Oral Solid Immediate-Release Uncoated Tablet Fast-Acting Anti-Diarrheal: Non-specific acute diarrhea management, chronic diarrheal stabilization, and ileostomy output reduction. Excipients Pharma Grade Lactose Monohydrate, Microcrystalline Cellulose, Corn Starch, Magnesium Stearate The Disintegration Scaffold: Optimized matrix for high mechanical stability and rapid water wicking. Lopinavir & Ritonavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically Yellow, Oval). The proprietary matrix ensures high bioavailability of poorly soluble Lopinavir.
Active Ingredient Strength (Standard) Therapeutic Role Lopinavir USP/BP 200 mg HIV-1 Protease Inhibitor Ritonavir USP/BP 50 mg Pharmacokinetic Booster (Pediatric Variant) 100 mg Lopinavir + 25 mg Ritonavir Pediatric HIV Management Excipients Q.S. Copovidone / Sorbitan Monolaurate / Silica Solubility Enhancers Loratidine Tablet
FreeProduct Composition & Available Strengths
We supply Loratadine in the internationally recognized 10 mg therapeutic dosage configuration, optimized for maximum daily compliance and clean absorption kinetics.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Loratadine USP / BP / IP 10 mg Oral Solid Immediate-Release Uncoated Tablet 24-Hour Allergy Control: Treatment of allergic rhinitis (hay fever), chronic idiopathic urticaria (hives), and ocular allergic reactions. Excipients Pharma Grade Lactose Monohydrate, Corn Starch, Magnesium Stearate The Disintegration Scaffold: Optimized matrix for high mechanical stability during bulk shipping and rapid water-wicking in the gut. Lorazepam Tablet
FreeProduct Composition & Available Strengths
We supply Lorazepam across the complete, internationally standardized therapeutic spectrum to allow for safe dose titration and exact behavioral control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Lorazepam USP / BP / IP 0.5 mg Oral / Sublingual Micro-Tablet Mild Anxiety & Pediatric Titration: For delicate introductory dosing and generalized anxiety management. Lorazepam USP / BP / IP 1.0 mg Oral / Sublingual Micro-Tablet Foundation Anxiolytic / Insomnia: Standard baseline dosage for acute panic control and pre-operative sedation. Lorazepam USP / BP / IP 2.0 mg Oral High-Potency Solid Tablet Critical Care Stabilization: For intensive management of acute manic states, alcohol withdrawal delirium, and status epilepticus. Losartan Potassium Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically Yellow or White, Oval). The coating protects the hygroscopic Losartan from moisture.
Active Ingredient Strength (Standard) Therapeutic Role Losartan Potassium USP/BP 50 mg Vasodilator (ARB) Hydrochlorothiazide USP/BP 12.5 mg Diuretic (Thiazide) (High Strength Variant) 100 mg Losartan + 25 mg HCTZ Severe Hypertension Excipients Q.S. Microcrystalline Cellulose / Lactose / Magnesium Stearate Filler / Lubricant Losartan Potassium, Amlodipine Besylate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White or Yellow, Oval/Round). The formulation uses the Besylate salt of Amlodipine for maximum stability.
Active Ingredient Strength (Standard) Therapeutic Role Losartan Potassium USP/BP 50 mg Vasodilator (ARB) Amlodipine Besylate USP/BP 5 mg (Eq. to Base) Vasodilator (CCB) (High Strength Variant) 50 mg Losartan + 10 mg Amlodipine
100 mg Losartan + 5 mg AmlodipineResistant Hypertension Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Filler / Super-Disintegrant Losartan Tablet
FreeProduct Composition & Available Strengths
We supply Losartan Potassium across the complete, internationally recognized therapeutic range to facilitate progressive dose titrations and precise maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Losartan Potassium USP / BP / IP 25 mg Oral Solid Film-Coated Tablet Pediatric & Low-Dose Titration: For introductory pediatric hypertension care or initial combination-therapy building. Losartan Potassium USP / BP / IP 50 mg Oral Solid Film-Coated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Losartan Potassium USP / BP / IP 100 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: For advanced hypertensive management, diabetic nephropathy progression delay, and stroke risk reduction in left ventricular hypertrophy. Mebendazole Tablet
FreeProduct Composition & Available Formats
We supply Mebendazole across the two primary compendial configurations required to execute either targeted individual eradication or high-velocity single-dose mass eradication protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebendazole USP / BP / IP 100 mg Oral Solid Chewable / Dispersible Tablet Targeted Multi-Dose Therapy: Standard baseline format for individual 3-day courses targeting specific multi-worm infestations (Pinworms, Roundworms, Hookworms). Mebendazole USP / BP / IP 500 mg High-Mass Oral Solid Single-Dose Tablet Mass Public Health Eradication: High-potency, single-dose format engineered for rapid deployment in mass community deworming campaigns. Mebeverine Tablet
FreeProduct Composition & Available Formats
We supply Mebeverine Hydrochloride in both rapid-acting immediate-release and advanced continuous-release configurations to accommodate customized patient compliance tracking.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebeverine Hydrochloride IP / BP / USP 135 mg Oral Solid Immediate-Release Film-Coated Tablet Targeted Acute Dosing: Fast-acting formulation designed for standard three-times-daily administration prior to localized food triggers. Mebeverine Hydrochloride IP / BP / USP 200 mg SR Sustained-Release Hydrophilic Polymer Matrix Tablet / Capsule Continuous 24-Hour Coverage: Premium, once- or twice-daily formulation engineered to release active molecules continuously, eliminating nocturnal spikes and maximizing compliance. Medroxyprogesterone Acetate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micronized Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the delicate steroid molecule.
Active Ingredient Strength Primary Clinical Function Medroxyprogesterone Acetate USP/Ph.Eur. 2.5 mg / 5 mg HRT Maintenance Standard: Continuous or sequential low-dose therapy for the prevention of endometrial hyperplasia in postmenopausal women receiving estrogen. Medroxyprogesterone Acetate USP/Ph.Eur. 10 mg Acute Gynecology Standard: High-efficacy adult dosing for the rapid arrest of abnormal uterine bleeding and the induction of withdrawal bleeding in secondary amenorrhea. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically utilizing advanced micronized API to overcome the severe hydrophobicity of the steroid, ensuring maximum, predictable gastric absorption) *Pack Sizes: 10×10 Blisters or 14-Day Calendar Packs (Optimized specifically for strict cyclic or continuous gynecological dispensing regimens).
Mefanamic Acid & Dicyclomine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant PVC/PVDC or Alu-Alu blister strips to ensure the absolute chemical stability of the combined APIs.
Active Ingredient Strength Primary Clinical Function Mefenamic Acid USP/Ph.Eur. 250 mg The Anti-Inflammatory Anchor: Rapidly reduces prostaglandin-induced pain, uterine inflammation, and heavy menstrual bleeding. Dicyclomine Hydrochloride USP/Ph.Eur. 10 mg The Antispasmodic Catalyst: Instantly relaxes violently contracting smooth muscle in the gastrointestinal and biliary tracts, and the uterus. Excipients Microcrystalline Cellulose / Maize Starch / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant (Engineered specifically to ensure the bulky Mefenamic Acid powder shatters and dissolves instantly upon reaching the gastric fluid, ensuring the 30-minute rapid onset required for acute pain rescue) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-volume, over-the-counter (OTC) or acute prescription dispensing regimens).
Mefenamic Tablet
FreeProduct Composition & Available Strengths
We supply Mefenamic Acid in standard, exact compendial strengths designed to support either acute, low-dose short-term relief or high-potency systemic anti-inflammatory regimens.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mefenamic Acid IP / BP / USP 250 mg Oral Solid Film-Coated Tablet Acute Titration & Dysmenorrhea: Optimized for quick-onset dosing during the initialization of menstrual pain management or mild dental distress. Mefenamic Acid IP / BP / USP 500 mg Oral Solid Film-Coated Tablet High-Potency Stabilization: Standard international baseline strength for functional menorrhagia (heavy bleeding), osteoarthritis flare-ups, and severe acute musculoskeletal pain. Mefloquine Tablet
FreeProduct Composition & Configuration
We supply Mefloquine Hydrochloride in the internationally standardized strength calibrated for both adult therapeutic clearance and weekly travel prophylaxis.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Mefloquine Hydrochloride IP / BP / USP 250 mg
(Equivalent to 228 mg Mefloquine Base)
Oral Solid Uncoated Tablet (Cross-scored for exact pediatric dividing) Dual-Mode Antimalarial: High-dose 3-day treatment for active clearance, or low-dose once-weekly regimen for traveler chemoprophylaxis. Excipients Pharma Grade Microcrystalline Cellulose, Lactose, Magnesium Stearate The Disintegration Core: Engineered for uniform mechanical compression and rapid disintegration. Melphalan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, handler-protective Amber Glass Bottles or specialized Alu-Alu cold-chain blisters to ensure the absolute chemical survival of the highly unstable alkylating agent.
Active Ingredient Strength Primary Clinical Function Melphalan USP/Ph.Eur. 2 mg Global Oncology Standard: Base therapeutic unit allowing for highly precise, weight-based or Body Surface Area (BSA) calculated “pulsed” dosing regimens. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically with a heavy film-coat to ensure immediate gastric transit and to completely seal the highly toxic, mutagenic core away from nurses and caregivers) *Pack Sizes: Amber Glass Bottles of 25/50 Tablets (Optimized specifically for strict, highly monitored hematology dispensing regimens).
Memantine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips, frequently customized into 4-week Titration Starter Packs.
Active Ingredient Strength Primary Clinical Function Memantine (as Hydrochloride) USP/Ph.Eur. 5 mg Initiation / Titration Standard: Base therapeutic unit utilized exclusively for the mandatory 4-week step-up protocol to build patient tolerance and prevent severe CNS adverse effects. Memantine (as Hydrochloride) USP/Ph.Eur. 10 mg Global Neurology Standard: High-efficacy adult maintenance dose, typically taken twice daily, for the sustained neuroprotection of the degenerating brain. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Slipper-Coating (Engineered specifically with a heavy, smooth film-coat to ensure immediate gastric transit and absolute ease of swallowing for elderly patients suffering from severe dysphagia) *Pack Sizes: 10×10 Blisters, Bottles of 60, or Customized 28-Day Titration Starter Kits (Optimized specifically for strict chronic geriatric dispensing regimens).
Mercaptopurine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite and protect healthcare workers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Mercaptopurine (as Monohydrate) USP/Ph.Eur. 50 mg Global Oncology & Autoimmune Standard: Scored tablets allowing for highly precise, weight-based or Body Surface Area (BSA) based dose titrations in pediatric and adult populations. Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate / Stearic Acid Diluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution) *Pack Sizes: Bottles of 25/50 or 10×10 Blisters (Optimized specifically for strict, heavily monitored chronic oncology dispensing regimens).
Mesalazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, pH-Targeted PR Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative 5-ASA molecule.
Active Ingredient Strength Primary Clinical Function Mesalazine (5-ASA) USP/Ph.Eur. 400 mg (PR) Initiation / Titration Standard: Base therapeutic unit for mild presentations or pediatric titration in pediatric gastroenterology. Mesalazine (5-ASA) USP/Ph.Eur. 800 mg / 1200 mg (PR) Global Gastroenterology Standard: High-efficacy adult maintenance doses designed to improve patient compliance by drastically reducing the daily pill burden. Excipients Methacrylic Acid Copolymer Type B & C (Eudragit L/S) / Hypromellose / Triethyl Citrate / Iron Oxide Colors / Talc Enteric & Prolonged-Release Polymers / Plasticizer / Glidant (Engineered specifically to form an impenetrable, acid-resistant shield that strictly delays drug release until reaching the high-pH environment of the lower gastrointestinal tract) Metformin Hydrochloride & Glimepiride Tablets
FreeProduct Composition & Strength
We supply this product in Bilayer Tablets or Matrix Tablets packed in Alu-Alu or PVC/PVDC Blisters.
Product Strength Metformin HCl (SR) Glimepiride Common Name 500/1 mg 500 mg 1 mg G1 Tablet 500/2 mg 500 mg 2 mg G2 Tablet 1000/2 mg 1000 mg 2 mg Forte / DS Tablet 1000/4 mg 1000 mg 4 mg High Strength Metformin Hydrochloride & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as Sustained Release (SR) Matrix Tablets packed in Alu-Alu Blisters.
Product Strength Metformin HCl (SR) Pioglitazone Common Name 500/15 mg 500 mg 15 mg Pio-M 15 500/30 mg 500 mg 30 mg Pio-M 30 1000/15 mg 1000 mg 15 mg Pio-M Forte 1000/30 mg 1000 mg 30 mg Pio-M DS Metformin Tablet
FreeProduct Composition & Portfolio Range
We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride IP / BP / USP 500 mg Hydrophilic Dual-Polymer Sustained-Release Initial Titration: For low-dose introductory management and early-stage Type 2 stabilization. Metformin Hydrochloride IP / BP / USP 750 mg Hydrophilic Dual-Polymer Sustained-Release Intermediate Scaling: Step-up strength to optimize glycemic indices without increasing tablet count. Metformin Hydrochloride IP / BP / USP 1000 mg Hydrophilic Dual-Polymer Sustained-Release High-Potency Maintenance: Maximizes daily therapeutic saturation in an elegant, once-daily single tablet format. Metformin Tablets
FreeProduct Composition & Available Specifications
We supply Metformin Hydrochloride across the full spectrum of compendial strengths and advanced kinetic delivery platforms to optimize patient compliance and reduce gastrointestinal side effects.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride USP / BP / IP 500 mg Oral Solid Immediate-Release Film-Coated Tablet Introductory Titration: Baseline format designed for low-dose introductory management and gradual step-up scaling. Metformin Hydrochloride USP / BP / IP 850 mg Oral Solid Immediate-Release Film-Coated Tablet High-Density Single Dose: Intermediate strength optimized for achieving target daily therapeutic thresholds with fewer tablets. Metformin Hydrochloride USP / BP / IP 1000 mg Oral High-Mass Immediate-Release Tablet Maximal Saturation Therapy: High-strength configuration calibrated for advanced glycemic control and high-dose combinations. Metformin Hydrochloride USP / BP / IP 500 mg / 1000 mg SR Extended/Sustained-Release Hydrophilic Polymer Matrix Premium GI-Comfort Compliance: Once-daily formulation utilizing a dual-layer hydrogel matrix to release active drug slowly, completely eliminating gastrointestinal distress. Methimazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the thionamide compound.
Active Ingredient Strength Primary Clinical Function Methimazole (Thiamazole) USP/Ph.Eur. 5 mg Maintenance / Titration Standard: Base therapeutic unit for precisely lowering doses as the patient approaches the euthyroid (normal) state, preventing drug-induced hypothyroidism. Methimazole (Thiamazole) USP/Ph.Eur. 10 mg Initial Suppression Standard: High-efficacy adult therapy for rapidly crashing toxic thyroid hormone levels during severe, active hyperthyroidism. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Odor-Masking Coating (Engineered specifically using strict geometric dilution to ensure the microscopic API dose is flawlessly distributed, and fi lm-coated to mask the compound’s inherent sulfurous taste) Methimazole Tablets
FreeTechnical & Logistics Specifications
HS Code: 3004.90.39 (Medicaments containing hormones or other products – Antithyroid)
CAS Number: 60-56-0 (Methimazole / Thiamazole)
Dosage Form: Uncoated or Film-Coated Tablet
Packaging: Alu-Alu or Alu-PVC Blisters. Protects the sensitive API from environmental humidity; our high-barrier packaging ensures 24-month stability in Zone IVb tropical climates.
Methotrexate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite.
Active Ingredient Strength Primary Clinical Function Methotrexate USP/Ph.Eur. 2.5 mg Global Autoimmune Standard: The absolute foundational unit for Rheumatoid Arthritis and Psoriasis, allowing for highly precise, incremental dose titration. Methotrexate USP/Ph.Eur. 5 mg / 7.5 mg / 10 mg Escalated / Oncology Standard: Higher-dose units for severe, refractory autoimmune disease, Choriocarcinoma, and maintenance therapy in Acute Lymphoblastic Leukemia (ALL). Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate Diluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, heavily monitored chronic dispensing regimens).
Methoxsalen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Dissolution Tablet or Liquid-Filled Softgel, packed exclusively in highly secure, light-blocking Alu-PVC or Amber Blister strips to ensure the absolute chemical stability of the highly photoactive molecule.
Active Ingredient Strength Primary Clinical Function Methoxsalen (8-Methoxypsoralen) USP/Ph.Eur. 10 mg Global Phototherapy Standard: Weight-based dosing unit designed for exact pharmacokinetic synchronization with scheduled clinical UVA light exposure. Excipients Microcrystalline Cellulose / Pregelatinized Starch / Colloidal Silicon Dioxide / Magnesium Stearate (If Tablet) OR Macrogol (PEG 400) / Gelatin (If Softgel) Fast-Dissolving Carrier / Disintegrant / Glidant (Engineered specifically to guarantee complete gastric breakdown and maximum systemic absorption within 60 to 90 minutes, ensuring the patient is perfectly “primed” for the light booth) *Pack Sizes: Bottles of 30 or 10×10 Blisters (Optimized specifically for strict, monitored bi-weekly dermatological dispensing regimens).
Methyl Cobalmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable Rapid-Melt Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of both the delicate coenzyme and the hyper-hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Methylcobalamin (Mecobalamin) Ph.Eur./USP 1500 mcg Global Neurology Standard: Mega-dose adult therapy for the aggressive regeneration of peripheral nerves and immediate correction of severe B12 anemia. Excipients Mannitol / Crospovidone / Microcrystalline Cellulose / Sucralose / Premium Cherry or Berry Flavoring / Magnesium Stearate Fast-Dissolving Carrier / Superdisintegrant / Diluent / Sweetener / Masking Agent (Engineered specifically to instantly melt in the saliva within 10 to 30 seconds, creating a highly palatable, sweet liquid that diffuses instantly into the sublingual capillaries) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, 3-to-6 month chronic neurology and diabetic dispensing regimens).
Methyl Ergonovine Maleate Tablet
FreeProduct Composition & Calibration Strength
We manufacture this critical emergency therapeutic in the globally accepted standard micro-dose strength optimized for postpartum routine oral management.
Active Ingredient Common Name Compendial Monograph Standard Strength Primary Clinical Target Methyl Ergonovine Maleate (Methylergometrine Maleate) USP / BP / IP 0.2 mg (200 mcg) The Uterotoner Matrix: Administered orally following initial IV/IM stabilization to maintain uterine tone and prevent bleeding recurrence. Excipients Pharma Grade Lactose, Starch, Povidone binders The Delivery Scaffold: Engineered for rapid physical disintegration and quick mucosal absorption. Methylcobalamin, Folic Acid & Pyridoxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable Film-Coated Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of the three distinct vitamin coenzymes.
Active Ingredient Strength Primary Clinical Function Methylcobalamin (Active B12) Ph.Eur./USP 1500 mcg Myelin Regenerator: Direct peripheral nerve repair and essential co-factor for homocysteine remethylation. Folic Acid (Vitamin B9) Ph.Eur./USP 5 mg Endothelial Shield: Mega-dose methyl-donor driving DNA synthesis, red blood cell formation, and toxic homocysteine clearance. Pyridoxine Hydrochloride (Vitamin B6) Ph.Eur./USP 3 mg Neurotransmitter Catalyst: Vital co-enzyme for the transsulfuration of homocysteine and the synthesis of GABA/Serotonin. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Titanium Dioxide / Premium Opaque Opadry Film Diluent / Superdisintegrant / Lubricant / Heavy UV-Blocking Coating (Engineered specifically to form an impenetrable light barrier, completely preventing the photolabile degradation of the B12 component) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, 3-to-6 month chronic neurology dispensing regimens).
Methylcobalamine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable Film-Coated Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of the delicate coenzyme.
Active Ingredient Strength Primary Clinical Function Methylcobalamin (Mecobalamin) Ph.Eur./USP 500 mcg Maintenance / Hematology Standard: Base therapeutic unit for the treatment of Megaloblastic/Pernicious anemia and general nutritional B12 deficiency. Methylcobalamin (Mecobalamin) Ph.Eur./USP 1500 mcg Global Neurology Standard: Mega-dose adult therapy for the aggressive regeneration of peripheral nerves in Diabetic Neuropathy, Sciatica, and Trigeminal Neuralgia. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Titanium Dioxide / Premium Opaque Opadry Film Diluent / Superdisintegrant / Lubricant / UV-Blocking Coating (Engineered specifically to form a heavy, opaque shield that completely locks out ultraviolet light, preventing the photolabile degradation of the active coenzyme) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, 3-to-6 month chronic neurology dispensing regimens).
Methyldopa Tablet
FreeProduct Composition & Available Strengths
We supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Methyldopa Anhydrous IP / BP / USP 250 mg Oral Solid Film-Coated Tablet (Scored for micro-titration) Initial Titration / Baseline Care: For early-stage gestational hypertension and lower-dose fine-tuning. Methyldopa Anhydrous IP / BP / USP 500 mg Oral Solid Film-Coated Tablet (Engineered for uniform mass release) High-Potency Maintenance: For advanced chronic hypertension during pregnancy and severe pre-eclamptic stabilization. Methylprednisolone Tablet
FreeProduct Composition & Available Strengths
We supply Methylprednisolone in a comprehensive, internationally standardized range of strengths to facilitate both low-dose chronic maintenance and the high-dose taper packs mandatory in clinical steroid therapy.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Methylprednisolone USP / BP / IP 4 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Baseline Dose / Tapering: For rheumatoid arthritis maintenance and step-down dose regimens. Methylprednisolone USP / BP / IP 8 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Intermediate Management: For moderate asthma exacerbations and chronic dermatological conditions. Methylprednisolone USP / BP / IP 16 mg Oral Solid Uncoated Tablet (Cross-scored for flexible division) High-Potency Control: For acute autoimmune flares, immunosuppression in organ transplants, and oncology support. Metoclopramide Tablet
FreeProduct Composition & Packaging Specification
We supply Metoclopramide in the globally standardized therapeutic strength optimized for adult baseline three-times-daily dosage regimens.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Function Metoclopramide Hydrochloride USP / BP / IP 10 mg Oral Solid Uncoated Tablet (Scored for micro-dosing titration) The Prokinetic Driver: Accelerates upper gastrointestinal transit and blocks central emetic signals. Excipients Pharma Grade Lactose, Starch, Magnesium Stearate The Core Scaffold: High-solubility matrix engineered for rapid physical disintegration. Metoprolol & Amlodipin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined molecules.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Tartrate/Succinate ER) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac workload, and neutralizes CCB-induced reflex tachycardia. Amlodipine (as Besylate) Ph.Eur./USP 5 mg Calcium Channel Blocker (CCB): Forces profound peripheral arterial vasodilation, dropping severe blood pressure and relieving coronary spasms. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Crospovidone / Magnesium Stearate / Premium Opadry Film / Iron Oxide Colors Diluent / Stabilizing Buffer / Superdisintegrant / Lubricant (Engineered specifically using bilayer press technology to physically separate the slightly acidic Metoprolol salt from the basic Amlodipine, preventing destructive chemical cross-talk) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Metoprolol & Ramipril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Succinate/Tartrate) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac output, and myocardial oxygen demand; protects against sudden cardiac death. Ramipril Ph.Eur./USP 2.5 mg / 5 mg ACE Inhibitor Driver: Forces profound systemic vasodilation, protects the kidneys (renoprotection), and halts pathological cardiac remodeling. Excipients Microcrystalline Cellulose / Sodium Stearyl Fumarate / Hypromellose / Sodium Bicarbonate / Iron Oxide Colors Low-Moisture Diluent / Lubricant / Film-Coating / Polymeric Stabilizer (Engineered specifically to physically isolate the acidic Ramipril from cross-reacting with the Metoprolol salt, preventing the formation of toxic diketopiperazine impurities) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Metoprolol Tablet
FreeCore Product Catalog:
Active Ingredient Monograph Standard Strengths Dosage Format Primary Clinical Target Metoprolol Tartrate IP/BP/USP 25 mg Immediate-Release Solid Tablet Acute Titration: For fine-tuned early adjustment in arrhythmias and mild hypertension. Metoprolol Tartrate IP/BP/USP 50 mg Immediate-Release Solid Tablet Standard Twice-Daily Blockade: Routine maintenance for Angina Pectoris and post-Myocardial Infarction stabilization. Metoprolol Tartrate IP/BP/USP 100 mg Immediate-Release Solid Tablet High-Threshold Control: For refractory tachyarrhythmias and intensive post-MI clinical management. Metronidazole Tablet
FreeProduct Composition & Available Strengths
We supply Metronidazole in standard, internationally recognized strengths optimized for adult and pediatric treatment regimens.
Active Ingredient Available Strengths Common Dosage Matrix Primary Clinical Target Metronidazole BP / IP / USP 200 mg Film-Coated / Uncoated Oral Tablet Pediatric & Low-Dose Titration: For delicate adjustments in mild amoebic dysentery or combination protocols. Metronidazole BP / IP / USP 400 mg Film-Coated / Uncoated Oral Tablet Standard Generic Backbone: Standard twice or thrice-daily dosing for dental abscesses and Giardiasis. Metronidazole BP / IP / USP 500 mg High-Potency Oral Tablet Institutional Target: High-volume strength preferred for anaerobic surgical prophylaxis and severe trichomoniasis. Metronidazole Vaginal Tablets
FreeProduct Composition & Strength
We supply this product as compressed Vaginal Tablets (Pessaries) in blister packs.
Active Ingredient Strength (Standard) Form Role Metronidazole IP/BP/USP 500 mg Uncoated / Film Coated Tablet Antiprotozoal / Antibacterial Lactic Acid Q.S. (Optional Additive) pH Regulator Excipients Q.S. Disintegrants / Binders Base for Tablet Midazolam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Immediate-Release Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly soluble maleate salt.
Active Ingredient Strength Primary Clinical Function Midazolam (as Maleate) Ph.Eur./USP 7.5 mg Initiation / Geriatric Standard: Base therapeutic unit for pre-surgical anxiety reduction and sleep induction in elderly or debilitated patients. Midazolam (as Maleate) Ph.Eur./USP 15 mg Global Anesthesiology Standard: High-efficacy adult dose for profound pre-procedural conscious sedation and the treatment of severe, treatment-refractory insomnia. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Diluent / Fast-Dissolving Carrier / Superdisintegrant / Lubricant (Engineered specifically to shatter upon contact with gastric fluid, ensuring peak plasma concentration is reached within 20 to 30 minutes) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, highly monitored hospital and short-term dispensing regimens).
Midodrine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Immediate-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly soluble hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Midodrine (as Hydrochloride) USP/Ph.Eur. 2.5 mg / 5 mg Initiation / Titration Standard: Base therapeutic units for careful dose-titration to elevate standing blood pressure without triggering dangerous supine hypertension. Midodrine (as Hydrochloride) USP/Ph.Eur. 10 mg Global Dysautonomia Standard: High-efficacy adult maintenance dose for severe neurogenic orthostatic hypotension. Excipients Microcrystalline Cellulose / Pregelatinized Starch / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Disintegrant / Glidant / Lubricant (Engineered specifically without heavy polymeric retardants to guarantee rapid, complete gastric dissolution, ensuring the prodrug reaches the liver instantly for conversion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, daytime-only chronic dispensing regimens).
Mifepristone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active synthetic steroid.
Active Ingredient Strength Primary Clinical Function Mifepristone (RU-486) Ph.Eur./USP 200 mg Global Reproductive Standard: High-dose adult therapy for the initiation of medical termination of early intrauterine pregnancy (typically up to 70 days gestation). Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant (Engineered specifically to ensure rapid, complete disintegration in the acidic gastric environment, guaranteeing maximum systemic absorption of the critical 200mg payload) *Pack Sizes: 1-Tablet Blister Packs (Optimized specifically for strict, highly regulated single-dose clinical dispensing protocols).
Minocycline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or opaque HDPE bottles to ensure the absolute chemical stability of the photosensitive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Minocycline (as Hydrochloride) USP/Ph.Eur. 50 mg (ER) Dermatology Maintenance Standard: Long-term, low-dose therapy for controlling inflammatory acne and severe Rosacea with minimal side effects. Minocycline (as Hydrochloride) USP/Ph.Eur. 100 mg (ER) Acute Clearance Standard: High-dose therapy for severe cystic acne breakouts, CA-MRSA skin infections, and Rheumatoid Arthritis flares. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate / Premium Opaque Opadry Film Hydrophilic ER Polymer / Diluent / Lubricant / UV-Blocking Coating (Engineered specifically to pace the gastric release over several hours, preventing the rapid blood-brain-barrier saturation that triggers vertigo) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 12-to-16 week chronic dermatology dispensing regimens).
Mirabegron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Mirtazapine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the tetracyclic compound.
Active Ingredient Strength Primary Clinical Function Mirtazapine Ph.Eur./USP 15 mg Initiation / Maximum Sedation Standard: Base unit. (Clinical Quirk: Due to histamine saturation, the 15mg dose is actually MORE sedating than the higher doses, making it the primary choice for severe insomnia.) Mirtazapine Ph.Eur./USP 30 mg / 45 mg Global Psychiatry Standard: High-efficacy adult maintenance therapy for severe Major Depressive Disorder (MDD). At these doses, increased norepinephrine release counteracts some of the histamine-induced sedation. Excipients Microcrystalline Cellulose / Crospovidone / Mannitol / Aspartame / Magnesium Stearate / Premium Flavoring Diluent / Superdisintegrant / Sweetening Agent / Lubricant (Engineered specifically for rapid gastric or sublingual dissolution, heavily utilizing artificial sweeteners and flavors to completely mask the intensely bitter API for geriatric compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Misoprostol Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets, often hexagonal or scored, to allow for precise dosing. Due to the high potency of the API, we ensure rigorous content uniformity.
Active Ingredient Strength (Standard) Therapeutic Role Misoprostol BP/USP 200 mcg (0.2 mg) Prostaglandin E1 Analogue Excipients Q.S. Microcrystalline Cellulose / HPMC Stabilizing Dispersion Matrix Modafinil Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White/Off-white, Round or Capsule Shaped). The formulation typically utilizes micronized API to ensure rapid onset.
Active Ingredient Strength (Standard) Therapeutic Role Modafinil USP/BP 100 mg Titration / Mild Cases Modafinil USP/BP 200 mg Standard Adult Dose Excipients Q.S. Lactose Monohydrate / Croscarmellose Sodium Filler / Disintegrant Montelukast Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets for adults (10mg) and Chewable Tablets (4mg/5mg) for pediatric use. The film coating ensures stability against atmospheric moisture.
Active Ingredient Strength (Standard) Therapeutic Role Montelukast Sodium BP/USP 10 mg Leukotriene Receptor Antagonist Excipients Q.S. Lactose Monohydrate / Croscarmellose Sodium Disintegrant & Binder Coating Agent Q.S. Opadry® Beige/Pink Moisture Barrier Film Morphine Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
Moxifloxacin & Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive antibiotic compounds.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg 4th-Gen Fluoroquinolone: Deep tissue and lung penetration to eradicate DNA replication in resistant respiratory and intra-abdominal pathogens. Cefixime (as Trihydrate) Ph.Eur./USP 400 mg 3rd-Gen Cephalosporin: Massive Gram-negative cell wall destruction, specifically targeting enteric pathogens like Salmonella typhi. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the hygroscopic Cefixime Trihydrate and mask the intensely bitter taste of Moxifloxacin) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 7-to-14 day acute critical-care anti-infective dispensing regimens).
Moxifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg Global Pulmonology Standard: High-dose adult therapy for the aggressive eradication of resistant respiratory, skin, and intra-abdominal pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the highly hygroscopic API and completely mask its intensely bitter taste) *Pack Sizes: 1×5 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-14 day acute critical-care dispensing regimens).
Moxonidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micro-Dosed Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Moxonidine Ph.Eur./BP 0.2 mg Initiation / Mild Standard: Base therapeutic unit for starting therapy, specifically titrated to assess patient tolerance and prevent initial hypotension. Moxonidine Ph.Eur./BP 0.3 mg / 0.4 mg Global Cardiology Standard: High-efficacy adult maintenance dose for the aggressive management of resistant and metabolic hypertension. Excipients Lactose Monohydrate / Povidone K30 / Crospovidone / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically using strict geometric dilution protocols to ensure the microscopic API dose is flawlessly and evenly distributed throughout the entire tablet batch) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict chronic cardiology dispensing regimens).
Multivitamin & Multimineral Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated or Sugar Coated Tablets (typically Red, Maroon, or Brown). The coating is an absolute necessity to prevent the oxidative degradation of vitamins by the mineral salts.
Category Ingredient (BP Grade) Strength (Standard) Fat-Soluble Vitamins Vitamin A (Retinol Acetate/Palmitate) BP 2500 IU / 5000 IU Vitamin D3 (Cholecalciferol) BP 200 IU / 400 IU Vitamin E (Tocopheryl Acetate) BP 10 mg / 15 IU Water-Soluble Vitamins Vitamin B1 (Thiamine Mononitrate) BP 2 mg / 10 mg Vitamin B2 (Riboflavin) BP 2 mg / 10 mg Vitamin B3 (Nicotinamide) BP 25 mg / 50 mg Vitamin B6 (Pyridoxine HCl) BP 1 mg / 3 mg Vitamin B12 (Cyanocobalamin) BP 1 mcg / 15 mcg Folic Acid BP 1 mg Vitamin C (Ascorbic Acid) BP 50 mg / 100 mg Minerals & Trace Elements Ferrous Fumarate / Sulphate BP 30 mg / 50 mg (Elemental Iron) Zinc Sulphate BP 15 mg (Elemental Zinc) Copper Sulphate BP 0.5 mg / 2 mg Selenium (as Sodium Selenite) BP 60 mcg / 70 mcg Iodine (as Potassium Iodide) BP 100 mcg / 150 mcg Multivitamin & Multimineral Tablets (Complete A-Z Formula)
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (typically Red, Maroon, or Brown). The coating is an absolute necessity to prevent the oxidative degradation of vitamins by the mineral salts.
Category Ingredient Strength (Standard) Fat-Soluble Vitamins Vitamin A (Acetate/Palmitate) 2500 IU / 5000 IU Vitamin D3 (Cholecalciferol) 200 IU / 400 IU Vitamin E (Acetate) 10 mg / 15 mg Water-Soluble Vitamins Vitamin B1 (Thiamine Mononitrate) 2 mg / 10 mg Vitamin B2 (Riboflavin) 2 mg / 10 mg Vitamin B6 (Pyridoxine HCl) 1 mg / 3 mg Vitamin B12 (Cyanocobalamin) 1 mcg / 15 mcg Vitamin C (Ascorbic Acid) 50 mg / 100 mg Nicotinamide (Vit B3) 25 mg / 50 mg Folic Acid (Vit B9) 1000 mcg (1 mg) Minerals & Trace Elements Ferrous Sulphate (Iron) 30 mg / 50 mg (Elemental) Zinc Sulphate Monohydrate 15 mg / 22.5 mg (Elemental) Copper Sulphate 0.5 mg / 2 mg Selenium Dioxide 60 mcg / 70 mcg Potassium Iodide 100 mcg / 150 mcg Multivitamin Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (typically Red, Yellow, or Brown). The sugar coating is mandatory to mask the strong odor of B-vitamins and protect the labile Vitamin A and C from oxidation.
Active Ingredient Strength (Standard IP/NFI) Therapeutic Role Vitamin A (Acetate) IP 2500 IU Vision / Immunity Vitamin B1 (Thiamine Mononitrate) IP 2 mg Carbohydrate Metabolism Vitamin B2 (Riboflavin) IP 2 mg Mucosal Health Vitamin B6 (Pyridoxine HCl) IP 1 mg Protein Synthesis Niacinamide IP 25 mg Cellular Energy Calcium Pantothenate IP 5 mg Metabolic Support Vitamin C (Ascorbic Acid) IP 50 mg Antioxidant / Collagen Vitamin D3 (Cholecalciferol) IP 200 IU Bone Mineralization Folic Acid IP 1 mg DNA Synthesis / Anemia Excipients Q.S. Gelatin / Sucrose / Talc Binder / Coating Multivitamin Tablets (Vitamin A, D3 & B-Complex)
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (typically Red, Yellow, or Brown). The sugar coating is critical to mask the strong odor of B-vitamins and protect Vitamin A from oxidation.
Active Ingredient Strength (Standard Prophylactic) Therapeutic Role Vitamin A (Acetate/Palmitate) 2500 IU / 5000 IU Vision / Immunity Vitamin D3 (Cholecalciferol) 200 IU / 400 IU Bone Mineralization Thiamine Mononitrate (Vit B1) 2 mg / 10 mg Nerve Function Riboflavin (Vit B2) 2 mg / 10 mg Cellular Energy Pyridoxine HCl (Vit B6) 1 mg / 3 mg Protein Metabolism Niacinamide 20 mg / 50 mg Skin Health / Energy Calcium Pantothenate 5 mg / 50 mg Metabolic Support Folic Acid 1 mg / 1.5 mg DNA Synthesis Excipients Q.S. Gelatin / Sucrose / Talc Binder / Coating Multivitamin Vitamin & B Complex Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often Red, Maroon, or Yellow) to mask the taste and odor of minerals.
Category Key Ingredients (Standard A-Z Profile) Fat Soluble Vitamins Vitamin A (2500 IU), Vitamin D3 (200 IU), Vitamin E (10 mg) Water Soluble Vitamins Vitamin C (50 mg), B1 (2 mg), B2 (2 mg), B6 (1.5 mg), B12 (1 mcg), Niacinamide (25 mg), Folic Acid (300 mcg), Calcium Pantothenate (5 mg) Essential Minerals Zinc Sulfate (Eq. 10 mg Zinc), Ferrous Fumarate (Eq. 30 mg Iron), Magnesium Oxide (10 mg), Calcium Carbonate (75 mg) Trace Elements Copper, Manganese, Iodine, Selenium (Q.S.) Mycophenolate Mofetil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and handler-protective Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Mycophenolate Mofetil USP/Ph.Eur. 250 mg Dose-Titration / Pediatric Standard: Base therapeutic unit for precise plasma-level titration and pediatric transplant management. Mycophenolate Mofetil USP/Ph.Eur. 500 mg Global Transplant Standard: High-dose adult maintenance therapy for the aggressive prevention of solid organ rejection. Excipients Microcrystalline Cellulose / Povidone K-90 / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Heavy Film-Coating (Engineered specifically to create a dense, impenetrable barrier over the cytotoxic API core, ensuring absolute handling safety for nurses and pharmacists) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic post-transplant dispensing regimens).
N-Acetyl Cysteine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Effervescent Tablet or Odor-Masked Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge Alu-Alu or Strip packs to ensure the absolute chemical stability of the highly hygroscopic API.
Active Ingredient Strength Primary Clinical Function N-Acetyl Cysteine (NAC) USP/Ph.Eur. 600 mg Global Pulmonology Standard: High-dose adult therapy for the rapid liquefaction of thick respiratory mucus and systemic antioxidant replenishment. Excipients (Effervescent Matrix) Citric Acid Anhydrous / Sodium Bicarbonate / Sucralose / Premium Orange-Lemon Flavoring / Macrogol 6000 Acid-Base Effervescent Couple / Sweetener / Odor-Masking Flavor / Lubricant (Engineered specifically to trigger a violent, complete dissolution in water within 60 seconds, creating a clear, pleasant-tasting respiratory therapeutic drink) *Pack Sizes: 10-Tablet Tubes, 10×10 Strip Packs, or Alu-Alu Blisters (Optimized specifically to absolutely lock out ambient moisture).
N-Acetylcysteine & Taurine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Odor-Masked Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic and sulfurous active ingredients.
Active Ingredient Strength Primary Clinical Function N-Acetylcysteine (NAC) USP/Ph.Eur. 150 mg Glutathione Precursor: Rapid neutralization of reactive oxygen species (ROS) to protect renal tubules and hepatic lobules. Taurine USP/Ph.Eur. 500 mg Intracellular Osmoregulator: Stabilization of glomerular cell membranes to prevent apoptosis and halt proteinuria. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Vanilla-Flavored Opadry Film Diluent / Superdisintegrant / Glidant / Heavy Odor-Masking Coating (Engineered specifically to lock in the noxious sulfur smell of NAC, ensuring absolute patient compliance for long-term chronic use) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic nephrology dispensing regimens).
Nalidixic Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The formulation is engineered for rapid disintegration to ensure the active ingredient is quickly processed for renal excretion.
Active Ingredient Strength (Standard) Therapeutic Role Nalidixic Acid BP/USP 500 mg Quinolone Antibacterial Excipients Q.S. Maize Starch / Gelatin Binder & Disintegrant Coating (Optional) Q.S. HPMC / Titanium Dioxide Film Coating Naltrexone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Taste-Masked Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Naltrexone Hydrochloride USP/Ph.Eur. 50 mg Global Addiction Standard: Single daily maintenance dose to ensure continuous, 24-hour blockade of opioid receptors and suppression of alcohol cravings. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Crospovidone / Magnesium Stearate / Colloidal Silicon Dioxide / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically to completely mask the violently bitter taste of the API, preventing the patient from spitting the pill out and ensuring total compliance) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strictly monitored, 30-day outpatient rehabilitation dispensing regimens).
Naproxen Sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hygroscopic sodium salt.
Active Ingredient Strength Primary Clinical Function Naproxen Sodium USP/Ph.Eur. 275 mg
(Equivalent to 250 mg Naproxen base)Acute Mild / OTC Standard: Base therapeutic unit for rapid relief of tension headaches, mild trauma, and OTC fever reduction. Naproxen Sodium USP/Ph.Eur. 550 mg
(Equivalent to 500 mg Naproxen base)Acute Severe Rx Standard: High-dose “loading” therapy to instantly abort severe acute migraines, acute gout flares, and post-surgical pain. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Talc / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the hygroscopic salt from humidity in the blister, but trigger a violent, immediate structural collapse the exact second it hits the stomach) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-turnover acute dispensing and retail pharmacy OTC placement).
Naproxen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Enteric-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient and the protective polymer matrix.
Active Ingredient Strength Primary Clinical Function Naproxen USP/Ph.Eur. 250 mg (EC) Initiation / Mild Standard: Base therapeutic unit for mild musculoskeletal trauma, acute gout, and primary dysmenorrhea. Naproxen USP/Ph.Eur. 500 mg (EC) Global Rheumatology Standard: High-dose adult maintenance therapy for severe Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Triethyl Citrate / Magnesium Stearate pH-Dependent Enteric Barrier / Diluent / Superdisintegrant / Plasticizer (Engineered specifically to absolutely block dissolution in the highly acidic stomach, preventing mucosal burns, and rapidly dissolving only in the alkaline duodenum) *Pack Sizes: 10×10 Blisters or Bottles of 100/500 (Optimized specifically for strict chronic orthopedic dispensing regimens and massive government health tenders).
Nateglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Disintegrating Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly soluble API.
Active Ingredient Strength Primary Clinical Function Nateglinide Ph.Eur./USP 60 mg Initiation / Mild Standard: Base therapeutic unit for patients nearing their HbA1c goal who only require mild postprandial glycemic control. Nateglinide Ph.Eur./USP 120 mg Global Clinical Standard: Primary adult maintenance dose for severe meal-time spikes, taken immediately before the three main meals of the day. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Glidant (Engineered specifically to shatter and dissolve in the stomach in under 15 minutes, guaranteeing the insulin surge perfectly matches the digestion of the meal) *Pack Sizes: 3×10 or 10×10 Blisters (Optimized specifically for high-turnover diabetic dispensing, as patients consume 3 tablets per day).
Nebivolol & Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic and pH-sensitive active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Nitric Oxide Donating Beta-Blocker: Reduces cardiac workload while promoting active peripheral vasodilation and preserving sexual function. Telmisartan Ph.Eur./USP 40 mg Metabolic ARB: Provides sustained 24-hour RAAS blockade and improves cellular insulin sensitivity (PPAR-γ modulation). Excipients Meglumine / Sodium Hydroxide / Microcrystalline Cellulose / Povidone K30 / Polysorbate 80 / Magnesium Stearate Alkalizing Agents (Meglumine) / Diluent / Binder / Surfactant (Engineered specifically to create a hyper-alkaline micro-environment for Telmisartan dissolution, physically isolated from the Nebivolol layer to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 5 mg Cardioselective & Vasodilatory Base: Reduces cardiac workload and provides active Nitric Oxide-driven peripheral vasodilation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Thiazide Diuretic Driver: Forces the excretion of excess sodium and water, massively amplifying the blood-pressure-lowering effect of the beta-blocker. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Polysorbate 80 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Wetting Surfactant / Moisture-Barrier Coating (Engineered specifically to protect the highly delicate racemic Nebivolol balance while ensuring rapid, synchronized gastric dissolution of the diuretic) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
Nelfinavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Due to the high dose required for therapeutic efficacy, we ensure the tablet is engineered for ease of swallowing without compromising the structural integrity of the high-API load.
Active Ingredient Strength (Standard) Therapeutic Role Nelfinavir Mesylate USP/BP 250 mg Standard Adult / Pediatric Dose Nelfinavir Mesylate USP/BP 625 mg High-Strength Adult Maintenance Excipients Q.S. Calcium Silicate / Crospovidone Disintegrant & Stabilizer Neomercazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly reactive thionamide molecule.
Active Ingredient Strength Primary Clinical Function Carbimazole Ph.Eur./BP 5 mg Maintenance / Titration Standard: Base therapeutic unit for the gradual tapering of therapy and long-term maintenance of euthyroidism. Carbimazole Ph.Eur./BP 10 mg / 20 mg Acute Initiation Standard: High-dose induction therapy to aggressively shut down severe, life-threatening thyrotoxicosis. Excipients Lactose Monohydrate / Maize Starch / Magnesium Stearate / Povidone K30 / Iron Oxide Yellow (for distinct clinical identification) Diluent / Binder / Lubricant (Engineered specifically for rapid, complete gastric dissolution to achieve peak methimazole blood levels within 1 to 2 hours) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrinology dispensing, as patients initiate on high doses and taper down over many months).
Neostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Neostigmine Bromide Ph.Eur./USP 15 mg Global Clinical Standard: Base therapeutic oral unit for the continuous, meticulously spaced symptomatic management of Myasthenia Gravis. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically for rapid, predictable gastric dissolution to ensure precise symptom control within 30 to 45 minutes of ingestion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic neurology dispensing, as patients may require up to 10-15 tablets per day in divided doses).
Nevirapine Tablet
FreeProduct Composition & Strengths
We supply this antiretroviral therapeutic in the globally accepted standard therapeutic strength optimized for adult combination maintenance therapy.
Active Ingredient Standard Strength Formulation Delivery Matrix Primary Clinical Function Nevirapine Anhydrous IP / BP / USP 200 mg Oral Solid Uncoated Tablet (Scored for flexible pediatric/titration dividing) The NNRTI Anchor: Suppresses viral replication loads when used in combination ARV regimens. Excipients Pharma Grade Lactose, Microcrystalline Cellulose, Sodium Starch Glycolate The Delivery Core: Ensures immediate physical disintegration and release kinetics. Niacinamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Purity Tablet, packed exclusively in highly secure, premium Alu-PVC blister strips or high-density HDPE aesthetic bottles to ensure the absolute chemical stability of the vitamin matrix.
Active Ingredient Strength Primary Clinical Function Niacinamide (Vitamin B3) USP/Ph.Eur. 500 mg Global Premium Dermatology Standard: High-dose adult therapy for systemic acne control, anti-aging ceramide synthesis, and hyperpigmentation reduction. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Stearic Acid / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Lubricant (Engineered specifically for rapid gastric dissolution to ensure peak systemic saturation and rapid delivery to the dermal layers) *Pack Sizes: 10×10 Blisters or Bottles of 60/100 (Optimized specifically for premium OTC retail and daily dermatological regimens).
Nicorandil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Tablet, packed exclusively in highly secure, heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile active ingredient.
Active Ingredient Strength Primary Clinical Function Nicorandil Ph.Eur./BP 5 mg Initiation / Titration Standard: Base therapeutic unit for the mandatory slow-titration protocol required to build patient tolerance and prevent severe “nitrate headaches.” Nicorandil Ph.Eur./BP 10 mg / 20 mg Global Cardiology Standard: High-dose adult maintenance therapy for severe, refractory stable angina pectoris. Excipients Maize Starch / Croscarmellose Sodium / Stearic Acid / Mannitol Low-Moisture Diluent / Superdisintegrant / Lubricant (Engineered specifically without hygroscopic binders to guarantee the tablet remains perfectly dry and structurally intact throughout its shelf life) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic cardiology dispensing regimens).
Nicotinamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or high-density HDPE bottles to ensure the absolute chemical stability of the highly soluble vitamin amide.
Active Ingredient Strength Primary Clinical Function Nicotinamide (Niacinamide) USP/Ph.Eur. 250 mg Dermatology / Acne Standard: Base therapeutic unit for the systemic reduction of inflammatory skin lesions and mild nutritional supplementation. Nicotinamide (Niacinamide) USP/Ph.Eur. 500 mg Oncology Prophylaxis / Pellagra Standard: High-dose adult therapy for non-melanoma skin cancer prevention and acute pellagra eradication. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Stearic Acid / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Lubricant (Engineered specifically for rapid, complete gastric dissolution to ensure peak systemic NAD+ saturation within 1 to 2 hours) *Pack Sizes: 10×10 Blisters or Bottles of 60/100 (Optimized specifically for chronic, twice-daily dermatological dispensing regimens).
Nicotinic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymer.
Active Ingredient Strength Primary Clinical Function Nicotinic Acid (Niacin) USP/Ph.Eur. 500 mg (ER) Initiation / Titration Standard: Base therapeutic unit for the mandatory, slow 4-week dose titration protocol required to build patient tolerance. Nicotinic Acid (Niacin) USP/Ph.Eur. 1000 mg (ER) Global Cardiology Standard: High-dose adult maintenance therapy for severe mixed dyslipidemia and extreme hypertriglyceridemia. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Stearic Acid / Colloidal Silicon Dioxide / Premium Opadry Film Hydrophilic Polymer Matrix / Diluent / Lubricant / Glidant (Engineered specifically to form a viscous, highly controlled gel barrier upon swallowing, metering the API release precisely into the gastrointestinal tract over 8-12 hours) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic cardiology dispensing regimens).
Nicoumalone Tablet
FreeProduct Composition & Calibration Spectrum
We manufacture Nicoumalone in a complete, highly precise range of strengths to allow for the exact dosage adjustments required to maintain narrow therapeutic targets.
Active Ingredient Common Name Compendial Monograph Available Strengths Primary Clinical Application Nicoumalone (Acenocoumarol) BP / IP / USP 1 mg Micro-Titration Phase: For delicate, low-dose fine-tuning in geriatric or sensitive patient profiles. Nicoumalone (Acenocoumarol) BP / IP / USP 2 mg Foundational Maintenance: The standard baseline dose for routine daily thromboembolic prophylaxis. Nicoumalone (Acenocoumarol) BP / IP / USP 3 mg Intermediate Control: For patients requiring step-up adjustment to hit targeted coagulation thresholds. Nicoumalone (Acenocoumarol) BP / IP / USP 4 mg High-Threshold Suppression: For rapid oral loading or patients presenting high chemical resistance to standard doses. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Active Ingredient Available Strengths Formulation Matrix Delivery System Primary Clinical Focus Nifedipine IP/BP/USP 10 mg Immediate-Release / Rapid-Onset Film Tablet Acute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions. Nifedipine IP/BP/USP 20 mg Sustained-Release (SR) Retard Matrix Twice-Daily Maintenance: Intermediate control for stable chronic hypertension. Nifedipine IP/BP/USP 30 mg Once-Daily Extended-Release (XR / XL) Matrix First-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension. Nifedipine IP/BP/USP 60 mg Once-Daily Extended-Release (XR / XL) Matrix High-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We supply Nifedipine in exact, internationally standardized strengths, optimized for immediate-release emergency titration or controlled-release daily maintenance.
Active Ingredient Available Strengths Formulation Mechanism Primary Clinical Target Nifedipine IP / BP / USP 10 mg Immediate or Modified Release Acute Titration / Tocolysis: For rapid blood pressure adjustment or suppression of premature labor. Nifedipine IP / BP / USP 20 mg Sustained / Retard Matrix Daily Maintenance: Continuous 12-to-24-hour plasma concentration for chronic hypertension and angina. Nimesulide ,Paracetamol & Chlorzoxazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Preferential COX-2 NSAID: Rapid abortion of localized musculoskeletal inflammation and tissue swelling. Paracetamol (Acetaminophen) BP/Ph.Eur. 325 mg Central Analgesic: Synergistic pain threshold elevation and antipyretic control. Chlorzoxazone USP/Ph.Eur. 250 mg Central Muscle Relaxant: Direct inhibition of spinal reflex arcs to break severe, locked muscle spasms. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, ensuring all three APIs are absorbed simultaneously for synchronized relief) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day Nimesulide therapy limit).
Nimesulide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Global Acute Standard: High-efficacy adult therapeutic unit for the rapid, short-term abortion of acute inflammatory pain. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Docusate Sodium / Povidone K30 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Surfactant / Binder (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, maximizing the drug’s surface area for ultra-fast gastrointestinal absorption) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day therapy limit).
Nimesulide, Paracetamol & Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Multi-Particulate Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly delicate enzyme component.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Preferential COX-2 NSAID: Rapid abortion of localized musculoskeletal inflammation and tissue pain. Paracetamol (Acetaminophen) BP/Ph.Eur. 325 mg Central Analgesic: Synergistic pain threshold elevation and antipyretic control. Serratiopeptidase (as Enteric-Coated Granules) 15 mg
(Equivalent to 30,000 Serratiopeptidase Units)Proteolytic Enzyme: Direct breakdown of fibrin and inflammatory exudate to physically drain severe localized edema. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate Enteric Polymer Shield / Diluent / Superdisintegrant / Binder (Engineered specifically to protect the enzyme from gastric acid while allowing the analgesics to dissolve instantly in the stomach) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day Nimesulide therapy limit).
Nitrazepam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient and prevent unauthorized access.
Active Ingredient Strength Primary Clinical Function Nitrazepam BP/Ph.Eur. 5 mg Initiation / Elderly Standard: Base therapeutic unit for the short-term management of severe insomnia, specifically titrated for elderly patients to prevent next-day falls. Nitrazepam BP/Ph.Eur. 10 mg Severe Psychiatric Standard: Maximum adult dose to force sleep in highly agitated, refractory, or acutely manic patients. Excipients Lactose Monohydrate / Maize Starch / Microcrystalline Cellulose / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Binder / Disintegrant / Lubricant (Engineered specifically for rapid gastric dissolution, inducing sleep within 30 to 60 minutes of ingestion) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 2-to-4 week acute psychiatric dispensing regimens to prevent dependency).
Nitrofurantoin Tablets
FreeA Nitrofurantoin tablet is an antibiotic specifically used to treat and prevent urinary tract infections (UTIs), such as cystitis. It works by damaging the DNA of bacteria in the urinary tract.
Nitrofurantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.
Active Ingredient Strength Primary Clinical Function Nitrofurantoin (Macrocrystals) USP/Ph.Eur. 50 mg Prophylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing. Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP 100 mg Global Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis. Excipients Carbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).
Nitroglycerin Tablet
FreeProduct Composition & Available Strengths
We supply Nitroglycerin Sublingual Tablets in exact, internationally calibrated low-dose strengths to allow for immediate rescue titration during acute ischemic episodes.
Active Ingredient Common Name Compendial Title Available Strengths Primary Clinical Target Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.4 mg Standard Rescue Dose: Preferred international standard for immediate acute angina abortion. Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.5 mg High-Threshold Prophylaxis: Calibrated for heavy coronary spasm management or pre-exertion protection. Norethisterone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent steroid hormone.
Active Ingredient Strength Primary Clinical Function Norethisterone Ph.Eur./USP 5 mg Global Gynecology Standard: High-dose therapeutic unit for acute hemorrhage cessation, endometriosis suppression, and menstrual cycle manipulation. Excipients Lactose Monohydrate / Maize Starch / Magnesium Stearate / Povidone K30 Diluent / Binder / Lubricant (Engineered specifically for rapid gastric dissolution to halt acute uterine bleeding within 24-48 hours of the first dose) Pack Sizes: 10×10 Blisters or 3×10 Calendar Packs (Optimized specifically for strict cyclical gynecology dispensing regimens).
Norfloxacin & Tinidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Norfloxacin USP/Ph.Eur. 400 mg Aerobic Gut/UTI Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Tinidazole USP/Ph.Eur. 600 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and pelvic anaerobes. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 5-to-10 day acute anti-infective dispensing regimens).
Norfloxacin Tablet
FreeProduct Composition & Strength
We supply Norfloxacin in the globally standardized therapeutic strength optimized for adult twice-daily dosage regimens.
Active Ingredient Strength (per Tablet) Primary Microbiological Function Norfloxacin USP / BP / IP 400 mg The DNA Gyrase Blocker: Eradicates susceptible urinary and gastrointestinal pathogens. Excipients Pharma Grade The Core Matrix: High-performance binders optimized for rapid tablet dissolution. Nystatin Tablet
FreeProduct Composition & Configuration
We supply this product in the internationally recognized standard therapeutic strength optimized for uniform, localized mucosal distribution.
Active Ingredient Strength (per Tablet) Formulation Delivery System Primary Clinical Function Nystatin IP / BP / USP 100,000 IU Non-Effervescent Local Insert: Designed for slow physical disintegration within vaginal mucosal fluids. The Polyene Fungicide: Eradicates superficial Candida strains locally. Excipients Pharma Grade Modified lactose, starch, and lubricating binding agents. The Comfort Base: Ensures non-irritating, smooth insertion profiles. Ofloxacin & Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Aerobic Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Ornidazole INN/Ph.Eur. 500 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and surgical-site anaerobes. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-5 day acute anti-infective dispensing regimens).
Ofloxacin & Satranidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the fluoroquinolone and nitroimidazole APIs.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Broad-spectrum fluoroquinolone for the eradication of aerobic bacterial pathogens. Satranidazole INN/Ph.Eur. 300 mg Premium nitroimidazole for the eradication of anaerobic bacteria and protozoa. Excipients Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Hypromellose Diluent / Superdisintegrant / Lubricant / Premium Film-Coating (Engineered to mask bitterness and ensure immediate gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for standard 3-to-5 day acute gastrointestinal and pelvic infection regimens).
Ofloxacin Tablets
FreeOfloxacin Tablets 200 mg
Each Filmcoated tablet contains :
Ofloxacin IP 200 mg
Excipients q.sYALLEY FLOX
Ofloxacin Tablets 200mg Each Film coated tablet contains :
Ofloxacin BP 200 mg
Excipients q.sOfnis -200
Ofloxacin Tablets
Each Filmcoated tablet contains :
Ofloxacin BP 200 mgUsage: – Treat bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Olanzapine & Fluoxetine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Capsule or Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative Olanzapine molecule.
Active Ingredient Strength Primary Clinical Function Olanzapine Ph.Eur./USP 3 mg / 6 mg / 12 mg Atypical Base: Modulates 5-HT2A/D2 receptors to stabilize severe mood swings and trigger prefrontal synergy. Fluoxetine (as HCl) Ph.Eur./USP 25 mg / 50 mg SSRI Driver: Forces a massive serotonin pool in the synaptic cleft to elevate refractory depressive lows. Excipients Pregelatinized Starch / Croscarmellose Sodium / Microcrystalline Cellulose / Magnesium Stearate / Opadry Film Moisture-Scavenging Diluent / Superdisintegrant / Binder / Premium Oxygen-Barrier Film-Coating (Engineered specifically to physically isolate the highly sensitive Olanzapine from cross-reacting with Fluoxetine) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Olanzepine Tablet
FreeProduct Composition & Available Strengths
We supply Olanzapine in standard, exact strengths to facilitate initial titration phases and safe daily maintenance therapy.
Active Ingredient Available Strengths Primary Clinical Target Olanzapine IP / BP / USP 2.5 mg Introductory Titration: For low-dose introductory cycles, elderly adjustment, or sensitive patient profiles. Olanzapine IP / BP / USP 5 mg Standard Maintenance: The baseline daily dosage for long-term schizophrenic and bipolar maintenance. Olanzapine IP / BP / USP 10 mg Acute Crisis Control: High-potency therapeutic dosing to stabilize acute manic or severe psychotic episodes. Olmesartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile ester prodrug.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg Initiation / Global Standard: Standard adult starting and maintenance dose for the continuous control of essential hypertension. Olmesartan Medoxomil Ph.Eur./USP 40 mg Severe Refractory Standard: Maximum adult maintenance dose for patients requiring further reduction in blood pressure. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Hydroxypropyl Cellulose / Magnesium Stearate / Titanium Dioxide Low-Moisture Diluent / Binder / Lubricant / Premium Moisture-Barrier Film-Coating (Engineered specifically to lock out ambient humidity and prevent the premature hydrolysis of the medoxomil group prior to ingestion) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Olmesartan, Amlodipine & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients across their entire shelf life.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg / 40 mg ARB Base: Blocks the renin-angiotensin-aldosterone system (RAAS) and provides critical diabetic renoprotection. Amlodipine (as Besylate) Ph.Eur./USP 5 mg / 10 mg CCB Vasodilator: Forces profound, sustained peripheral arterial relaxation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Diuretic Volume Controller: Flushes excess sodium/water and massively amplifies the efficacy of the ARB component. Excipients Silicified Microcrystalline Cellulose / Pregelatinized Starch / Croscarmellose Sodium / Magnesium Stearate / Opadry Protective Film Moisture-Scavenging Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to physically isolate the highly sensitive Olmesartan ester from the alkaline Amlodipine salt to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Omeprazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Enteric-Coated Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly acid-labile benzimidazole derivative.
Active Ingredient Strength Primary Clinical Function Omeprazole BP/USP/Ph.Eur. 10 mg OTC / Maintenance Standard: Approved unit for over-the-counter frequent heartburn relief and long-term remission maintenance of healed esophagitis. Omeprazole BP/USP/Ph.Eur. 20 mg Global Clinical Standard: Primary adult daily dose for active GERD, gastric ulcers, and standard H. pylori eradication protocols. Omeprazole BP/USP/Ph.Eur. 40 mg Severe Refractory Standard: High-dose therapy for severe erosive esophagitis, NSAID-induced bleeding ulcers, and Zollinger-Ellison Syndrome. Excipients Methacrylic Acid Copolymer / Hypromellose (HPMC) / Sugar Spheres / Macrogol / Titanium Dioxide pH-Dependent Enteric Coating / Sub-coating Barrier / Core Substrate / Plasticizer (Engineered specifically to resist gastric fluid at pH 1.2 but dissolve instantly at duodenal pH 6.8) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 100 (Optimized specifically for strict 14-to-28 day acute GI healing regimens).
Ondansetron Orally Disintegrating Tablets
FreeProduct Composition & Available Formats
We supply Ondansetron ODT in the two primary compendial configurations required to support initial introductory pediatric dosing up to high-potency surgical and oncological maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Delivery Matrix Primary Clinical Application Ondansetron Base / Hydrochloride USP / BP / IP 4 mg Fast-Dispersing Hydrophilic Matrix (ODT) Pediatric & General Antiemetic: First-line baseline dosing for acute gastroenteritis, pediatric oncology protocols, and mild post-operative nausea. Ondansetron Base / Hydrochloride USP / BP / IP 8 mg Fast-Dispersing Hydrophilic Matrix (ODT) High-Potency Emetic Control: Advanced strength engineered for highly emetogenic chemotherapy cycles, abdominal radiation protocols, and immediate post-surgical recovery fields. Ondansetron Tablet
FreeProduct Composition & Available Strengths
We supply this critical supportive therapeutic in standard, internationally recognized strengths designed for exact preventative and rescue dosing.
Active Ingredient Available Strengths Primary Clinical Target Ondansetron HCl IP / BP / USP 4 mg Standard Prophylaxis: For moderate emetogenic chemotherapy, general post-operative rescue, and pediatric care. Ondansetron HCl IP / BP / USP 8 mg High-Potency Protection: For highly emetogenic cisplatin-based cancer regimens and severe surgical recovery. Ondansitron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Flash-Dispersion ODT or Standard Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant peelable Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Ondansetron (as HCl Dihydrate) Ph.Eur./USP 4 mg (ODT / FCT) Pediatric & PONV Standard: Base therapeutic unit for post-operative nausea, severe pediatric gastroenteritis, and mild emetic triggers. Ondansetron (as HCl Dihydrate) Ph.Eur./USP 8 mg (ODT / FCT) Global Oncology Standard: High-dose adult maintenance therapy for highly emetogenic chemotherapy (CINV) and radiation therapy (RINV). Excipients (ODT Formulation) Mannitol / Crospovidone / Aspartame / Colloidal Silicon Dioxide / Premium Mint Flavoring Lyophilized Matrix / Superdisintegrant / Sweetener / Saliva-Stimulating Flavor (Engineered specifically to draw saliva into the tablet matrix, forcing a violent, sub-5-second structural collapse on the tongue without a bitter aftertaste) *Pack Sizes: 10×10 Peelable Alu-Alu Blisters (Optimized specifically for strict oncology and surgical dispensing regimens).
Oral Rehydration Salts (Sachets)
FreeProduct Composition & Osmolarity Calibration
We manufacture the exact Low-Osmolarity ORS configuration, which has been clinically proven to reduce stool volume, eliminate the need for intravenous infusions by greater than 33%, and physically shorten recovery windows compared to old high-osmolarity variants.
1. Powder Weight per Sachet (To Make 1 Litre of Solution)
Active Ingredient Mass per Sachet (Grams) Primary Physiological Function Glucose (Anhydrous) IP / BP / USP 13.50 g The Driver: Drives the active sodium transport mechanism. Sodium Chloride IP / BP / USP 2.60 g The Replenisher: Replaces lost extracellular fluid ions. Trisodium Citrate Dihydrate IP/BP/USP 2.90 g The Buffer: Corrects systemic metabolic acidosis. Potassium Chloride IP / BP / USP 1.50 g The Balancer: Prevents systemic hypokalemia. Total Weight 20.50 g Standard sachet yield for exactly 1000 mL of water. Orciprenaline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly soluble sulphate salt.
Active Ingredient Strength Primary Clinical Function Orciprenaline Sulphate BP/Ph.Eur. 10 mg Pediatric / Initiation Standard: Base therapeutic unit for pediatric asthma management and dose titration. Orciprenaline Sulphate BP/Ph.Eur. 20 mg Global Adult Standard: Maximum adult maintenance dose for severe, chronic obstructive pulmonary disease (COPD). Excipients Microcrystalline Cellulose / Lactose Monohydrate / Maize Starch / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Binder / Disintegrant / Lubricant (Engineered specifically for rapid gastric dissolution and fast systemic absorption, providing relief within 30 minutes of oral administration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-turnover acute dispensing and massive government health tenders).
Orlistat Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Micro-Pellet Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the highly delicate API.
Active Ingredient Strength Primary Clinical Function Orlistat INN/Ph.Eur. 60 mg OTC / Retail Standard: Base therapeutic unit approved in many regions for over-the-counter (OTC) weight loss management in overweight adults. Orlistat INN/Ph.Eur. 120 mg Global Clinical Standard: Prescription-strength adult maintenance dose for clinical obesity (BMI > 30) and severe metabolic syndrome. Excipients (Capsule Pellets) Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Povidone / Talc Diluent / Superdisintegrant / Wetting Surfactant / Binder (Engineered specifically to maximize the dispersion of the API across the entire gastrointestinal lumen to maximize enzyme binding) *Pack Sizes: Bottles of 84/120 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic bariatric dispensing regimens, taken with every major meal).
Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredient.
Active Ingredient Strength Primary Clinical Function Ornidazole INN/Ph.Eur. 500 mg Global Clinical Standard: Base therapeutic unit for the rapid eradication of protozoal and anaerobic pathogens. Excipients Microcrystalline Cellulose / Maize Starch / Sodium Starch Glycolate / Hypromellose / Titanium Dioxide Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to create an impenetrable barrier that completely masks the notoriously bitter, foul taste of the nitroimidazole API, ensuring flawless patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-10 day acute anti-infective dispensing regimens).
Oseltamivir Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.
Active Ingredient Strength Primary Clinical Function Oseltamivir Phosphate USP/Ph.Eur. 75 mg (Equivalent to Oseltamivir free base) Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B. Excipients Pregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl Fumarate Diluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption) *Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).
Oxcarbazepine Tablet
FreeProduct Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
Active Ingredient Available Strengths Primary Clinical Target Oxcarbazepine IP / BP / USP 150 mg Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. Oxcarbazepine IP / BP / USP 300 mg Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. Oxcarbazepine IP / BP / USP 600 mg High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization. Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Pancreatin & L-Ornithine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the biological proteins and the highly hygroscopic amino acid.
Active Ingredient Strength Primary Clinical Function Pancreatin (Porcine Origin) Ph.Eur./USP 170 mg
(Standardized Lipase/Protease/Amylase)Gastrointestinal Standard: Intraluminal enzymatic digestion of complex macronutrients to reverse malabsorption. L-Ornithine (as L-Ornithine L-Aspartate / LOLA) 150 mg Hepatology Standard: Hepatic urea cycle activation for aggressive ammonia detoxification and liver regeneration. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate Enteric Barrier Coating (for Pancreatin) / Diluent / Superdisintegrant (Engineered specifically to separate the amino acid from the enzymes and ensure targeted duodenal release of the biologicals) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance chronic hepato-gastro dispensing regimens).
Pancreatin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Enteric-Coated Tablet or Hard Capsule (containing Enteric Minimicrospheres), packed exclusively in highly secure, moisture-resistant Alu-Alu blisters or desiccant-lined HDPE bottles to ensure the absolute stability of the biological proteins.
Active Ingredient Strength (Standardized USP Units) Primary Clinical Function Pancreatin (Porcine Origin) Ph.Eur./USP 10,000 Lipase Units
(approx. 33,200 Protease / 33,200 Amylase)Pediatric / Initiation Standard: Base therapeutic unit for pediatric Cystic Fibrosis patients and meal-snack titration. Pancreatin (Porcine Origin) Ph.Eur./USP 25,000 Lipase Units
(approx. 85,000 Protease / 74,700 Amylase)Global Clinical Standard: High-dose adult maintenance therapy for severe Exocrine Pancreatic Insufficiency and Pancreatectomy. Excipients Methacrylic Acid Copolymer / Macrogol / Simethicone / Microcrystalline Cellulose / Triethyl Citrate Enteric Barrier Coating / Plasticizer / Anti-Foaming Agent / Diluent (Engineered specifically to protect the biological extract from gastric acid and ensure rapid, synchronized dissolution in the duodenum) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-volume daily dispensing where patients may consume 3 to 10 units daily with every meal and snack).
Pantoprazole & Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly acid-labile Pantoprazole and the SR polymer network.
Active Ingredient Strength Primary Clinical Function Pantoprazole Sodium Sesquihydrate USP/Ph.Eur. 40 mg (Enteric-Coated) Global Clinical Standard: Profound, 24-hour suppression of gastric acid production. Domperidone Maleate BP/Ph.Eur. 30 mg (Sustained-Release) Continuous 24-hour peripheral prokinetic action to accelerate gastric emptying and prevent nausea. Excipients Methacrylic Acid Copolymer / Hypromellose (HPMC) / Mannitol / Magnesium Stearate Enteric Barrier Coating / Hydrophilic SR Polymer Matrix / Diluent (Engineered specifically to perfectly isolate the two APIs and control their entirely separate intestinal dissolution rates) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 14-to-28 day chronic gastroenterology dispensing regimens).
Pantoprazole Tablets
FreePantoprazole Tablets IP 40 mg
Each Enteric Coated tablet contains
Pantoprazole Sodium IP
Eq. To Pantoprazole 40 mgPenta-20
Pantoprazole Tablets 20 mg
Each Enteric Coated Tablet Contains
Pantoprazole Sodium Sesquihydrate
Eq To Pantoprazole 20 mgPenta – 40
Pantoprazole Tablets 40 mg
Each Entreric Coated tablet contains
Pantoprazole Sodium Sesquihydrate
Eq. To pantoprazole 40 mgUsage: – Heartburn, acid reflux and gastro-esophageal reflux disease
Category: – Antacid & Anti ulcer drugs
Therapeutic category: – Antiulcer, Antacid
Paracetamol & Caffeine Anhydrous Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets or Uncoated Tablets. The anhydrous caffeine allows for a harder, more durable tablet suitable for bulk transport.
Active Ingredient Strength (Standard) Strength (Extra Power) Technical Grade Paracetamol IP/BP/USP 500 mg 650 mg Micronized Caffeine Anhydrous IP/BP/USP 30 mg 50 mg / 65 mg Moisture Content < 0.5% Excipients Q.S. Starch / PVP K-30 Binder Paracetamol & caffeine tablets
FreeProduct Composition & Strength
We supply this product as Film Coated or Uncoated Tablets in blister packs. Multiple strength combinations are available.
Product Variant Paracetamol Content Caffeine (Anhydrous) Common Name Standard Extra 500 mg 30 mg Panadol Extra Generic High Caffeine 500 mg 65 mg Migraine Relief Forte Strength 650 mg 50 mg Extra Strength Paracetamol & Diclofenac Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White, Orange, or Red). The coating is non-enteric to ensure immediate disintegration.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/USP 325 mg / 500 mg Central Analgesic Diclofenac Potassium IP/USP 50 mg Rapid Anti-Inflammatory Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Binder / Super-Disintegrant Paracetamol & Diclofenac Sodium Tablets
FreeProduct Composition & Strength
We supply this product as Enteric Coated or Film Coated Tablets in blister packs.
Active Ingredient Strength (Standard) Role Diclofenac Sodium IP/BP/USP 50 mg Anti-inflammatory / Analgesic Paracetamol IP/BP/USP 500 mg Analgesic / Antipyretic Excipients Q.S. Binder / Disintegrant Paracetamol & Orphenadrine Citrate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets in blister packs. We offer both Standard and Forte strengths.
Product Variant Paracetamol Content Orphenadrine Citrate Common Name Standard Strength 450 mg 35 mg Norgesic Generic Forte Strength 650 mg 50 mg Norgesic Forte Generic Excipients Q.S. — Binder / Filler Paracetamol Caffeine Chlorpheniramine Maleate Phenylephrine Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) optimized for maximum clinical efficacy.
Active Ingredient Strength (per Tablet) Primary Clinical Function Paracetamol (Acetaminophen) 325 mg / 500 mg The Pain & Fever Reliever: Targets aches and chills. Caffeine (Anhydrous) 30 mg The Potentiator: Boosts pain relief and alertness. Chlorpheniramine Maleate 2 mg / 4 mg The Antiallergic: Stops sneezing and runny nose. Phenylephrine HCl 5 mg / 10 mg The Decongestant: Clears blocked sinuses. paracetamol caffeine phenylephrine cpm Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (often colored/shaped for brand differentiation). This is a “fixed-dose combination” optimized for adult efficacy.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/BP/USP 500 mg Fever & Pain Reducer Caffeine (Anhydrous) 30 mg Analgesic Booster / Alertness Phenylephrine HCl 5 mg / 10 mg Nasal Decongestant Chlorpheniramine Maleate 2 mg / 4 mg Antiallergic Paracetamol Diclo Sodium Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated or Enteric Coated Tablets (typically White, Orange, or Yellow). The coating protects the stomach from the direct irritation of Diclofenac.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/USP 500 mg / 325 mg Central Analgesic / Antipyretic Diclofenac Sodium IP/USP 50 mg Peripheral Anti-Inflammatory Excipients Q.S. Maize Starch / Magnesium Stearate / Talc Binder / Lubricant Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Standard) or Film Coated/Caplets (Easy Swallow). We offer varying release profiles.
Active Ingredient Strength (Standard) Role Paracetamol IP/BP/USP 500 mg Global Standard Adult Dose Paracetamol IP/BP/USP 650 mg High Potency / Sustained Pain Paracetamol IP/BP/USP 1000 mg (ER) Extended Release (Osteoarthritis) Excipients Q.S. Starch (Binder) / Lubricant Paracetamol Tablets
FreeParacetamol Tablets IP
Each Uncoated tablet contains :
Paracetamol IP 500 mgParacetamol Tablets IP 650 mg
Each uncoated Tablet Contains:
Paracetamol IP 650 mg
Excipients – QSParacetamol Tablets BP
Each Uncoated tablet contains :
Paractamol BP 100 mgParacetamol Tablets BP
Each Uncoated tablet contains :
Paracetamol BP 250 mgParafen te
Paracetamol with Ibuprofen Tablets
Each Uncoated tablet contains :
Ibuprofen IP 400 mg
Paracetamol IP 325 mgPARACETAMOL AND CAFFEINE TABLETS
Each uncoated Tablets Contains:
Paracetamol BP 325 mg
Caffeine anhydrous BP 30 mg
Excipients – QSParacetamol and Orphenadrine Citrate Tablets
Each uncoated tablet contains:
Orphenadrine citrate 35 mg
Paracetamol 450 mg
Excipients – QS
Each Uncoated Caplet contains :
Paracetamol BP 500 mg
Caffeine Anhydrous BP 30 mgPARACETAMOL AND CAFFEINE
Each uncoated Tablet contains:
Paracetamol BP 325 mg
Caffeine BP 30 mg
q.s. –PARACETAMOL,CAFFEINE,PHENYLEPHRINE HCL AND CHOLRPHENIRAMINE MALEATE TABLETS
Each Uncoated Tablet Contains:
Paracetamol BP 325 mg
Caffeine BP 30 mg
Chlorpheniramine maleate BP 2 mg
Phenylephrine Hcl BP 2.5 mg
Colour : Sunset Yellow –
Excipients – QSPARACETAMOL,CAFFEINE,PHENYLEPHRINE AND CHLORPHENIRAMINE TABLETS
Each uncoated Tablet contains:
Paracetamol BP 325 mg
Caffeine BP 15 mg
Phenylephrine BP 2.5 mg
Chlorpheniramine BP 2 mg
Tartrazine In House –Usage: – Treat aches and pain
Category: – Anti Analgesic Painkiller Drugs
Therapeutic category: – NSAID, Analgesic, Antipyretic, Anti Inflammatory
Paracetamol, Caffeine & Phenylephrine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets or Film Coated Tablets. The absence of an antihistamine makes this the ideal “Work-Safe” cold remedy.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/BP/USP 500 mg / 650 mg Fever & Pain Reducer Caffeine Anhydrous IP/BP/USP 30 mg Alertness / Analgesic Booster Phenylephrine HCl IP/BP/USP 5 mg / 10 mg Nasal Decongestant Excipients Q.S. Povidone / Starch / MCC Paracetamol, Caffeine, Phenylephrine HCl & CPM Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets or Film Coated Tablets (often colored Red, Blue, or Bi-layered). The formulation is balanced for adult physiology.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/BP/USP 500 mg Fever & Pain Reducer Caffeine Anhydrous IP/BP/USP 30 mg Analgesic Potentiator / Alertness Phenylephrine HCl IP/BP/USP 5 mg / 10 mg Nasal Decongestant Chlorpheniramine Maleate IP/BP/USP 2 mg / 4 mg Antiallergic / Antihistamine Excipients Q.S. Starch / MCC / Colorants Paracetamol, Diclofenac Potassium & Caffeine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often capsule-shaped). The coating masks the bitter taste of Caffeine and the astringency of Diclofenac.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/BP/USP 325 mg / 500 mg Central Analgesic / Antipyretic Diclofenac Potassium BP/USP 50 mg Rapid Anti-Inflammatory Caffeine Anhydrous BP/USP 30 mg Adjuvant / Vasoconstrictor Excipients Q.S. Microcrystalline Cellulose / HPMC Paracetamol, Diclofenac Sodium & Caffeine Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for maximum therapeutic synergy.
Paroxetine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the extended-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 12.5 mg (CR) Initiation Standard: Base titration unit to safely acclimatize the brain and minimize initial side effects. Gold standard for PMDD. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 25 mg (CR) Global Clinical Standard: Standard adult maintenance dose for Major Depressive Disorder and Severe Panic Disorder. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 37.5 mg (CR) Advanced Psychiatric Standard: High-dose maintenance therapy for treatment-resistant depression and refractory anxiety. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Lactose Monohydrate / Magnesium Stearate / Triethyl Citrate Hydrophilic SR Polymer Matrix / Enteric Coating / Diluent / Plasticizer (Engineered to absolutely block stomach acid and control the exact 24-hour intestinal diffusion rate) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Pentoxifylline Tablets
FreePentoxifylline Tablets 400 mg
Each Filmcoated tablet contains :
Pentoxifylline BP 400 mgUsage: – To reduce leg pain caused by poor blood circulation
Category: – Anti Cardiovascular drugs
Therapeutic category: – Cardiovascular
Perindopril Erbumine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips equipped with active desiccants to ensure the absolute chemical stability of the highly degradable Erbumine salt.
Active Ingredient Strength Primary Clinical Function Perindopril Erbumine Ph.Eur./USP 2 mg Initiation Standard: Base titration dose for elderly patients or those with severe heart failure/renal impairment to prevent sudden hypotension. Perindopril Erbumine Ph.Eur./USP 4 mg Hypertension Standard: Standard adult maintenance dose for the continuous control of essential hypertension. Perindopril Erbumine Ph.Eur./USP 8 mg Cardiovascular Risk Standard: Maximum maintenance dose for profound risk reduction in patients with stable coronary artery disease. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Hydrophobic Colloidal Silica / Magnesium Stearate Diluent / Alkaline Stabilizer / Moisture Scavenger / Lubricant (Engineered specifically to create a hyper-dry internal tablet matrix that absolutely prevents hydrolytic cyclization of the API) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Phenazopyridine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant PVC/PVDC or Alu-PVC blister strips to ensure the stability of the active dye compound.
Active Ingredient Strength Primary Clinical Function Phenazopyridine Hydrochloride USP/Ph.Eur. 100 mg Standard OTC/Initiation dose for mild-to-moderate urinary tract discomfort. Phenazopyridine Hydrochloride USP/Ph.Eur. 200 mg Global Prescription Standard: Maximum adult dose for severe dysuria and post-operative catheter trauma. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for rapid gastric dissolution and swift renal clearance) Phenazopyridine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.
Active Ingredient Strength Primary Clinical Function Phenazopyridine HCl USP/Ph.Eur. 100 mg OTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief. Phenazopyridine HCl USP/Ph.Eur. 200 mg Prescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax Coating Diluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).
Pheniramine Maleate Tablets
FreePheniramine Maleate Tablets IP 25 mg
Each Uncoated Tablet Contains :
Pheniramine Maleate IP 25 mgPhenobarbital Tablets
FreePhenobarbitone Tablets IP
Each Uncoated tablet contains :
Phenobarbitone IP 30 mg
Excipients q.sPhenobarbitone Tablets IP 60 mg
Phenobarbital Tablets IP 60 mg
Each Uncoated tablet contains :
Phenobarbitone IP 60 mg
Phenobarbital
Excipients q.sPhenobarbital Tablets BP
Each Uncoated tablet contains :
Phenobarbital BP 30 mgPhenobarbital Tablets BP 60 mg
Each Uncoated tablet contains :
Phenobarbital BP 60 mg Excipients q.sPHENOBARBITAL TABLETS BP 90 MG Each Uncoated tablet contains : Phenobarbital BP 90 mg
Excioients 0 QSPhenobarbital Tablets BP 100 mg
Each Uncoated tablet contains :
Phenobarbital BP 100 mg Excipients -QSUsage: – To control seizures
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Phenytoin Tablets
FreePhenytoin Sodium tablets IP
Each Sugarcoated tablet contains :
Phenytoin Sodium IP 100 mgPhenytoin Sodium Tablets IP 100 mg
Each Filmcoated Tablets Contains:
Phenytoin Sodium IP 100 mgPhenytoin Tablets BP
Each Sugar Coated tablet contains :
Phenytoin Sodium 25 mgPhenytoin Sodium Tablets BP
Each Sugar Coated tablet contains :
Phenytoin Sodium BP 100 mgUsage: – Treat epilepsy
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Anticonvulsant, Antiepileptic
Phytomenadione Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Opaque Coated Tablet, packed exclusively in highly secure, moisture-resistant, and entirely light-blocking Alu-Alu or Opaque PVC/PVDC blister strips to ensure the absolute chemical stability of the photosensitive vitamin.
Active Ingredient Strength Primary Clinical Function Phytomenadione (Vitamin K1) BP/USP 10 mg Global Clinical Standard: Base therapeutic unit for the predictable reduction of elevated INR and treatment of hypoprothrombinemia. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Colloidal Silicon Dioxide / Magnesium Stearate / Titanium Dioxide Diluent / Binder / Glidant / Lubricant / Heavy Opaque Film-Coating (Engineered specifically to form an impenetrable barrier against ultraviolet and visible light degradation) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-turnover pharmacy dispensing and cardiology ward stockpiles).
Pioglitazone Tablets
FreePioglitazone Tablets IP 15 mg
Each Uncoated tablet contains :
Pioglitazone Hydrochloride IP
Eq. To Pioglitazone 15 mgPioglitazone Tablets IP 30 mg
Each Uncoated tablet contains :
Pioglitazone Hydrochloride IP
Eq. To Pioglitazone 30 mgPioglitazone With Metformin Tablet
Each Film Coated Tablet contains :
Pioglitazone Hydrochloride IP
Eq. to Pioglitazone 15 mg
Metformin Hydrochloride IP 500 mgUsage: – Type 2 diabetes mellitus
Category: – Anti Diabetic drugs
Therapeutic category: – Anti Diabetic
Piracetam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-gauge PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic API.
Active Ingredient Strength Primary Clinical Function Piracetam Ph.Eur./USP 400 mg Initiation / Pediatric Standard: Base unit for pediatric dyslexia and mild vertigo management. Piracetam Ph.Eur./USP 800 mg Global Cognitive Standard: Standard adult maintenance dose for age-related cognitive decline and memory impairment. Piracetam Ph.Eur./USP 1200 mg Acute Neurology Standard: Massive-dose unit designed specifically for Cortical Myoclonus and intensive post-stroke rehabilitation protocols to minimize pill burden. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol (PEG) / Colloidal Silicon Dioxide / Magnesium Stearate High-Density Diluent / Superdisintegrant / Premium Film-Coating (Engineered specifically to compress the massive API load into a smooth, swallowable, moisture-resistant oblong tablet) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic neurology dispensing where patients may consume 2.4g to 4.8g daily).
Piroxicam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet or Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly insoluble active ingredient.
Active Ingredient Strength Primary Clinical Function Piroxicam USP/Ph.Eur. 10 mg Initiation / Elderly Standard: Reduced dose for elderly patients or those with mild renal impairment to mitigate gastrointestinal risks. Piroxicam USP/Ph.Eur. 20 mg Global Clinical Standard: Maximum adult daily dose for the once-daily, continuous suppression of severe rheumatoid and osteoarthritis. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically with high-grade surfactants to force the rapid gastric dissolution of the highly water-insoluble Piroxicam API) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic rheumatology and orthopedic dispensing regimens).
Pramipexole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly light-sensitive dihydrochloride monohydrate salt.
Active Ingredient Strength Primary Clinical Function Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP 0.125 mg Micro-Dose Standard: Mandatory initiation unit to prevent orthostatic shock, and the gold-standard maintenance dose for RLS. Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP 0.25 mg / 0.5 mg Titration Standard: Mid-level doses for the gradual, safe escalation of Parkinson’s therapy. Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP 1 mg Advanced PD Standard: High-dose maintenance therapy for severe, refractory Parkinson’s Disease. Excipients Mannitol / Maize Starch / Povidone K25 / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered for immediate gastric dissolution and rapid, highly predictable systemic absorption) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance chronic neurology dispensing and complex titration regimens).
Prasugrel Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips containing dedicated desiccants to ensure the absolute chemical stability of the highly volatile thienopyridine molecule.
Active Ingredient Strength Primary Clinical Function Prasugrel HCl INN/Ph.Eur. 5 mg Dose-Adjusted Standard: Maintenance dose strictly for vulnerable patients weighing < 60 kg or aged ≥ 75 years to minimize fatal bleeding risk. Prasugrel HCl INN/Ph.Eur. 10 mg Global Clinical Standard: Standard adult maintenance dose following a 60 mg acute loading dose in the Cath Lab. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Hypromellose / Triacetin Diluent / Superdisintegrant / Moisture-Barrier Film-Coating (Engineered specifically to prevent hydrolytic degradation and ensure ultra-fast gastric release) *Pack Sizes: 10×10 Alu-Alu Blisters or 28/30-Tablet Calendar Blisters (Optimized specifically for strict 12-month post-PCI dual-antiplatelet dispensing regimens).
Praziquantel Tablets
FreePraziquantel Tablets USP 600 mg
Each Film Coated Tablet Contains:
Praziquantel USP 600 mgUsage: – Treat infections of certain parasites
Category: – Anthelmintic drugs
Therapeutic category: – Anthelmintic, Antiprotozoal, Antiparasitic
Prazosin Tablets
FreePrazosin Tablets IP 2 mg
Each filmcoated tablet contains:
Prazosin Hydrochloride IP
Eq to Prazosin 2 mgPRAZOSIN TABLETS IP 2.5 MG Each film coated Tablet Contains:
Prazosin hydrochloride IP equivalent to prazosin 2.5 mg Excipients q.s.PRAZOSIN TABLETS IP 5 MG Each film coated Tablet Contains:
Prazosin hydrochloride IP equivalent to prazosin 5 mg Excipients q.s.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Prednisolone Tablets
FreePrednisolone Tablets IP 5 mg
Each uncoated tablet contains:
Prednisolone IP 5 mgPrednisolone Tablets IP 10 mg
Each uncoated tablet contains:
Prednisolone IP 10 mgPrednisolone Tablets IP 20 mg
Each uncoated tablet contains:
Prednisolone IP 20 mg
Excipients q.sPrednisolone Tablets IP 10 mg
Each uncoated tablet contains:
Prednisolone IP 10 mgPregabalin & Methylcobalamin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly light-sensitive B12 coenzyme and the SR polymer network.
Active Ingredient Strength Primary Clinical Function Pregabalin INN/Ph.Eur. 75 mg (Sustained-Release) 24-hour controlled suppression of neuropathic pain and hyperalgesia. Methylcobalamin (Mecobalamin) JP/USP 1500 mcg Global Clinical Standard: High-dose active B12 for the anatomical regeneration of the myelin sheath. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Colloidal Silicon Dioxide / Titanium Dioxide / Magnesium Stearate Hydrophilic SR Polymer Matrix / Diluent / Glidant / UV-Blocking Film-Coating (Engineered to control the exact 24-hour diffusion rate while shielding the API from light degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic diabetology and neurology dispensing regimens).
Pregabalin & Nortriptyline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure absolute chemical stability and to mask the extremely bitter taste of the TCA component.
Active Ingredient Strength Primary Clinical Function Pregabalin INN/Ph.Eur. 50 mg / 75 mg Calcium channel neuromodulation for the direct suppression of hyperactive nerve firing. Nortriptyline Hydrochloride BP/USP 10 mg (Base Equivalent) Global Clinical Standard: SNRI/TCA action to amplify the brain’s natural descending pain-inhibiting pathways. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Film-Coating (Engineered specifically to ensure immediate, synchronized gastric dissolution while completely masking the bitter taste of Nortriptyline) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic neurology dispensing regimens).
Pregabalin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Capsule or Extended-Release Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active amino acid derivative and prevent illicit tampering.
Active Ingredient Strength Primary Clinical Function Pregabalin INN/Ph.Eur. 75 mg Initiation Standard: Base titration unit to safely acclimatize the brain and minimize initial dizziness. Pregabalin INN/Ph.Eur. 150 mg / 300 mg Global Clinical Standard: Advanced maintenance doses for severe diabetic neuropathy, fibromyalgia, and refractory epilepsy. Excipients (Capsules) Pregelatinized Starch / Talc / Hard Gelatin Shell Diluent / Glidant / Capsule Matrix (Engineered for immediate gastric dissolution and rapid systemic onset within 1 hour) *Pack Sizes: 10×10 Alu-Alu Blisters or 14-Capsule Titration Packs (Optimized specifically for strict chronic pain dispensing regimens and controlled-substance tracking).
Primaquine Tablets
FreePrimaquine Phosphate Tablets IP 2.5 mg
Each Sugar Coated Tablet contains :
Primaquine Phosphate IP
Eq. To Primaquine 2.5 mgPrimaquine Phosphate tablets IP 2.5 mg
EACH FILM COATED TABLET CONTAINS:
Primaquine phosphate IP Equivalent to primaquine 2.5 mg
Primaquine Phosphate Tablets IP 7.5 mg
Each Sugar Coated Tablet contains :
Primaquine Phosphate IP
Eq. To Primaquine 7.5 mgPrimaquine Phosphate tablets IP 7.5 mg
EACH FILM COATED TABLET CONTAINS:
Primaquine phosphate IP , Equivalent to primaquine 7.5 mg
PRIMAQUINE PHOSPHATE TABLETS IP 15 MG
Each film coated Tablet Contains:
Primaquine Phosphate IP equivalent to primaquine 15 mgExcipients q.s.
Primaquine Phosphate Tablets 2.5 mg
Each Sugar coated Tablet contains:
Primaquine Phosphate BP
Eq. To Primaquine 2.5 mg
Excipients q.sPRIMAQUINE TABLETS 7.5 MG
Each film coated tablet contains:
Primaquine Phosphate BP – eq. to primaquine BP 7.5 mg
– Redoxide of iron –
– Excipients – QSUsage: – Treat or prevent malaria
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
Prochlorperazine Tablets
FreeProchlorperazine Maleate Tablets IP 5 mg
Each Uncoated Tablet contains :
Prochlorperazine Maleate IP 5 mgUsage: – control severe nausea and vomiting
Category: – Antipsychotic / CNS Drugs
Therapeutic category: – Antipsychotic
Procyclidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Procyclidine HCl BP/Ph.Eur. 5 mg Global Clinical Standard: Base therapeutic unit for the rapid reversal of EPS and parkinsonian rigidity. Excipients Lactose Monohydrate / Sodium Starch Glycolate / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder / Lubricant (Engineered for rapid gastric dissolution and ultra-fast crossing of the blood-brain barrier) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-volume daily dispensing in acute psychiatric and neurology wards).
Progesterone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the micronized bio-identical hormone.
Active Ingredient Strength Primary Clinical Function Progesterone (Micronized) Ph.Eur./USP 200 mg (SR) HRT & Amenorrhea Standard: Base dose for secondary amenorrhea and endometrial protection during estrogen HRT. Progesterone (Micronized) Ph.Eur./USP 300 mg / 400 mg (SR) IVF & Obstetrics Standard: High-dose maintenance for Luteal Phase Support in ART/IVF and prevention of preterm birth. Excipients Hypromellose (HPMC) / Sodium Lauryl Sulfate / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Wetting Agent / Diluent (Engineered specifically to maximize the dissolution of the highly insoluble micronized steroid and control its 24-hour release) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance obstetric protocols and IVF cycles).
